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ABSTRACT

Ligand and Metal Effects on the CO-Release Reactivity of Metal Acireductone and
Flavonolate Complexes
by

Katarzyna Grubel, Doctor of Philosophy
Utah State University, 2011

Major Professor: Dr. Lisa M. Berreau
Department: Chemistry and Biochemistry

The research reported herein involves synthetic metal complexes of relevance to
dioxygenase enzymes (Ni(II)-containing acireductone dioxygenase (Ni(II)-ARD) and
quercentinase (2,4-flavonol dioxygenase) that promote oxidative carbon-carbon bond
cleavage and CO release. The experiments focus on the elucidation of structure-reactivity
relationships and evaluation of the conditions under which CO is generated.
It had been proposed that hydrogen bond donors in the secondary environment of
the active site metal center in Ni(II)-ARD influence the coordination of the acireductone
substrate on the nickel center. To evaluate this proposal, we investigated the Ni(II)
coordination chemistry of an acireductone-type enolate anion using a supporting chelate
ligand having two internal hydrogen bond-donors. The resulting complex exhibited
differences in terms of the organic product distribution in a CO release reaction resulting
from oxidative C-C bond cleavage of the enolate ligand relative to this reported for the
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hydrophobic, 6-Ph2TPA-supported (6-Ph2TPA = N,N-bis((6-phenyl-2-pyridyl)methyl)N-((2-pyridyl)methyl)amine) analogue.
In another study, we found that changes in the supporting chelate ligand or metal
center influenced the coordination chemistry of the acireductone-type enolate anion. This
chemistry highlighted the propensity of the enolate to undergo isomerization without CO
release in the presence of water. Rigorously excluding water enabled the isolation of a
Ni(II) enolate complex of the 6-PhTPA ligand and examination of its oxidative CO
release chemistry, as well as the spectroscopic characterization of the first Co(II)
complex of an acireductone-type enolate.
To elucidate factors influencing the CO-release reactivity of metal-flavonoid
complexes, some of which have relevance to quercentinase enzymes, we synthesized and
characterized the first series of structurally-related metal-flavonolate complexes [(6Ph2TPA)M(3-Hfl)]X (M = Mn(II), Co(II), Ni(II), Cu(II), Zn(II), Cd(II), Hg(II); X = OTfor ClO4-). Exposure of these complexes to UV light initiated photooxidative carboncarbon bond cleavage and CO release in a metal-dependent manner, with closed-shell d10
metals giving rise to the highest rate of CO release. These studies suggest that metal
flavonolate species may be useful as a new type of photo-induced CO release molecules
(CORMs). Such species are of current interest for possible therapeutic applications.

(217 pages)
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CHAPTER 1
CO RELEASE IN BIOLOGICAL AND SYNTHETIC SYSTEMS

Physicochemical Properties of Carbon Monoxide
Carbon monoxide (CO) is an air-stable, diatomic molecule with molar mass 28.01
g/mol and density 1.145 g/cm3 at 298 K and 1 atm.1 The molecule has ten valence
electrons and, since all of them are paired-up, a singlet ground state. It contains a triple
bond with length of 1.128 Å and dissociation energy 1077 kJ/mol at 298 K1,2, which
makes it one of the strongest bonds known. The bond is slightly polarized (0.122 D),3
allowing carbon monoxide to be used as a ligand toward metal centers where it acts as
both σ-donor and π-acceptor. Selected properties of CO are presented in Table 1-1.

Table 1-1. Selected Physicochemical Properties of
Carbon Monoxide.1
Property

Value

Molecular Weight

28.01 g/mol

Boiling Point

-191.6 °C

Melting Point

-205.0 °C

Autoignition Point

606.0 °C

Density

1.250 g/L at 0 °C, 1 atm
1.145 g/L at 25 °C, 1 atm
0.968 (air = 1)

Density (Vapor)
Solubility in H2O

Flammable Limits in Air

3.54 ml/100 ml at 0 °C, 1 atm
2.14 ml/100 ml at 25 °C, 1 atm
1.83 ml/100 ml 37 °C, 1 atm
12-75 vol. %
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A Brief History of Carbon Monoxide
Carbon monoxide (CO) is proposed to be one of the most important components
of the primordial soup and therefore contributed to the evolution of life4 and the Universe
in general.4e However, due to its colorless and odorless nature, as well as a strong
association with blood components, for millennia carbon monoxide was regarded as a
poison and a silent killer.5-10 The oldest reference to its lethal nature can be found in the
works of Aristotle (384-322 B. C.), where he described how the inhalation of coal fumes,
in which carbon monoxide is the main component, led to poisoning and death.5 Also, a
case study by Lascaratos and Marcetos showed that in 363 and 364 A.D. two Byzantine
emperors, Julian the Apostate and his successor Jovian, were poisoned by inhalation of
coal fumes.6 Throughout the ages, carbon monoxide, even though its mode of action was
not known, was recognized as a harmful and deadly agent. However, it was not until 1794
in the General Prussian State Laws that the first rules for proper protection against the
coal fumes were passed.5
The first preparation of pure CO gas is attributed to de Lassone, who
accomplished it in 1776.5,7 Over the next few years, the properties and structure of CO
were established and described. In the mid 19th century, some aspects of the action of
carbon monoxide on the human body were elucidated first by Bernard, and then by
Hoppe-Seyler.5 The 20th century brought about the introduction of illuminating gas (a
mixture of combustible gases, mainly methane and hydrogen with smaller amounts of
carbon monoxide, propane, butane, acetylene, ethylene, or natural gas) for industrial and
domestic purposes, and led to an increased risk of CO poisoning, but also to a better
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understanding of carbon monoxide toxicity.5 In 1895, Haldane described how the binding
of carbon monoxide to hemoglobin8a decreased its capacity for transporting oxygen.8b,c
Additionally, it had been known since 1868 that CO poisoning could be alleviated by
inhalation of oxygen under atmospheric pressure.5 Therefore, in 1960 a Hyperbaric
Oxygenation (HBO) therapy for CO-poisoned patients was introduced.9 Even though
more recently there have been questions raised about this treatment,10 to date, the HBO
procedure remains the most effective treatment for the carbon monoxide poisoning.11
Considering the acute toxicity of carbon monoxide, it may come as a surprise that
this molecule is produced endogenously in humans. The first mention of the presence of
CO in human blood dates back to Nicloux’s report from 1898.5 Nearly a century later, in
1991, Marks postulated that carbon monoxide is not only a poison and a waste product of
heme degradation, but may actually possess a physiological role.12 Almost a decade later,
it was shown that CO exhibits powerful cytoprotective,13a anti-inflammatory,13b and
antiapoptotic13c properties. However, even before those beneficial effects of CO were
experimentally demonstrated, in the early 1990’s it was proposed that CO could be a
neural transmitter and regulate cyclic guanylyl monophosphate (cGMP) in a way similar
to that of nitric oxide (NO).14 Another significant discovery was made in 2001 when it
was shown that the administration of exogenous carbon monoxide (1% vol. in air)
repressed heart graft rejection in a mouse-to-rat transplant.15 These interesting findings
opened up a completely new field and prompted scientists to investigate both natural and
synthetic systems as possible therapeutic agents for CO release. Specific approaches
currently under investigation toward delivering CO include: (i) inhalation of CO gas, (ii)
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up- or down-regulation of the CO-producing enzymes responsible for heme catabolism,
and (iii) application of synthetic CO-releasing molecules.16
Enzymatic Carbon Monoxide Release
In nature, carbon monoxide release from an organic molecule is catalyzed by three
types of enzymes: heme oxygenases (HOs) in humans, and acireductone dioxygenase
(ARD) and 2,4-quercetin dioxygenase (quercetinase) in bacteria and fungi.
Endogenous CO Production by Heme Oxygenase
Although in the human body small amounts of CO may be produced as a byproduct of the cytochrome P-450 cycle and lipid peroxidation, the main source of
endogenous CO production comes from heme degradation catalyzed by heme oxygenase
enzymes (Scheme 1-1).5,7,12-25 Heme oxygenases (HOs) are found in three isoforms: (i)
inducible HO-1 expressed in response to cellular stress, (ii) HO-2, which is controlled by
post-translational modifications, and (iii) a recently discovered HO-3 of yet unknown
purpose.17 The mechanism of the degradation of heme involves three consecutive steps
(Scheme 1-1): (i) hydroxylation of an α-carbon of the porphyrin, (ii) conversion of the
Fe(III)-α-meso-heme produced in the first step into Fe(II)-verdoheme and CO, and (iii)
cleavage of the Fe(II)-verdoheme ring and formation of biliverdin and free Fe(II)
ion.16b,c,18 Heme degradation catalyzed by HOs was discovered in 1968 by Tenhunen and
Schmidt.19 Since then, it has been shown that the production of carbon monoxide from
heme degradation might be influenced by many factors, including multiple hematological
diseases such as, but not restricted to, anemia, sickle cell disease, and cystic fibrosis. In a
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Scheme 1-1.

healthy individual, the rate of CO production oscillates around 18.8 µmol/h and its
average concentration in tissues is in the nanomolar range.20 During heme degradation,
HOs produce one equivalent of carbon monoxide per each heme molecule. The main site
of CO production is the liver, where the majority of heme catabolism takes place.20,21
CO Release Catalyzed by Acireductone Dioxygenase
Acireductone dioxygenase (ARD) is a member of the cupin superfamily of
proteins and is found at the only branch point in the methionine salvage pathway in
bacteria (Scheme 1-2). To our knowledge, it is the only enzyme known wherein the nature
of the products formed depends exclusively on the identity of the metal ion present in the
active site.22-25 The Fe(II)-containing form catalyzes the on-pathway reaction converting
the 1,2-dihydroxy-3-oxo-5-(methylthio)pent-1-ene (acireductone) to 4-methylthio-2-
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Scheme 1-2.

ketobutyrate and formic acid (Scheme 1-2). It should be noted that this is the same
reaction that occurs in the absence of the ARD enzyme.26 The Ni(II)-containing ARD
enzyme catalyzes an off-pathway reaction, yielding CO, formic acid, and 3(methylthio)propionic acid (Scheme 1-2).22-26 Thus, the nature of the metal center is
important to inducing carbon monoxide release in this system. The difference in the
reactivity of the enzymes is proposed to stem from different coordination modes of the
substrate to the metal center (Figure 1-1), resulting in the activation of different C-C
bonds for oxidative cleavage reactions.22,24 Interestingly, in 1999 Dai et al. demonstrated
that the substitution of a Ni(II) by Co(II) in the active site of the ARD also results in an
enzyme that catalyzes the CO-producing reaction.25 In terms of the influence of active site
residues, it has been proposed that the presence of a hydrogen-bonding arginine residue(s)
in the secondary environment helps to position and stabilize the metal-bound enediolate
in the active site of Ni(II)-ARD.24
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Figure 1-1. Proposed ES adducts in the reactions catalyzed by acireductone dioxygenase.

CO Release Catalyzed by 2,4-Quercetin Dioxygenase
Quercetin is a flavonol which is widely distributed in plants. Because it exhibits
antibacterial27 and antifungal28 properties, both bacteria and fungi have developed a
defense mechanism in the form of an enzyme, quercetin dioxygenase, which breaks down
this molecule. Degradation of quercetin to a 2-protocatechuoylphloroglucinol carboxylic
acid molecule (O-benzoylsalicylic acid, depside) was described as early as in 1958.29 Two
years later, CO release during the same reaction was reported.30
Quercetin dioxygenase catalyzes the oxidative cleavage of a C=C bond (Scheme
1-3).31 Like the ARD enzyme, 2,4-quercetin dioxygenase belongs to the cupin
superfamily of proteins.32 In 1971, it was shown that the fungal quercetinase contains a
mononuclear Cu(II) in its active site.33 The enzyme produced by bacteria, e.g. Bacillus
subtilis and Streptomyces sp. FLA, is instead able to incorporate several different divalent
metals while retaining at least partial activity.34,35 The most active forms of the
quercetinase enzyme were obtained during the reconstitution of the apo form of the
enzyme from the Streptomyces sp. FLA with Ni(II) or Co(II).35 However, it is not known
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Scheme 1-3.

how the different metal ions influence the enzymatic CO production in this system and/or
whether changes in the metal center influence the chemistry other than fine tuning of the
redox potential of the enzymatic active site.
Carbon Monoxide Release in Synthetic Systems
Carbon Monoxide-Releasing Molecules (CORMs)
In his initial paper from 2002, Motterlini laid the groundwork for the development
of a new class of pharmaceuticals: carbon monoxide-releasing molecules (CORMs).36
Since this report, the field has been developing rapidly and in as little as nine years many
patents involving CORMs have been filed.16a So far, they mainly involve metal-carbonyl
species (Figure 1-2),37 although some organic CORMs such as borates,37c aldehydes,
esters, imines, etc.16a have also been proposed. Interestingly, in 2002, a patent describing
CO release from methylene chloride was filed.16a Nonetheless, none of those molecules
offers the much-needed control over the CO dosage supplied to a desired target, as
majority of CORMs release CO immediately upon dissolution.37j Additionally, the metalcontaining CORMs reported to date contain heavy metals. Moreover, the definite amount
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Figure 1-2. Examples of known CO-releasing molecules.

of CO gas released from those systems cannot be accurately controlled. For example,
even though the most widely used CORM-3 ([RuCl(gly)(CO)3]) releases precisely one
CO molecule in 37 °C in water, its half life in human plasma is only 3.6 minutes, making
CO delivery very unspecific.37b The majority of currently known CORMs suffer from
similar setbacks.37j

10
A promising way to control carbon monoxide release is sensitization of CORMs
toward light. It is known that photodynamic therapy allows for precise control over
location, dosage, and timing of the therapeutical agent.38 In this regard, several photoactivated CORMs have been reported.37f,g,i,38 Such compounds are stable in the dark and
release CO upon irradiation with light. A challenge in the development of new
photoswitchable CORMs is the adjustment of the irradiation wavelength toward longer
values (far visible and near IR wavelengths; > 600 nm).39
Most recently, new ways of controlled CO release and delivery from CORMs,
such as CO-releasing micelles40 and enzyme-triggered CORMs (ET-CORM), have been
proposed.41 These new systems are designed to avoid the inherent toxicity of heavy metals
as well as the use of high frequency irradiation.
CO Release in Model Systems of Ni(II)-Containing
Acireductone Dioxygenase
The first synthetic model of the active site of Ni(II)-containing ARD was reported
in 2005 by the Berreau group.42a A mononuclear Ni(II)-enolate complex supported by a
hydrophobic 6-Ph2TPA ligand was synthesized and isolated (1, Scheme 1-4). Because no
procedure for synthesis of the natural substrate was known, a model (Figure 1-3) of the
native substrate was used. This compound is not a substrate for the acireductone
dioxygenase enzyme due to the presence of a phenyl substituent on the C(1) carbon.
Complex 1 was shown to undergo an O2-dependent aliphatic C-C bond cleavage of the
enolate to yield either a monobenzoate complex (2, Scheme 1-4), or a dibenzoate complex
(3, Scheme 1-4), depending on the protonation level of the metal-bound acireductone.42,43
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Scheme 1-4.

In both cases it was noted that during the reaction the organic by-product benzil was being
formed along with CO. To elucidate the possible pathways leading to formation of
observed products, mechanistic studies were undertaken. As a result of these
investigations, it was concluded that the oxidative C-C bond cleavage using the phenylcontaining model acireductone proceeds through diphenyl triketone and hydroperoxide as
intermediates. Additionally, DFT calculations showed that the monoanionic form of
acireductone analogue is predisposed to extrude CO during the oxidative C-C bond

Figure 1-3. Relevant acireductones.
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cleavage (Scheme 1-5). This predisposition is a direct result of a presence of the phenyl
substituent on carbon C(1) of the acireductone.42b

Scheme 1-5. Proposed oxidation of model acireductone starting from 1. For clarity, the
supporting 6-Ph2TPA ligand has been truncated.

As mentioned in the description of the enzymatic CO release in the Ni(II)-ARD
system, the secondary environment of the active site in the ARD enzyme contains at least
one arginine residue.24 It was proposed that this amino acid may play a crucial role in
stabilizing the doubly deprotonated substrate on the metal center through the formation of
hydrogen bonds.22,24

To evaluate this possibility, a new ligand, 6-NA-6-Ph2TPA,

containing one hydrogen bond donor arm was synthesized and used to investigate how
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secondary hydrogen bonds influence the coordination of an acireductone-type ligand.
Using the 6-NA-6-Ph2TPA ligand, a trinuclear Ni(II) enediolate complex was isolated and
characterized (4, Figure 1-4).44 Notably, the acireductone analog exhibits a different
coordination mode in this complex, forming two five-membered rings that bridge two
Ni(II) centers. Complex 4 undergoes reaction with O2 to generate two equivalents of a
Ni(II) benzoate complex, CO, benzyl, and a Ni benzoate salt (Scheme 1-6). It is
noteworthy that
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O labeling experiments involving either 1 in the presence of one

equivalent of base (Scheme 1-4 (top)) or 4 (Scheme 1-6) resulted in identical
incorporation of labeled oxygen into the benzoate complexes (86% via inspection by mass
spectrometry).44 This result is not surprising since it was implied that a putative, dianionic
species was formed in the pathway shown across the top of Scheme 1-4.43 In 2010 the
isolation, characterization, and reactivity of this proposed intermediate was further
investigated.45 It was shown that the treatment of 1 with one equivalent of base results in
displacement of the supporting ligand 6-Ph2TPA and formation of the hexanickel cluster
(5, Figure 1-5) with λmax = ~420 nm (Scheme 1-4). Because isolation of the bulk material
from the reaction mixture proved impossible, an alternative synthetic route for obtaining
the cluster was employed. This independently synthesized species was then exposed to O2
in the presence of 1/6 equivalent of 6-Ph2TPA, yielding a product distribution identical
with the oxidation reaction starting from 1 and one equivalent of base (Scheme 1-4 (top)).
Additionally, 18O labeling studies of the oxidation reaction starting from 5 resulted in the
level of isotope incorporation (83%-86%), which matched well with the reaction starting
from 1 in presence of one equivalent of base (86%).
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Figure 1-4. 6-NA-6-Ph2TPA ligand (left) and core of 4 in which the supporting ligand
has been truncated (right).

Scheme 1-6.

Figure 1-5. ORTEP representations of 5. View from the top (left), one layer of the cluster
(center), and side view with truncated acireductone ligand (right).
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As outlined above, introduction of one hydrogen bond donating arm to the
supporting ligand enabled stabilization of an enediolate species in a multinuclear
structure.43 Hypothesizing that the introduction of multiple hydrogen-bonding appendages
to the chelate ligand might enable stabilization of a mononuclear species with doubly
deprotonated model acireductone, such studies were initiated and their results are offered
in Chapter 2.
To further elucidate factors influencing the formation of the acireductone-type
enolate complexes, additional studies involving changes in the metal center, Ni(II) to
Co(II), and supporting chelate ligand, 6-Ph2TPA to 6-PhTPA, were performed. The
outcome of these investigations provided better insight into the challenges encountered in
acireductone coordination chemistry. This issue is further discussed in Chapter 3.
CO Release in Model Systems of 2,4-Quercetin Dioxygenase
Initial models of the quercetinase enzymes were reported in 1979 and involved
simple, base catalyzed oxygenation of quercetin or other flavonols.46 However, the first
structure of a metal-containing complex to mimic the enzyme active site was reported
more than a decade later in 1990.47 Since at that time only the copper-containing fungal
quercetinase was known, the complexes contained exclusively Cu(I) or Cu(II) as the
metal ion. These complexes involved homoleptic flavonolate coordination,48 or copper
centers supported by a monodentate phosphine ligand.47 However, there have now been at
least 11 different ligands (see examples in Figure 1-6) and over eight quercetin analogues
used for this purpose.49b Multiple Cu-flavonolate species have been prepared and shown
to release CO in DMF when heated.49

16

Figure 1-6. Examples of supporting ligands used in model studies of 2,4-quercetin
dioxygenase.

Although a cobalt complex-promoted oxidation of quercetin was reported as early
as 1974,50 the first cobalt(III)-coordinated flavonolate structure was solved in 1992.51
Further studies of metal-flavonolate complexes provided structures of Fe(III)-,51
Mn(II)-,52b Ni(II)-,53 and Zn(II)-containing54 compounds. Nonetheless, despite a growing
structural database for metal flavonolate complexes, each complex contained a different
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supporting ligand and/or a different oxidation state of the metal ion. As a result, it was
impossible to assess the influence of the metal ion on the oxidative C-C bond cleavage of
the metal-bound flavonolate moiety. To address this deficiency, the Berreau group has
developed the very first series of a model 3-hydroxyflavonolate anion coordinated on
divalent metal centers supported by the same, hydrophobic 6-Ph2TPA ligand. This
allowed for direct comparison of the influence of the metal ion on both the coordination
mode and spectroscopic features of the metal-bound flavonolate. This comparison is
further discussed in Chapter 4. Having synthesized and characterized the aforementioned
family of flavonolate complexes, we were positioned to investigate the O2-dependent
reactivity and CO release reactivity of these complexes under various conditions. Results
of these investigations are further explored in Chapters 5 and 6.
Conclusions
Carbon monoxide is a small molecule with increasing significance to human health.
Because of its growing importance, it is imperative to understand the factors controlling
its release in enzymatic systems, as well as its release from synthetic complexes. In the
Berreau group, we are interested in elucidating factors influencing CO release in synthetic
systems of relevance to CO producing enzymes. In the subsequent chapters of this
dissertation the influence of both chelate ligand and metal ion on CO production in
synthetic systems of relevance to acireductone dioxygenase and 2,4-flavonol dioxygenase
is presented.
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CHAPTER 2
O2-DEPENDENT ALIPHATIC CARBON-CARBON BOND CLEAVAGE
REACTIVITY IN A Ni(II) ENOLATE COMPLEX HAVING A HYDROGEN BOND
DONOR MICROENVIRONMENT; COMPARISON WITH A HYDROPHOBIC
ANALOG1
Abstract
A mononuclear Ni(II) complex having an acireductone type ligand, and supported by the
bnpapa
ligand,

(N,N-bis((6-neopentylamino-2-pyridyl)methyl-N-((2-pyridyl)methyl)amine
[(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4

(14),

has

been

prepared

and

characterized by elemental analysis, 1H NMR, FTIR, and UV-vis. To gain insight into the
1

H

NMR

features

of

14,

the

air

stable

analog

complexes

[(bnpapa)Ni(CH3C(O)CHC(O)CH3)]ClO4 (16) and [(bnpapa)Ni(ONHC(O)CH3)]ClO4
(17) were prepared and characterized by X-ray crystallography, 1H NMR, FTIR, UV-vis,
mass spectrometry, and solution conductivity measurements. Compounds 16 and 17 are
1:1 electrolyte species in CH3CN. 1H and 2H NMR studies of 14, 16, and 17 and
deuterated analogs revealed that the complexes having six-membered chelate rings for the
exogenous ligand (14 and 16) do not have a plane of symmetry within the solvated cation

1

Coauthored by Katarzyna Grubel, Amy L. Fuller, Bonnie M. Chambers, Atta M. Arif,
and Lisa M. Berreau. Reproduced with permission from Inorganic Chemistry 2010, 49,
1071-1081. Copyright 2010 American Chemical Society.
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and thus exhibit more complicated 1H NMR spectra. Compound 17, as well as other
simple Ni(II) complexes of the bnpapa ligand (e.g. [(bnpapa)Ni(ClO4)(CH3CN)]ClO4 (18)
and [(bnpapaNi)2(µ-Cl)2](ClO4)2 (19)), exhibit 1H NMR spectra consistent with the
presence

of

a

plane

of

symmetry

within

the

cation.

Treatment

of

[(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14) with O2 results in aliphatic carbon-carbon
bond

cleavage

within

the

acireductone-type

ligand

and

the

formation

of

[(bnpapa)Ni(O2CPh)]ClO4 (9), benzoic acid, benzil, and CO. Use of 18O2 in the reaction
gives high levels of incorporation (>80%) of one labeled oxygen atom into 9 and benzoic
acid. The product mixture and level of 18O incorporation in this reaction is different than
that exhibited by the analog supported the hydrophobic 6-Ph2TPA ligand, [(6Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (2). We propose that this difference is due to
variations in the reactivity of bnpapa- and 6-Ph2TPA-ligated Ni(II) complexes with
triketone and/or peroxide species produced in the reaction pathway.
Introduction
Interest in how the secondary environment of a metal center influences the reactivity of
metal-bound ligands stems from the possible roles of secondary interactions in metalcatalyzed reactions in biological systems.1 In the acireductone dioxygenases Ni(II)-ARD
and Fe(II)-ARD, which contain the same protein component, it is proposed that
differences in the secondary environment surrounding the divalent metal center influence
the coordination mode of the acireductone substrate and the regioselectivity of the
oxidative carbon-carbon bond cleavage reaction.1 Specifically, in Ni(II)-ARD the
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positioning of a tryptophan side chain (W162) is suggested to promote the formation of a
six-membered chelate ring in the enzyme substrate adduct (Scheme 2-1(top)).2 Reaction
of this adduct with O2 results in oxidative cleavage of the C(1)-C(2) and C(2)-C(3) bonds
and the formation of CO and carboxylate products. For Fe(II)-ARD, a more open active
site is suggested to enable the formation of a five-membered chelate enediolate structure,
within which only C(1)-C(2) bond cleavage occurs upon reaction with O2 (Scheme 21(bottom)). For both Ni(II)-ARD and Fe(II)-ARD secondary hydrogen bonding
interactions involving an arginine residue are suggested to stabilize enolate/enediolate
coordination.

Scheme 2-1.

Interest in reactions of relevance to Ni(II)-ARD also stems from the fact that
carbon monoxide is a molecule of current interest in biological systems. In humans, CO is
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primarily produced via the oxidative breakdown of heme catalyzed by heme oxygenases.3
While carbon monoxide is typically viewed as a toxic gas, recent studies have shown that
this small molecule can have beneficial health effects. The signaling mechanism of CO is
similar to that of NO in that it activates soluble guanylyl cyclase to produce cyclic
guanylyl monophosphate (cGMP).3 This compound is involved in pathways pertinent to
smooth muscle relaxation, platelet inhibition, and cell growth and differentiation. As
these factors are related to several diseases, recent studies have focused on efforts toward
the development of CO-releasing compounds for use as therapeutic agents.4 The majority
of the chemical compounds tested so far have been transition metal carbonyl species,5
although a main group CO-releasing compound (Na2[H3BCO2]) has been recently
reported.4 We are interested in the CO release properties of acireductones and
flavonolates, both of which possess three consecutive carbon centers having an oxygen
substituent. In fungal and bacterial systems, quercetin dioxygenases catalyze CO release
from a metal-coordinated flavonolate in a 2,4-dioxygenolytic ring cleavage reaction.6-14 In
a broad sense, we are interested in understanding in detail the chemical factors that
modulate the CO-release reactivity of metal-coordinated acireductone and flavonolate
species, with a long-term goal of producing new types of CO-releasing compounds
containing these novel structural motifs.
Our laboratory has reported the only examples to date of synthetic complexes of
relevance to substrate- and product carboxylate-bound forms of Ni(II)-ARD.15-18 We
recently reported that use of a chelate ligand having a mixed hydrophobic/hydrogen bond
donor secondary environment produced the first example of a Ni(II) enediolate complex
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Figure 2-1. Supporting chelate ligands used to isolate Ni(II) enediolate (top) and enolate
(bottom) complexes of relevance to Ni(II)-ARD.

of an acireductone-type ligand (1, Figure 2-1(top)).18 Somewhat surprisingly, this
complex was originally generated under similar conditions to those used to produce the
mononuclear Ni(II) enolate complex [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (2,
Figure 2-1(bottom)). These combined results indicate that the presence of a hydrogen
bond donor in the secondary environment influences the coordination chemistry of an
acireductone-type ligand.
In terms of carboxylate chemistry, we discovered that the secondary environment
of the chelate ligand affects the coordination chemistry of Ni(II)-carboxylate species that
are generated in O2-dependent ARD-type reactions. As shown in Scheme 2-2 (top), a
Ni(II)-carboxylate ligand in a hydrophobic microenvironment undergoes a shift from
bidentate to monodentate in the presence of water (conversion of compounds 3-5 to 68).17 No evidence was found for this type of carboxylate shift chemistry in bnpapa-ligated
Ni(II) carboxylate complexes (9-11, Scheme 2-2 (bottom)). In these analogs, the
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Scheme 2-2.

hydrogen bond donor appendages interact with one oxygen atom of the bidentate
carboxylate. In a Ni(II) benzoate complex supported by a chelate ligand containing both
hydrophobic

phenyl

appendages

and

a

hydrogen

bond

donor,

[(6-NA-6-

Ph2TPA)Ni(O2CPh)(H2O)]ClO4 (12), a bidentate coordinated carboxylate ligand was also
identified.18
From our initial studies, it is clear that the ligand environment of a Ni(II) center
influences the chemistry of an acireductone-type ligand. In the studies outlined herein, we
have further evaluated the influence of the chelate ligand environment by preparing and
characterizing the enolate complex [(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14) as an
analog to the 6-Ph2TPA-supported 2 (Figure 2-1). Complex 14 has been characterized by
elemental analysis, 1H NMR, FTIR, and UV-vis. Comparative O2 reactivity studies for 2
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and 14 have been performed under conditions wherein the inorganic and organic
byproducts were identified. Interestingly, these reactions differ in the specific mixture of
products that is generated and in the level of

18

O incorporation in the benzoate/benzoic

acid products. We propose that these differences are due to variations in the reactivity of
bnpapa-

and

6-Ph2TPA

ligated

Ni(II)

complexes

with

triketone

and

peroxide/hydroperoxide species produced in the reaction pathway.
In the course of this research, as a means of gaining additional insight in the
spectroscopic and solution properties of [(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14),
we have also prepared and characterized mononuclear bnpapa-supported Ni(II)
acetoacetonato and hydroxamato complexes, as well as perchlorate and chloro
derivatives. Preparation of this family of complexes has enabled a structural comparison
with a similar family of 6-Ph2TPA-supported mononuclear Ni(II) complexes. This
comparison has provided insight into the structural factors that may be responsible for the
differences in O2 reactivity between [(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14) and
[(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (2) as noted above.
Experimental
General Methods. All reagents and solvents were obtained from commercial
sources and were used as received unless otherwise noted. Solvents were dried according
to published procedures and were distilled under N2 prior to use.19 Air sensitive reactions
were performed in the MBraun Unilab glovebox or a Vacuum Atmospheres MO-20
glovebox under a N2 atmosphere. The ligand bnpapa and the Ni(II) complex [(6-
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Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (2) were prepared according to literature
procedures.15,17
Physical Methods. 1H NMR spectra of Ni(II) complexes were obtained using a
Bruker ARX-400 spectrometer as previously described.20 Chemical shifts (in ppm) are
referenced to the residual solvent peak(s) in CHD2CN (1H, 1.94 (quintet) ppm). UV-vis
spectra were collected on a HP8453A spectrometer at ambient temperature. FTIR spectra
were recorded on a Shimadzu FTIR-8400 spectrometer as KBr pellets. Conductance
measurements were made at 22(1) °C using an YSI model 31A conductivity bridge with a
cell having a cell constant of 1.0 cm-1 and using Me4NClO4 as a 1:1 electrolyte standard.
Preparation of the acetonitrile and standard solutions for conductance measurements and
subsequent data analysis were performed as previously described.21 Mass spectrometry
data was obtained at the Mass Spectrometry Facility, Department of Chemistry,
University of California, Riverside. Elemental analyses were performed by Atlantic
Microlabs, Inc., Norcross, Georgia, or Canadian Microanalytical Service, Inc., British
Columbia.

Caution! Perchlorate salts of metal complexes with organic ligands are
potentially explosive. Only small amounts of material should be prepared, and these
should be handled with great care.22

[(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14). Under a N2 atmosphere,
equimolar amounts of bnpapa (0.273 mmol) and Ni(ClO4)2·6H2O (0.273 mmol) were

33
mixed in acetonitrile and stirred until the ligand had fully dissolved. Me4NOH⋅5H2O
(0.301 mmol) was then added to the mixture, which was stirred for additional 15 minutes,
resulting in a dark green solution. The solution was added to solid 2-hydroxy-1,3diphenylpropan-1,3-dione23 (0.301 mmol) and the mixture was stirred for 4 h, yielding a
very dark orange/red solution. The solvent was then removed under reduced pressure. The
solid was dissolved in CH2Cl2 and the solution was filtered through a celite plug. The
filtrate was concentrated and brought to dryness under vacuum, leaving a dark orange/red
solid, which was washed with Et2O and dried under vacuum. Yield: 83%. Anal. Calcd for
C43H51N6O7ClNi: C, 60.19; H, 5.99; N, 9.79. Found: C, 60.52; H, 5.88; N, 9.57. UV-vis
[CH3CN, nm (ε, M-1cm-1)] 393(10,000); FTIR: (KBr, cm-1) 3420 (br s, νNH), 1094 (νClO4),
621 (νClO4).
[(bnpapa)Ni(CH3C(O)CHC(O)CH3)]ClO4 (16). A solution of Ni(ClO4)2·6H2O
(0.15 mmol) in CH3CN (~1 mL) was added to solid bnpapa (0.15 mmol). The resulting
mixture was stirred for 20 min at room temperature. The solution was then transferred to
a vial containing Me4NOH⋅5H2O (0.15 mmol). To this mixture 2,4-pentanedione (0.15
mmol) was added and the resulting solution was stirred overnight. The solvent was then
removed under reduced pressure. The remaining solid was dissolved in CH2Cl2 (~5 mL)
and the solution was filtered through a celite/glass wool plug. Pentane diffusion into
CH2Cl2 yielded purple crystals suitable for X-ray crystallography. The crystals were
crushed and dried under vacuum prior to elemental analysis. Yield: 46%. Anal. Calcd for
C33H47ClN6NiO6: C, 55.21; H, 6.60; N, 11.71. Found: C, 55.28; H, 6.55; N, 11.70. FTIR
(KBr, cm-1) ~3300 (s, νNH), 1089 (νClO4), 622 (νClO4). UV-vis [CH3CN, nm (ε, M-1cm-1)]
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244(31600), 305(17800), 543(sh), 966(19); FAB-MS [m/z (relative intensity)]: 617 ([M –
ClO4]+, 100%).
[(bnpapa)Ni(ONHC(O)CH3)]ClO4 (17). A solution of Ni(ClO4)2·6H2O (0.11
mmol) in CH3CN (~1 mL) was added to solid bnpapa (0.11 mmol). The resulting mixture
was stirred for 5 min at the room temperature. The solution was then transferred to a vial
containing Me4NOH⋅5H2O (0.12 mmol) and acetohydroxamic acid (0.12 mmol), and the
resulting solution was stirred for 1 h. The solvent was then removed under reduced
pressure. The remaining solid was dissolved in CH2Cl2 (~5 mL) and the solution was
filtered through a celite/glass wool plug. Diffusion of diethyl ether into a
CH2Cl2/MeOH/iPrOH (1:0.5:1) solution of the compound yielded purple crystals suitable
for single crystal X-ray crystallography. These crystals were crushed and dried under
vacuum

prior

to

elemental

analysis.

Yield:

60%.

Anal.

Calcd

for

C30H44N7NiO6Cl⋅0.25AHA⋅0.35CH2Cl2: C, 51.93; H, 6.34; N, 13.12. Found: C, 51.55; H,
6.41; N, 13.63. The presence of acetohydroxamic acid (AHA) in the crystalline sample
was confirmed by X-ray crystallography. The presence of CH2Cl2 in the elemental
analysis sample was confirmed by 1H NMR. FTIR (KBr, cm-1) ~3288 (s, νNH), 1103
(νClO4), 621 (νClO4); UV-vis [CH3CN, nm (ε, M-1cm-1)] 247(25800), 325(10400), 548(sh),
977(32); ESI/APCI-MS [m/z (relative intensity)]: 592.2914 ([M – ClO4]+, 100%).
[(bnpapa)Ni(ClO4)(CH3CN)]ClO4 (18). A solution of Ni(ClO4)2·6H2O (0.07
mmol) in CH3CN (~1 mL) was added to solid bnpapa (0.07 mmol). The resulting mixture
was stirred for 20 min at room temperature. The solvent was then removed under reduced
pressure and the residue was dissolved in CH2Cl2. Pentane diffusion yielded purple
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crystals suitable for X-ray crystallography. The crystals were crushed and dried under
vacuum

prior

to

elemental

analysis.

Yield:

54%.

Anal.

Calcd

for

C30H43Cl2N7NiO8·1/2CH2Cl2: C, 45.69; H, 5.53; N, 12.23. Found: C, 45.32; H, 5.60; N,
12.09. UV-vis [CH3CN, nm (ε, M-1cm-1)] 318(10300), 553(15), 931(17); FTIR (KBr, cm1

) ~3400 (s, νNH), 1103 (νClO4), 624 (νClO4); FAB-MS [m/z (relative intensity)]: 617 ([M –

ClO4 – CH3CN]+, 100%).
[(bnpapaNi)2(µ-Cl)2](ClO4)2 (19). A solution of Ni(ClO4)2·6H2O (0.14 mmol) in
MeOH (~1 mL) was added to a solution of bnpapa (0.14 mmol) in MeOH (~1 mL). The
resulting mixture was stirred for 20 min at room temperature. The solution was then
transferred to a vial containing Me4NCl⋅5H2O (0.14 mmol) and the resulting mixture was
stirred for 1 h. The solvent was then removed under reduced pressure. The remaining
solid was dissolved in CH2Cl2 (~5 mL), and the solution was filtered through a
celite/glass wool plug. Diffusion of diethyl ether into a CH2Cl2 solution of the compound
yielded green crystals suitable for X-ray crystallography. The crystals were crushed and
dried under vacuum prior to elemental analysis. Yield: 33%. Anal. Calcd for
C28H40Cl2N6NiO4: C, 51.40; H, 6.16; N, 12.84. Found: C, 51.15; H, 6.29; N, 12.88. FTIR
(KBr, cm-1) ~3340 (s, νNH), 1095 (νClO4), 621 (νClO4); UV-vis [CH3CN, nm (ε, M-1cm-1)]
325(15900), 600(31), 1032(33); ESI/APCI-MS [m/z (relative intensity)]: 553.2348 ([M –
2ClO4]2+, 100%).
O2 Reactivity of 14: Product Isolation and 18O Labeling Studies. Complex 14
(0.101 mmol) was dissolved in 10 mL of acetonitrile and O2 was bubbled through the
solution for ~1 min. The reaction was then left stirring overnight at ambient temperature.
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Over the course of this time, the color changed from deep orange/red to pale yellow. CO
production was verified by the PdCl2 method.24 The solvent was removed under reduced
pressure and the resulting solid was dissolved in hexanes:ethyl acetate (4:1) and the
solution was passed through a silica plug. This produced a yellow filtrate containing the
organic products from the reaction. Ni(II) complexes that adhered to the silica gel were
then eluted using acetonitrile, followed by methanol. As determined by TLC, 1H NMR,
and GC-MS, the organic fraction contained primarily benzoic acid (11 mg overall yield –
91% based on production of one equivalent of free benzoic acid per enolate ligand;
sample is 88-90% benzoic acid based on 1H NMR), with a small amount of benzil
(PhC(O)C(O)Ph; 10-12%) and a trace amount of the ester PhC(O)OCH2C(O)Ph present.
The ester was identified via independent synthesis.25 This compound is an isomer of 2hydroxy-1,3-diphenylpropan-1,3-dione,23 and the reaction leading to ester formation will
be discussed in detail elsewhere. In each reaction, two Ni(II) complexes were eluted from
the

column,

[(bnpapa)Ni(O2CPh)]ClO4

(9)

and

[(bnpapa)Ni(PhC(O)C(O)CHC(O)Ph)]ClO4 (15), the latter of which was present in a very
low amount (<5%) and was identified via mass spectrometry (ESI-MS [m/z (relative
intensity)]: 769.3376 (M – ClO4)+, 100%)). The formation of 15 is related to the trace
ester formation in the reaction and will be discussed in detail elsewhere. The yield of the
metal complexes was ~88% by mass following the column (based on stoichiometric
formation of [(bnpapa)Ni(O2CPh)]ClO4 (9)). Thus, from this data, the formation of
[(bnpapa)Ni(O2CPh)]ClO4 (9) was judged as quantitative. Use of 18O2 in the reaction of
14 with O2 produces benzoic acid with 81% incorporation of one labeled oxygen atom.
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No

18

O incorporation was found in benzil or the ester PhC(O)OCH2C(O)Ph, as

determined by GC-MS. Mass spectral analysis of the metal complexes indicated 87% 18O
incorporation into one oxygen atom of the benzoate ligand of 9. No

18

O incorporation

was found in 15.
Reanalysis of O2 reactivity of [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4
(2). Compound 2 was treated with an excess of O2 in a reaction very similar to that
outlined above using 14. An identical work-up procedure was also performed. The
organic products generated were benzoic acid and benzil in a reproducible ~75:25 ratio. A
trace amount of the ester PhC(O)OCH2C(O)Ph is also generated, as determined by GCMS and 1H NMR. The total yield of organic products was ~96% based on the proposed
formation of one equivalent of free benzoic acid per enolate ligand of 2. As previously
reported, the Ni(II) complex, [(6-Ph2TPA)Ni(O2Ph)]ClO4 (3) is produced in this
reaction.16

A

trace

amount

of

the

enolate

complex

[(6-

Ph2TPA)Ni(PhC(O)C(O)CHC(O)Ph)]ClO416 is also generated. The reaction leading to
the formation this complex will be discussed in detail elsewhere. The total mass of
complexes isolated suggests a ~70% yield based on the stoichiometric formation of 3.
However, a control experiment using [(6-Ph2TPA)Ni(O2Ph)]ClO4 (3) indicated that
~30% of the material is lost in the column purification process used to isolate the metal
complexes from the reaction mixture. Thus, the formation of 3 is nearly quantitative in
the O2 reaction of 2. Use of 18O2 in the reaction produced free benzoic acid with 59% 18O
incorporation in one oxygen atom position, and the benzoate complex 3 having 64%
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incorporation in one oxygen atom. The level of isotope incorporation into 3 is slightly
higher than that previously reported (~50%) based on multiple 18O reactions.16
18

O2 reactivity of [Me4N][PhC(O)C(OH)C(O)Ph]. We have previously reported

that treatment of the salt [Me4N][PhC(O)C(OH)C(O)Ph] with O2 results in the formation
of tetramethylammonium benzoate, benzoic acid, and CO.16 We have repeated this
reaction using 18O2 and have found by mass spectrometry that the benzoate/benzoic acid
contains ~65%

18

O incorporation when generated from Me4NOH·5H2O and

PhC(O)C(OH)C(O)Ph in dry CH3CN. Pre-drying of the Me4NOH·5H2O under vacuum
for 24 h prior to use in the reaction produced a slightly higher level of 18O incorporation
(72%) in the benzoate/benzoic acid product.
X-ray Crystallography. A single crystal of each compound 16, 17⋅⋅1/4AHA
(AHA = acetohydroxamic acid), 18⋅⋅CH2Cl2, and 19⋅⋅2CH2Cl2 was mounted on a glass
fiber with traces of viscous oil and then transferred to a Nonius KappaCCD
diffractometer equipped with Mo Kα radiation (λ = 0.71073 Å) for data collection. For
unit cell determination, ten frames of data were collected at 103(1) K or 150(1) K with an
oscillation range of 1 deg/frame and an exposure time of 20 sec/frame. Final cell
constants were determined from a set of strong reflections from the actual data collection.
All reflections were indexed, integrated, and corrected for Lorentz polarization and
absorption effects using DENZO-SMN and SCALEPAC.26 The structures were solved by
a combination of direct and heavy-atom methods using SIR 97. All of the non-hydrogen
atoms were refined with anisotropic displacement coefficients. Unless otherwise stated,
all hydrogen atoms were assigned isotropic displacement coefficients U(H) = 1.2U(C) or
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1.5U(Cmethyl), and their coordinates were allowed to ride on their respective carbons using
SHELXL97.27 Complex 16 crystallizes in the space group P-1, with two carbon atoms of
one neopentyl group exhibiting disorder over two positions. Complex 17⋅⋅1/4AHA
crystallizes in the space group C2/c with three oxygen atoms of the perchlorate anion and
the carbon atoms of one neopentyl group exhibiting disorder. Complex 18⋅⋅CH2Cl2
crystallizes in the space group P21/c. The CH2Cl2 solvate molecule exhibits disorder.
Complex 19⋅⋅2CH2Cl2 crystallizes in the space group P21/n, with one CH2Cl2 exhibiting
disorder in the position of one chlorine atom.
Results
Preparation

and

Characterization

of

[(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14). Treatment of the bnpapa chelate ligand
with equimolar amounts of Ni(ClO4)2⋅6H2O, Me4NOH⋅5H2O, and 2-hydroxy-1,3diphenylpropan-1,3-dione in CH3CN, followed by work up using CH2Cl2, yielded a deep
orange/red solid. Unfortunately, repeated attempts to produce crystals of this complex
suitable for single crystal X-ray crystallography were unsuccessful. Instead, the
orange/red solid was characterized by elemental analysis, UV-vis, FTIR, and 1H NMR.
The elemental analysis data is consistent with the proposed formulation. The π→π*
transition of the coordinated enolate ligand of 14 is found at 393 nm (ε ~ 10,000 M-1cm1

). The wavelength and intensity of this absorption feature is generally similar to that

reported for [(6-Ph2TPA)Ni((PhC(O)C(OH)C(O)Ph)]ClO4 (2; λmax = 399 nm (ε ~ 6,800
M-1cm-1)).16 A broad absorption feature at ~3420 cm-1 in the infrared spectrum of 14 is
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consistent with hydrogen bonding interactions involving the neopentylamine groups of
the bnpapa chelate ligand. Based on structural studies of air stable analogs (vide infra),
we propose that this hydrogen bonding involves an oxygen atom of the chelating enolate
ligand that is positioned trans to the tertiary amine nitrogen donor of the chelate ligand.
Air Stable Analogs. To aid in the interpretation of the 1H NMR spectroscopic
features of 14, air stable analog complexes containing a bidentate acetoacetonato
([(bnpapa)Ni(CH3C(O)CHC(O)CH3)]ClO4

(16))

or

hydroxamato

([(bnpapa)Ni(CH3C(O)NHO)]ClO4 (17)) ligand were prepared and comprehensively
characterized. For solution conductivity and spectroscopic studies, the perchlorate
complex [(bnpapa)Ni(ClO4)(CH3CN)]ClO4 (18) and chloride complex [(bnpapaNi)2(µCl)2](ClO4)2 (19) were also prepared and characterized.
X-ray Crystallography. The cationic portions of 16 and 17 are shown in Figure
2-2, and those of 18 and 19 are shown in Figure 2-3. Details of the data collection and
refinement are given in Table 2-1. Selected bond distances and angles are given in Table
2-2. The mononuclear 16 and 17 each contain a pseudo-octahedral Ni(II) center with the
oxygen donor atoms of the chelate ligand positioned trans to N(3) and N(6). The
respective Ni-O/N bonds of the primary coordination sphere are similar in these
complexes, with the most noticeable difference in bond lengths being that the Ni-N
interactions involving the neopentylamine-appended pyridyl donors are ~0.02 Å longer in
16 than those found in the hydroxamato complex (17). In terms of bond angles, a more
acute O(1)-Ni(1)-O(2) angle in 17 (81.86(10)°) than that found in 16 (94.98(3)°) is due to
the difference in chelate ring size of the bidentate O,O-donor ligands. In both complexes,
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an oxygen atom of the bidentate chelate ligand accepts two hydrogen bonds from the
neopentyl amine groups of the supporting chelate ligand. These interactions are
characterized by N(H)….O distances of 2.8-2.9 Å.

Figure 2-2. Thermal ellipsoid drawings of the cationic portions of 16 and 17. All
ellipsoids are drawn at the 50% probability level. Hydrogen atoms, other thanthe neopentyl
amine N-H hydrogen atoms, and the hydroxyamate N-H hydrogen in 17, have been
omitted for clarity.
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Figure 2-3. Thermal ellipsoid drawings of the cationic portions of 18 and 19. All
ellipsoids are drawn at the 50% probability level. Hydrogen atoms other than the
neopentyl amine N-H hydrogen atoms have been omitted for clarity.
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Table 2-1. Summary of X-ray Data Collection and Refinement.a
16

17⋅⋅1/4AHA

18⋅⋅CH2Cl2

19⋅⋅2CH2Cl2

Empirical formula

C33H47ClN6NiO6

C30.50H45.25ClN7.25NiO6.5

C31H45Cl4N7NiO8

C58H84Cl8N12Ni2O8

Mr

717.93

711.25

844.25

1478.39

Crystal system

triclinic

monoclinic

monoclinic

monoclinic

Space group

P-1

C2/c

P21/c

P21/n

a/ Å

8.9810(2)

32.3396(8)

8.8221(2)

10.9123(2)

b/ Å

10.9647(2)

11.4649(3)

20.0037(4)

18.9857(3)

c/ Å

18.2657(4)

19.4692(3)

21.7170(4)

16.9677(3)

α /°

102.6548(12)

90

90

90

β /°

96.3498(11)

93.1236(14)

91.7754(11)

96.6495(10)

γ /°

93.1764(13)

90

90

90

V / Å3

1738.34(6)

7207.9(3)

3830.66(14)

3491.68(10)

2

8

4

2

Dc / Mg m

1.372

1.312

1.464

1.406

T/K

150(1)

103(1)

150(1)

150(1)

0.38 × 0.30 × 0.28

0.20 x 0.20 x 0.15

0.38 × 0.38 × 0.33

0.38 × 0.30 × 0.25

µ/ (mm )

0.687

0.644

0.842

0.904

2θ max (°)

55.00

55.04

54.96

54.96

Z
-3

Crystal size/ mm
-1

Completeness to θ 97.9
(%)
Reflections collected 12170

99.5

99.2

99.8

15128

14723

15105

Independent reflections 7825

8259

8717

7984

Rint

0.0219

0.0401

0.0255

0.0200

Variable parameters

577

486

469

422

R1 / wR2b

0.0491/0.1289

0.0620/0.1452

0.0636/0.1571

0.0432/0.1038

1.043

1.040

1.042

1.081

0.758/-0.778

0.790/-0.626

0.783/-1.250

0.499/-0.530

Goodness-of-fit (F2)
-3

∆ρ max/min / e Å

a
Diffractometer: Nonius KappaCCD; Radiation used: Mo Kα (λ = 0.71073 Å). bR1 = ∑ | |Fo| - |Fc| | / ∑ |Fo|; wR2 = [∑[w(Fo2Fc2)2]/[∑(Fo2)2]]1/2, where w = 1/[σ2(Fo2) + (aP)2 + bP].
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Table 2-2. Selected Bond Distances (Å) and Angles (°).
16

17⋅⋅1/4AHA

18⋅⋅CH2Cl2

Ni(1)-O(1)

2.0162(18)

2.018(2)

2.177(2)

Ni(1)-O(2)

2.0183(17)

2.058(2)

Ni(1)-N(2)

2.1509(19)

2.137(3)

2.151(3)

2.1998(19)

Ni(1)-N(3)

2.0762(19)

2.076(3)

2.055(3)

2.0648(19)

Ni(1)-N(4)

2.154(2)

2.134(3)

2.164(3)

2.2267(19)

Ni(1)-N(6)

2.061(2)

2.048(3)

2.042(3)

2.038(2)

Ni(1)-N(7)

19⋅⋅2CH2Cl2

2.049(3)

Ni(1)-Cl(1)

2.4284(6)

Ni(1)-Cl(1)#1

2.4485(6)

O(1)-Ni(1)-O(2)

90.94(8)

81.86(10)

O(1)-Ni(1)-N(6)

172.86(8)

94.53(10)

O(2)-Ni(1)-N(6)

95.76(8)

174.68(10)

O(1)-Ni(1)-N(3)

89.89(8)

178.78(10)

O(2)-Ni(1)-N(3)

178.63(7)

99.35(11)

N(6)-Ni(1)-N(3)

83.46(8)

84.26(11)

85.97(13)

O(1)-Ni(1)-N(2)

91.27(7)

99.44(11)

99.80(10)

O(2)-Ni(1)-N(2)

99.02(7)

89.69(10)

N(6)-Ni(1)-N(2)

90.13(7)

87.04(11)

88.72(11)

88.00(7)

N(3)-Ni(1)-N(2)

79.86(7)

80.67(11)

80.84(11)

79.27(7)

O(1)-Ni(1)-N(4)

88.86(8)

100.25(12)

98.42(10)

O(2)-Ni(1)-N(4)

99.99(8)

91.27(10)

N(6)-Ni(1)-N(4)

87.55(8)

93.24(11)

89.12(11)

90.16(7)

N(3)-Ni(1)-N(4)

81.12(8)

79.68(11)

80.84(11)

79.58(7)

N(2)-Ni(1)-N(4)

160.98(8)

160.22(11)

161.66(11)

90.23(12)

176.14(10)

N(6)-Ni(1)-N(7)

179.59(13)

N(7)-Ni(1)-N(3)

94.09(12)

N(7)-Ni(1)-N(2)

90.89(11)

N(7)-Ni(1)-N(4)

91.29(11)

N(7)-Ni(1)-O(1)

89.71(11)

85.13(8)

N(6)-Ni(1)-Cl(1)

97.34(6)

N(3)-Ni(1)-Cl(1)

177.53(6)

N(2)-Ni(1)-Cl(1)

100.65(5)

N(4)-Ni(1)-Cl(1)

100.48(5)

45
Table 2-2. continued
N(6)-Ni(1)-Cl(1)#1

177.63(6)

N(3)-Ni(1)-Cl(1)#1

93.76(6)

N(2)-Ni(1)-Cl(1)#1

89.74(5)

N(4)-Ni(1)-Cl(1)#1

91.70(5)

Cl(1)-Ni(1)-Cl(1)#1

83.77(2)

Ni(1)-Cl(1)-Ni(1)#1

96.23(2)

Solution Conductivity Properties. The acetoacetonato complex 16 and the
hydroxamato complex 17 both are 1:1 electrolytes in CH3CN, as determined by variable
concentration conductance measurements.21 Onsager plots for these complexes (Figure 24) exhibit slopes similar to the 1:1 standard Me4NClO4, and a notably different slope than
that exhibited by [(bnpapa)Ni(ClO4)(CH3CN)](ClO4)2 (18 (Figure 2-3(top)) or
[(bnpapaNi)2(µ-Cl)2](ClO4)2 (19, Figure 2-3(bottom)), both of which are 1:2 electrolyte
species in CH3CN.

Figure 2-4. Onsager plots of the solution conductivity properties of 9, 16-19, and the 1:1
standard Me4NClO4 in CH3CN at 22(1) °C.
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1

H

NMR

Spectra.

The

1

H

NMR

features

of

analytically

pure

[(bnpapa)Ni(CH3C(O)CHC(O)CH3)]ClO4 (16) and [(bnpapa)Ni(ONHC(O)CH3)]ClO4
(17) in CD3CN at 22(1) °C in the region of 20-80 ppm are shown in Figure 2-5(b) and (c).
These are compared to the 1H NMR spectral features of the O2-sensitive enolate complex
[(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14, Figure 2-5(a)). The resonances in the 2080 ppm region include those of pyridyl β-H ring protons and a portion of the benzylic
proton resonances.20 The 1H NMR spectra of 14 and 16 (Figure 2-5(a) and (b)) are
similar, both having a more complicated appearance than that of the hydroxamato
compound 17. Based on the conductivity data presented above for the air stable 16 and
17, which are both 1:1 electrolyte species in acetonitrile, the greater complexity of the 1H
NMR spectrum of 16, relative to the spectral features of 17, is not due to the formation of
multinuclear species in solution. 2H NMR studies of analogs of 14, 16, and 17 supported
by a version of the bnpapa chelate ligand (Figure 2-6) having deuterium atoms at the

Figure 2-5. 1H NMR spectral features of (a) 14, (b) 16, and (c) 17 in the region of 20-80
ppm. Spectra obtained in CD3CN at 22(1) °C.
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Figure 2-6. Positions of deuteration in bnpapa ligand used for 2H NMR investigations.
The 2H substitution is present in both neopentyl-appended pyridyl donors.

benzylic positions, as well as partial deuteration of the β-H positions of the
neopentylamine-appended pyridyl rings, indicated the presence of three unique benzylic
proton resonances for 14 and 16 in the region of 165-175 ppm. This is consistent with no
plane of symmetry within the cation.20 However, 17 exhibits only one benzylic proton
resonance in the same region, which is consistent with the presence of a plane of
symmetry containing the unsubstituted pyridyl donor and the hydroxamato ligand. The
factors that govern the subtle differences in solution structure of the cationic portions of
14, 16, and 17 are not entirely clear, but appear to relate to the chelate ring size of the
O,O-donor ligand coordinated to the Ni(II) center. Specifically, the compounds having a
six-membered chelate O,O-donor lack a plane of symmetry in the solution form of the
cation. We note that the 1:2 electrolyte compounds [(bnpapa)Ni(ClO4)(CH3CN)](ClO4)2
(18) or [(bnpapaNi)2(µ-Cl)2](ClO4)2 (19) both exhibit 1H NMR spectra similar to 17
wherein an effective plane of symmetry renders the two neopentylamine-appended
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pyridyl donors equivalent in solution (Figure 2-7). Ni(II) carboxylate complexes of the
general formula [(bnpapa)Ni(O2CR)]ClO4 (R = Ph, (CH2)2SCH3, and H) also exhibit 1H
NMR spectra that are generally similar to the spectrum found for the hydroxamato
complex 17.17 In terms of comparing chelate ligand environments, the mononuclear Ni(II)
complexes

[(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4

(2)

and

[(6-

Ph2TPA)Ni(RC(O)CHC(O)R)]ClO4 (R = Ph, CH3) exhibit spectra which indicate the
presence of a plane of symmetry within the cation.15,16 Thus, the bnpapa-ligated Ni(II)
six-membered ring enolate complexes 14 and 16 exhibit unique solution 1H NMR
properties relative to their hydrophobic analogs. Based on the structural and solution
features of the air stable acetoacetonato complex 16, and the similarity of the 1H NMR
spectrum of this complex to the spectrum of [(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4
(14), we propose that the O2-reactive enolate complex 14 has a structure that is similar to
the analog supported by 6-Ph2TPA (Figure 2-8), but is distorted such that no plane of
symmetry relates the neopentylamine pyridyl donors in the solution form of the cation.

Figure 2-7. 1H NMR spectral features of (a) 18 and (b) 19, in the region of 20-80 ppm.
Spectra obtained in CD3CN at 22(1) °C.
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Figure 2-8. (a) Proposed structure of [(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14). (b)
Structure of [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (2) as determined by X-ray
crystallography.3

Reaction of 14 with O2. Exposure of a CH3CN solution of 14 to O2 results in an
immediate color change from deep orange/red to yellow. CO production in this reaction
was identified qualitatively using the PdCl2 method.24 The inorganic and organic products
of the reaction were separated by column chromatography and identified (Scheme 2-3).
One equivalent of benzoic acid is generated along with a small amount of benzil
(PhC(O)C(O)Ph; ratio of benzoic acid to benzil is ~90:10) and a trace amount of the ester
PhC(O)OCH2C(O)Ph, the latter of which was identified via independent synthesis.25 The
reaction leading to ester formation will be described elsewhere. The monobenzoate
complex [(bnpapa)Ni(O2CPh)]ClO4 (9) is produced in nearly quantitative yield in the
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Scheme 2-3. Major products identified in reaction of 14 and 2 with O2; results of
reactions performed using 18O2.

reaction leading to ester formation will be described elsewhere. The monobenzoate
complex [(bnpapa)Ni(O2CPh)]ClO4 (9) is produced in nearly quantitative yield in the
reaction,

with

a

trace

amount

of

a

second

Ni(II)

complex,

[(bnpapa)Ni(PhC(O)C(O)CHC(O)Ph]ClO4 (15), being identified by mass spectrometry.
The production of 15 is related to the presence of the ester PhC(O)OCH2C(O)Ph in the
reaction and will be discussed elsewhere. Use of
benzoic acid with 81%

18

18

O2 in the reaction with 14 produces

O incorporation in one oxygen atom position. No

18

O

incorporation was found in benzil or the ester PhC(O)OCH2C(O)Ph, as determined by
GC-MS. Mass spectral analysis of the Ni(II) products indicated that the benzoate complex
9 had 87%

18

O incorporation in one oxygen atom of the benzoate ligand. No

incorporation was found in 15. We note that the level of

18

18

O

O incorporation for the

reaction involving 14 is slightly higher than that reported for the Ni(II)-ARD enzymatic
reaction (77.5%).28
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The work-up procedure used to isolate the organic and inorganic products of the
reaction of 14 with O2 is slightly different in terms of solvents used from the procedure
that we previously reported for identification of the products of the reaction of [(6Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (2) with O2. 16 The new conditions are more
amenable to the isolation of free benzoic acid in the reaction mixture. Therefore, the
reaction involving 2 was repeated under conditions identical with those employed for
[(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14), with the results shown in Scheme 2-3.
CO production was again identified qualitatively using the PdCl2 method.24 In this
reaction a ~75:25 mixture of benzoic acid and benzil is produced, along with a trace
amount of the ester PhC(O)OCH2C(O)Ph. The Ni(II)-containing products are [(6Ph2TPA)Ni(O2CPh)]ClO4

(3)

and

a

trace

Ph2TPA)Ni(PhC(O)C(O)CHC(O)Ph)]ClO4 (20).16,17 Use of
18

yielded benzoic acid with 59%

amount
18

of

[(6-

O2 in the reaction with 2

O incorporation in one oxygen atom position, and the

benzoate complex 3 having 64% incorporation in one oxygen atom. We note that the
level of isotope incorporation in 3 is slightly higher that than previously reported (~50%),
but is similar to that found for the O2 reaction of the salt [Me4N][PhC(O)C(OH)C(O)Ph],
which decomposes upon reaction with
(~65% incorporation of one

18

18

O2 to give [Me4N][O2CPh] and benzoic acid

O into carboxylate group) and CO. Thus, the reaction

involving 2 gives a mixture of organic products (benzoic acid and benzil), but with a
similar level of

18

O incorporation to that found for the O2 reaction of

[Me4N][PhC(O)C(OH)C(O)Ph].
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Overall, the studies outlined above revealed two interesting differences in the O2
reactivity

of

[(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4

(14)

and

[(6-

Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (2). First, the O2 reaction involving the bnpapaligated complex 14 produces less of the side product benzil. Second, the reaction
involving 14 has a higher level of

18

O incorporation in the benzoic acid/benzoate

products. These combined results provide evidence that the chelate ligand environment is
influencing the aliphatic carbon-carbon bond cleavage reaction pathway.
Comparison of the Secondary Environments of bnpapa- and 6-Ph2TPAligated Ni(II) Complexes. To date, we have structurally characterized four bnpapa- and
thirteen 6-Ph2TPA-ligated mononuclear Ni(II) complexes. Shown in Tables 2-3 and 2-4
are bond distances and angles involving the neopentyl-appended pyridyl donors in the
bnpapa complexes and the phenyl-appended pyridyl donors in the 6-Ph2TPA derivatives.
Several conclusions can be drawn from comparison of the microenvironments in these
two families of complexes. First, the neopentylamine amine-appended pyridyl donors in
the bnpapa ligand, which have a substituent that is more electron donating and less
sterically demanding relative to the phenyl substituents of the 6-Ph2TPA ligand, have
slightly shorter Ni-N distances (overall average of bnpapa complexes 2.14 Å; 6-Ph2TPA
complexes 2.22 Å). There is also a more linear N-Ni-N bond angle (overall average of
bnpapa complexes 161°; 6-Ph2TPA complexes 154°) between the substituted pyridyl
groups. Second, the phenyl-appended pyridyl donors of 6-Ph2TPA exhibit more variation
in terms of Ni-N distances (~0.12 Å) in response to the presence of different exogenous
ligands. This is not surprising in that aryl-appended pyridyl donors of chelate ligands

53
have been shown to fully dissociate from a metal center in response to exogenous ligand
coordination.29 Third, the microenvironment of bnpapa-ligated complexes is more
compact, as determined by comparison of the distance between the two neopentylamine
nitrogen atoms (~5.6 Å) versus that of the ipso carbons of the phenyl appendages of 6Ph2TPA (~6.4 Å).

Table 2-3. Structural Properties of bnpapa-ligated Mononuclear Ni(II) Complexes.
Complex
[(bnpapa)Ni(ClO4)(CH3CN)]ClO4

N(2)-Ni-N(4)
(º)a
161.66(11)

Ni-N(2), Ni-N(4)
(Å) a
2.151(3), 2.164(3)

N(H)…N(H)
(Å)
5.7

this work

[(bnpapa)Ni(ONHC(O)CH3)]ClO4

160.22(11)

2.137(3), 2.134(3)

5.5

this work

[(bnpapa)Ni(CH3C(O)CHC(O)CH3)]ClO4

160.98(8)

2.1509(19), 2.154(2)

5.6

this work

161.78(12)

2.125(3), 2.136(3)

5.6

17

[(bnpapa)Ni(O2Ph)]ClO4

b

a

Ref.

b

N(2) and N(4) are the neopentylamine-appended pyridyl donors of the bnpapa ligand. Data reported for one of two crystalline forms
of the complex that were previously reported.

Table 2-4. Structural Properties of 6-Ph2TPA-ligated Mononuclear Ni(II) Complexes.
Complex

a

Ni-N(3), Ni-N(4)
(Å)a
2.218(5), 2.200(5)

C(Ph)…C(Ph)
(Å) b
6.3

Ref.

[(6-Ph2TPA)Ni(CH3CN)(CH3OH)](ClO4)2

N(3)-Ni-N(4)
(º)a
158.59(16)

[(6-Ph2TPA)Ni(ONHC(O)CH3)]ClO4

147.19(7)

2.229(2), 2.263(2)

6.4

20

[(6-Ph2TPA)Ni(CH3C(O)CHC(O)CH3)]ClO4

150.41(8)

2.217(2), 2.221(2)

6.4

16

[(6-Ph2TPA)Ni(PhC(O)C(O)CHC(O)Ph)]ClO4

158.40(11)

2.209(3), 2.333(3)

6.5

16

[(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4

157.04(8)

2.271(2), 2.323(2)

6.6

15

[(6-Ph2TPA)NiCl(CH3CN)]ClO4

157.67(10)

2.081(3), 2.213(2)

6.4

20

[(6-Ph2TPA)Ni(O2CPh)]ClO4

149.83(6)

2.1458(16), 2.234(16)

6.2

16

[(6-Ph2TPA)Ni(O2CPh)(H2O)]ClO4

158.28(10)

2.216(2), 2.241(2)

6.4

17

[(6-Ph2TPA)Ni(O2C(CH2)2SCH3)]ClO4

141.57(10)

2.233(3), 2.193(3)

6.3

17

[6-Ph2TPA)Ni(O2(CH2)2SCH3)(H2O)]ClO4

159.33(12)

2.240(3), 2.186(3)

6.3

17

[(6-Ph2TPA)Ni(O2CCH2SCH3)]ClO4

148.73(8)

2.198(2), 2.165(2)

6.3

17

[(6-Ph2TPA)Ni(O2CCH2SCH3)(H2O)]ClO4

150.97(7)

6.4

17

[(6-Ph2TPA)Ni(O2CH)(H2O)]ClO4

158.42(11)

2.1884(17),
2.2050(17)
2.194(3), 2.218(3)

6.3

17

b

N(3) and N(4) are the phenyl-appended pyridyl donors of the 6-Ph2TPA ligand. Ipso carbon atoms of phenyl appendages.

20

54
Discussion
As shown in Scheme 2-1, a key issue in the chemistry of acireductone
dioxygenases is how the coordination mode of the acireductone substrate may influence
the reaction with O2. Pochapsky and coworkers have suggested, on the basis of NMR
experiments, that differences in the secondary environment in Ni(II)- versus Fe(II)containing ARD enzyme may be responsible for inducing different coordination modes of
the acireductone substrate.1 Specifically, in Ni(II)-ARD the side chain of the tryptophan
residue is positioned such that the binding pocket for the acireductone is smaller than that
found in Fe(II)-ARD. This is proposed to induce the formation of a six-membered chelate
ring structure, which leads to 1,3-dioxygenolytic bond cleavage and CO production. We
note that in both Ni(II)- and Fe(II)-containing acireductone dioxygenases an arginine
residue is positioned within the active site, likely within hydrogen-bonding distance of the
coordinated acireductone.1
As an approach toward evaluating the influence of the secondary environment on
the chemistry of Ni(II) complexes having an acireductone-type ligand, we have prepared
and characterized [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (2), which has a
hydrophobic microenvironment, and [(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14),
which contains a hydrogen-bond donor secondary environment. Based on the results of
analytical and spectroscopic studies, we propose that the coordination mode of the
acireductone-type ligand in these complexes is similar, with each having a six-membered
chelate ring. However, the solutions structures of 2 and 14 differ in terms of the presence
of a plane of symmetry that relates the modified pyridyl donors, with the hydrogen bond
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donor pocket lacking such symmetry. Treatment of each complex with O2 results in CO
production and aliphatic carbon-carbon bond cleavage, with the major products in each
reaction being a mononuclear Ni(II) benzoate complex, benzoic acid, and CO. In both
reactions, the formation of the side product benzil was also identified. The yield of this
byproduct

is

higher

in

the

reaction

involving

[(6-

Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (2). Notably, this reaction exhibits a level of
18

O incorporation in the benzoate/benzoic acid products that is ~20% lower than the

reaction involving 14. A possible rationale for the differences in product distribution and
18

O incorporation between the reactions involving 2 and 14 could be that differing

pathways for carbon-carbon bond cleavage may be operative as outlined in Scheme 2-4.
Pathway A involves a cyclic peroxide resulting from two-electron oxidation of the
coordinated acireductone analog. Carbon-carbon bond cleavage in this type of structure
would produce two equivalents of benzoate/benzoic acid, with each product having one
labeled oxygen atom if the reaction were performed using
benzoic

acid

in

high

yield

in

the

18

O2. The production of
reaction

involving

[(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14), and the observed high level of

18

O

incorporation, suggests that this pathway could possibly be operative for this reaction.
However, the production of a small amount of benzil in the reaction involving 14
suggests that another type of reactivity is also occurring. For both complexes, we propose
that benzil is generated via a pathway B type reaction sequence (Scheme 2-4).
Specifically, two electron oxidation of the coordinated acireductone type ligand could
produce 1,3-diphenyltriketone and a solvated Ni(II) complex of the chelate ligand. It has
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Scheme 2-4. Possible reaction pathways for oxidative carbon-carbon bond cleavage in
the Ni(II) enolate complexes 2 and 14. The supporting chelate ligands have been
omitted for clarity.

been previously shown that 1,3-diphenyltriketone will undergo phenyl or benzyl
migration in the presence of a Lewis acids such as AlCl3 to give benzil and carbon
monoxide.30 If this type of reaction pathway is occurring with the complexes described
herein, the secondary environment of the [(bnpapa)Ni(sol)2]2+ and [(6-Ph2TPA)Ni(sol)2]2+
cations (sol = solvent; e.g. CH3CN) could influence interactions between the Ni(II) center
and the 1,3-diphenyltriketone. For example, the larger pocket for the 6-Ph2TPA-ligated
Ni(II) center could be a key factor in promoting Lewis acid activation of a carbonyl
moiety of the triketone, which is necessary for the migration reaction leading to benzil
production.30 This is a possible rationale for the higher amount of benzil produced in the
reaction involving 2. In terms of the lower level of 18O incorporation found this reaction,
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triketones are known to hydrate easily at the central carbonyl, and this may be a pathway
for the introduction of unlabeled oxygen atoms into the benzoate/benzoic acid products.31
The observation that the salt [Me4N][PhC(O)CH(OH)C(O)Ph] undergoes reaction with
18

O2 to produce a similar level of 18O incorporation (~65%) in the benzoic acid product as

is found for the reaction involving 2 suggests that both may proceed via a similar reaction
pathway.

18

O incorporation into the carbon-carbon bond cleavage products could occur

via reaction of the free triketone with hydroperoxide to form a five-membered cyclic
peroxide species from which carbon-carbon bond cleavage could occur. Pochapsky has
previously shown that treatment of 2,3,4-pentanetrione with H2O2 results in the formation
of CO and two equivalents acetic acid.32 No isotope labeling studies were reported for
this reaction.
The higher level of 18O incorporation in the benzoate/benzoic acid products of the
reaction involving 14 is interesting. Based on the results of our current experiments, it is
unclear whether exclusively pathway B chemistry is occurring in the O2 reactions of 14
and 2, or whether a portion of the labeled product is generated via pathway A type
reactivity. If exclusively pathway B chemistry is operative, an important distinction
between the two supporting chelate ligand systems is that the bnpapa-ligated Ni(II) center
may coordinate the hydroperoxide anion within the hydrogen bond donor pocket. The
bnpapa chelate ligand has been previously used to stabilize mononuclear Zn(II) and
Cu(II) hydroperoxide complexes.33,34 To date, similar complexes have not been reported
using the 6-Ph2TPA ligand. Thus, differences in the anion coordination properties
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between the bnpapa and 6-Ph2TPA-supported complexes could contribute to the observed
differences in reactivity between 2 and 14.
The results of this investigation have enabled the formulation of hypotheses
regarding the reaction pathways of 2 and 14 with O2 (Scheme 2-4) that can now be tested
in individual control reactions. For example, we are now performing experiments to
examine

the

reactivity

of

[(6-Ph2TPA)Ni(CH3CN)(CH3OH)](ClO4)235

and

[(bnpapa)Ni(ClO4)(CH3CN)]ClO4 (18) with 1,3-diphenyltriketone and H2O2 to evaluate
the efficacy of pathway B chemistry leading to the observed products. Additionally, we
are pursuing kinetic studies of the reactions of complexes 2 and 14 with O2, as well as
examining the reactivity of [Me4N][PhC(O)C(OH)C(O)Ph] with O2 via computational
methods to assess its reactivity relative to that found in the native C(1)-H acireductone
substrate processed by the acireductone dioxygenases.36
Conclusions
Using the hydrogen-bond donor ligand bnpapa, a mononuclear Ni(II) complex of
the formula [(bnpapa)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (14) has been isolated and
characterized. Based on comparison of the spectroscopic features of this complex to those
of air stable analogs, the structure of 14 is proposed to be generally similar to that
previously reported for [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (2). Notably,
complexes 2 and 14 exhibit differences in their O2-dependent aliphatic carbon-carbon
bond cleavage reactivity in terms of the product mixture generated and the level of

18

O

incorporation in the benzoate/benzoic acid products. Two possible reaction pathways
leading to

18

O incorporation into the benzoate/benzoic acid products are proposed, with

59
one pathway involving the formation of a triketone and hydroperoxide anion. Comparison
of the chemical features of several bnpapa- and 6-Ph2TPA-ligated complexes suggests
that differences in the pocket size and anion binding properties for these two ligand types
may be key factors in producing the observed differences in reaction products.
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CHAPTER 3
INFLUENCE OF WATER ON THE FORMATION OF O2-REACTIVE DIVALENT
METAL ENOLATE COMPLEXES OF RELEVANCE TO ACIREDUCTONE
DIOXYGENASES1
Abstract
Reaction

conditions

were

PhTPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4

evaluated

for
(3)

the

preparation
and

of

[(6[(6-

Ph2TPA)Co(PhC(O)C(OH)C(O)Ph)]ClO4 (7), two complexes of structural relevance to
the enzyme/substrate (ES) adduct in Ni(II)- and Co(II)-containing forms of acireductone
dioxygenase. The presence of water in reactions directed at the preparation of 3 and 7 was
found to result in isomerization of the enolate precursor 2-hydroxy-1,3-diphenylpropane1,3-dione to give the ester 2-oxo-2-phenylethylbenzoate. Performing synthetic procedures
under dryer conditions reduced the amount of ester production and enabled the isolation
of 3 in high yield. This complex was comprehensively characterized, including by X-ray
crystallography. Using similar conditions for the 6-Ph2TPACo-containing system, the
amount of ester generated was only modestly affected, but the formation of a benzoate
complex ([(6-Ph2TPA)Co(O2CPh)]ClO4, 10) resulting from ester hydrolysis was

1

Coauthored by Katarzyna Grubel, Gajendrasingh K. Ingle, Amy L. Fuller, Atta M. Arif,
and Lisa M. Berreau. Reproduced with permission from Dalton Transactions 2011, 49,
1071-1081. Copyright 2011 The Royal Society of Chemistry.
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prevented. The best preparation of 7 was found to involve dry conditions and short
reaction times. The difference in water-dependent chemistry encountered in the (6PhTPA)Ni- and (6-Ph2TPA)Co-containing systems appears to relate to differences in the
M-OH/H2O chemistry of the metal/ligand combinations. The approach outlined herein
toward determining appropriate reaction conditions for the preparation of 3 and 7
involved the preparation and characterization of several air-stable (6-PhTPA)Ni- and (6Ph2TPA)Co-containing analogue complexes having enolate, solvent, and benzoate
ligands. These complexes were used as paramagnetic 1H NMR standards for evaluation of
reaction mixtures containing 3 and 7.
Introduction
Acireductone dioxygenases (ARDs) catalyze dioxygenase-type oxidative reactions
involving the cleavage of one or more aliphatic carbon-carbon bonds in an intermediate
generated in the methionine salvage pathway.1 With Ni(II) or Co(II) as the active site
metal ion (Ni(II)-ARD or Co(II)-ARD), the cleavage reaction results in the formation of
carboxylic acid products and CO (Scheme 3-1, top).1 This reaction is proposed to proceed
from an enzyme/substrate (ES) adduct having a coordinated enediolate moiety. To date,
our laboratory has produced the only synthetic complexes of structural relevance to the
ES adduct in Ni(II)-ARD using a C(1)-Ph containing analog of the native acireductone
substrate

(Scheme

3-1,

middle).2

Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4

These

complexes,
(1)

[(6and

[(bnpapa)Ni(PhC(O)C(OH)C(O)Ph]ClO4 (2) (Scheme 3-1, bottom), undergo reaction
with O2 to produce CO and carboxylate/carboxylic acid products in a reaction similar to
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Scheme 3-1. Top: Reaction catalyzed by Ni(II)-ARD. Middle: Native and alternative
substrates for Ni(II)-ARD; C(1)-phenyl-containing model substrate. Bottom: Structural
drawings of 1 and 2.

the Ni(II)-ARD enzymatic reaction.2 However, the formation of a small amount of
another organic product, benzil (PhC(O)C(O)Ph), in the reactions involving 1 and 2,
suggested the possibility of a “hydroperoxide” pathway for oxidative carbon-carbon bond
cleavage reactivity involving triketone and OOH- intermediates. This proposed pathway is
supported by recent computational and mechanistic studies for the oxidative carboncarbon bond cleavage reaction involving 1.3 This mechanism differs from a radical
pathway4 available for carbon-carbon bond cleavage in the native substrate for the
enzyme and is consequence of the phenyl substituent at the C(1)-carbon. Thus, while our
previous studies show that the C(1)-phenyl-containing acireductone analog introduces
mechanistic differences in terms of its oxidative cleavage reactivity, it is a convenient
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species for exploring bioinspired coordination chemistry of an acireductone-type
molecule. We note that prior to our preparation and characterization of 1, only a single
complex having an acireductone type ligand had been previously characterized by X-ray
crystallography.5 This complex, [Ru(bipy)2(µ-C4H4O3)Ru(bipy)2](PF6)2, was generated as
a byproduct in an ethylene glycol-containing reaction mixture and no further chemistry of
the complex was reported. The [C4H4O3]2- acireductone-type ligand bridges the two
ruthenium centers via two five-membered chelate rings. We have a reported a similar
coordination motif for the dianionic form of the C(1)-phenyl-containing acireductone
analog in Ni(II) trinuclear and cluster complexes.6,7
In

further

exploration

of

the

coordination

chemistry

of

the

[PhC(O)C(OH)C(O)Ph]- anion, we describe herein our efforts to prepare analogs of 1
containing a sterically less-demanding supporting chelating ligand, 6-PhTPA,8 or a
different metal ion, Co(II). Notably, we have found that the preparation of [(6PhTPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4

(3)

and

[(6-

Ph2TPA)Co(PhC(O)C(OH)C(O)Ph)]ClO4 (7) is complicated by water-dependent
isomerization chemistry involving the C(1)-phenyl-containing acireductone analog which
results in the formation of an ester. While we were able to modify the reaction conditions
to successfully isolate and characterize 3, the Co(II) chemistry is more complicated and
includes ester hydrolysis reactivity. Our approach toward identifying the best conditions
under which to generate 7 involved the preparation and characterization of three new 6Ph2TPA-supported Co(II) complexes that were used as paramagnetic 1H NMR standards.
Overall, these studies demonstrate that the conditions required for the preparation of
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metal enolate complexes of relevance to the ES adduct in acireductone dioxygenases
depend on several factors, including the presence of water in the reaction mixture.
Results and Discussion
Isomerization reactivity of a C(1)-phenyl containing acireductone analog and the
preparation of [(6-PhTPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (3). In our initial attempts
to prepare the 6-PhTPA-supported Ni(II) complex 3, we used reaction conditions
identical

to

those

which

had

enabled

us

to

isolate

the

O2-reactive

[(6-

Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph]ClO4 (1) in high yield (>90%).2a These conditions are
referred to herein as the “wet” conditions. Karl-Fischer titration of the CaH2-dried
acetonitrile typically used in this type of reaction indicated a concentration of [H2O]
~3000 ppm. For the preparation of 3, these conditions proved problematic, as a mixture
of Ni(II) complexes was generated, as determined by 1H NMR (Figure 3-1(a)), along with
a significant amount of an isomerization product, 2-oxo-2-pheylethyl benzoate9 (~46%
isolated yield based on dione; Scheme 3-2(b)). This ester, 2-oxo-2-pheylethyl benzoate,
has been previously reported to form upon treatment of 2-hydroxy-1,3-diphenylpropane1,3-dione with sodium bicarbonate in H2O/methanol.10 In this prior report, a reaction
pathway was proposed wherein the deprotonated keto form undergoes intramolecular
attack of the C(2)-O- moiety on an adjacent carbonyl (Scheme 3-3). This results in the
formation of a new C-O bond and the cleavage of a C-C bond involving the C(2) center.
We had not previously identified this rearrangement chemistry in preparing 1. However,
we have now reexamined the organic products remaining following the isolation of 1 and
have found that some ester is generated in this reaction, but it is only approximately half
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Figure 3-1. A region of the 1H NMR spectra for (a) the reaction mixture produced upon
treatment of 6-PhTPA with an equimolar amount of Ni(II)(ClO4)2⋅6H2O and slight
stoichiometric excesses of Me4NOH·5H2O and 2-hydroxy-1,3-diphenylpropan-1,3-dione
in CH3CN (~3000 ppm H2O); (b) [(6-PhTPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (3); (c)
[(6-PhTPA)Ni(PhC(O)CHC(O)Ph)]ClO4
(4);
(d)
[(6PhTPA)Ni(CH3CN)(CH3OH)](ClO4)2 (5); (e) [(6-PhTPA)Ni(O2CPh)]ClO4 (6). Spectra be are for analytically pure compounds. The 1H NMR spectra were collected in CD3CN at
ambient temperature and were referenced to the 1H NMR signal of CD2HCN (1.94 ppm).

of what is found in the 6-PhTPA system. We propose that this difference in ester
formation for the 6-Ph2TPA and 6-PhTPA systems might involve differences in
interactions of the Ni(II) center in each complex with the reactants due to the modulation
of the hydrophobic microenvironment by the differing chelate ligands. Specifically,
factors such as the greater possible propensity of the 6-PhTPA complex to form dimeric
structures, as well as electronic effects at the metal, and differing anion association
constants, may be responsible for the observed differences in reactivity. Notably, we
discovered that reducing the amount of water in the reaction mixture involving the 6-
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Scheme 3-2. (a) Previously reported synthetic route for the preparation of 1. (b) Synthetic
routes for the preparation of 3.

Scheme 3-3. Proposed pathway of isomerization of 1,3-diphenylpropane-1,3-dione to
generate 2-oxo-2-pheylethylbenzoate.10

PhTPA-supported Ni(II) complex via predrying of the base and use of extra dry CH3CN
(<10 ppm H2O) enables the isolation of 2 in high yield (94%, Scheme 3-2(b)).
Additionally, only a trace amount of ester was detected in this reaction mixture. These
combined results indicate that water plays a key role in this system in promoting the
isomerization reactivity that results in ester formation, and that a lower amount of ester
formation correlates with a higher yield of the desired enolate complex 3. Complex 3
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(Figure 3-2) has a six-coordinate Ni(II) center with the longest Ni-N interaction being for
the phenyl-substituted pyridyl donor (Ni(1)-N(4), 2.202(4) Å). This distance is slightly
shorter than that found for the Ni-NPhPy bonds in 1 (Ni(1)-N(3) 2.271(2) Å, Ni(1)-N(4)
2.323(2) Å),2a presumably due to reduced steric hindrance as a second phenyl-appended
pyridyl donor is not present in 3. The remaining bond distances/angles in this complex are
similar to those found in 1. The spectroscopic properties of 3 are also generally similar to
those found for 1. For example, both complexes form orange-brown solutions with λmax
at 393 (6800 M-1cm-1) and 399 (10300 M-1cm-1) nm, respectively.2b The 1H NMR features
of 3 in the region of 70-10 ppm are shown in Figure 3-1(b) and collected in Table 3-1.
Prior 1H NMR studies of 6-Ph2TPA-ligated Ni(II) complexes have identified this
region as containing pyridyl ring proton resonances that are sensitive to changes in
ligation at the Ni(II) center.11,12 In order to perform spectral comparisons for 6-PhTPAsupported Ni(II) complexes, the air stable dibenzoylmethane-derived enolate complex

Figure 3-2. Thermal ellipsoid drawing of the cationic portion of 3. Ellipsoids are drawn at
the 50% probability level. Hydrogen atoms except the hydroxyl proton of the enolate
ligand are not shown for clarity.
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[(6-PhTPA)Ni(PhC(O)CHC(O)Ph)]ClO4 (4, Figure 3-3(top), the solvent-bound complex
(6-PhTPA)Ni(CH3CN)(CH3OH)](ClO4)2 (5, Figure 3-3(bottom)), and the benzoate
complex [(6-PhTPA)Ni(O2CPh)]ClO4 (6) were prepared and characterized.

Figure 3-3. Thermal ellipsoid drawings of the cationic portions of 4 (top) and 5 (bottom).
Ellipsoids are plotted at the 50% probability level. Hydrogen atoms, except the methanol
proton of the coordinated methanol ligand in 5, are not shown for clarity.
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Table 3-1. 1H NMR chemical shifts for 3-6 in CD3CN at 298 K.
shift (ppm)a

assignment

∆ν1/2(Hz)b

rel area

[(6-PhTPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (3)
α

150.0

c

c

β

41.6, 34.8

183, 172

1, 1

β’

44.5, 13.3

450, 179

2, 2

γ

c

c

c

γ’

10.6

91.6

c

57.7, 23.3, c

c, c, c

c, c, c

CH2

[(6-PhTPA)Ni(PhC(O)CHC(O)Ph)]ClO4 (4)
α

148.6

c

c

β

43.8, c

355

c, c

β’

41.1, 34.8

183, 214

1, 1

γ

13.2

175

2

γ’

c

c

c

138.2, 51.0, 50.5

c, c, c

c, c, c

-13.1

256

1

CH2
CH (dbm)

[(6-PhTPA)Ni(CH3CN)(CH3OH)](ClO4)2 (5)
α

150.0

c

c

β

52.8, c

543, c

c, c

β’

49.2, 40.8

484, 324

c, 1

γ

14.6

126

c

γ’

10.1

107

c

[(6-PhTPA)Ni(O2CPh)]ClO4 (6)
α

150.9

2922

1

β

46.3, 36.2

c, 328

c, 1

β’

49.3, 45.1

362, 244

2, c

γ

13.5

72

2

γ’

10.0

84

1

77.5, c, c

c, c, c

CH2
a

c, c, c
1

Chemical shifts in ppm relative to the residual solvent peak of CHD2CN ( H, 1.94 (quintet) ppm). bLine widths
are full width at a half-maximum. cCould not be determined.
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Complexes 4 and 5 were investigated using single crystal X-ray crystallography. Details
of the X-ray data collection are given in Table 3-2. Selected bond distances and angles for
the complexes are shown in Table 3-3. Both 4 and 5 exhibit a pseudo-octahedral
geometry with the longest Ni-N bond distance being for the phenyl-appended pyridyl
donor. As is evident by comparison of the 1H NMR spectra shown in Figure 3-1(b)-(e),
complexes having a six-membered ring enolate ligand (Figure 3-1(b) and (c); 3 and 4)
exhibit generally similar 1H NMR features that are clearly distinct from those exhibited
by solvent (Figure 3-1(d), 5) or benzoate-coordinated (Figure 3-1(e), 6) compounds
(Table 3-1). That being said, we note that all of the complexes exhibit a pattern of
isotropically shifted resonances for the pyridyl ring protons with chemical shifts in the
order α-H > β-H > γ-H.11
Having the family of complexes 3-6 fully characterized has enabled us to use 1H
NMR to examine the mixture of Ni(II) complexes in the “wet” reaction conditions,
wherein a significant amount of ester is generated. As shown in Figure 3-1(a) it is evident
that the desired Ni(II) enolate complex 2 is present, as resonances at 44.5, 41.6, 34.8, and
13.3 ppm are present. It is also clear that a Ni(II) solvent-coordinated complex, such as
[(6-PhTPA)Ni(CH3CN)(CH3OH)](ClO4)2 (5), if present, is a very minor species. This
suggests that all of the 6-PhTPA-ligated Ni(II) species in solution have one or more
coordinated non-solvent ligands. A small amount of the Ni(II)-benzoate complex 6 may
be present in the reaction mixture, as evidenced by signals at the 49.3 and 36.2 ppm. We
note that preliminary O2 reactivity studies indicate that complex 3 undergoes oxidative
carbon-carbon bond cleavage upon exposure to oxygen to give products similar to those
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Table 3-2. Summary of X-ray Data Collection and Refinement.
3⋅⋅CH2Cl2

4⋅⋅Et2O

5

8⋅⋅0.5CH3CN

10

Empirical formula

C40H35Cl3N4NiO7

C43H43ClN4NiO7

C27H29Cl2N5NiO9

C46H38.5ClCoN4.5O4

C37H31ClCoN4O6

Formula weight

848.78

821.97

697.16

844.69

722.04

Crystal system

Monoclinic

Orthorhombic

Orthorhombic

Tetragonal

Monoclinic

Space group

Cc

Pcab

P212121

I-4

P21/c

a/ Å

23.2096(5)

16.0204(3)

9.8884(2)

34.4730(5)

11.0736(2)

b/ Å

15.9822(4)

19.2924(6)

10.8891(2)

34.4730(5)

24.5657(5)

c/ Å

11.9687(2)

25.0918(7)

28.1201(4)

13.5221(3)

12.18640(10)

α /°

90

90

90

90

90

β /°

117.2760(12)

90

90

90

100.8097(10)

γ /°

90

90

90

90

90

V /Å3

3946.02(15)

7755.2(4)

3027.85(9)

16069.5(5)

3256.25(9)

4

8

4

16

4

Dc / Mg m

1.429

1.408

1.529

1.397

1.473

T/K

150(1)

150(1)

150(1)

150(1)

150(1)

Color

Orange

Orange

Purple

Red-Brown

Green

Crystal habit

Prism

Plate

Prism

Plate

Plate

Crystal size/ mm

0.25 x 0.23 x 0.20

0.38 x 0.38 x 0.10

0.33 x 0.25 x 0.20

0.35 x 0.35 x 0.13

0.35 x 0.23 x 0.10

Diffractometer

Nonius KappaCCD

Nonius KappaCCD

Nonius KappaCCD

Nonius KappaCCD

Nonius KappaCCD

µ/ (mm-1)

0.749

0.627

0.878

0.550

0.664

2θ max /°

54.94

54.98

54.96

54.96

54.96

Reflections collected 8111

16226

6591

15365

14646

Independent
reflections
Rint

8104

8868

6591

15360

7451

0.0445

0.0767

0.0000

0.0395

0.0374

Variable parameters

498

677

400

1060

566

Z
-3

R1 / wR2 (I > 0.0539 / 0.1320
2sigma(I))b
Goodness-of-fit (F2) 1.066

0.0552 / 0.1015

0.0654 / 0.1377

0.0638 / 0.1236

0.0385 / 0.0811

1.015

1.040

1.072

1.023

∆ρ max/min / e Å-3

0.972 / -0.684

0.452 / -0.465

0.699 / -0.976

0.475 / -0.586

0.337 / -0.512

Flack parameter

0.510(5)

a

-0.01(3)
b

0.371(16)
2

Radiation used: Mo Kα (λ = 0.71073 Å). R1 = ∑ | |Fo| - |Fc| | / ∑ |Fo|; wR2 = [∑[w(Fo -Fc2)2]/[∑(Fo2)2]]1/2 where w = 1/[σ2(Fo2) +
(aP)2 + bP].
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Table 3-3. Selected bond lengths (Å) and angles (°).a
3⋅⋅CH2Cl2

4⋅⋅Et2O

5

8⋅⋅0.5CH3CN

10

M-N(1)

2.048(4)

2.077(3)

2.089(5)

2.134(5)

2.1117(17)

M-N(2)

2.084(3)

2.101(3)

2.097(5)

2.135(5)

2.1773(17)

M-N(3)

2.122(4)

2.110(3)

2.090(5)

2.291(5)

2.1192(18)

M-N(4)

2.202(4)

2.149(2)

2.170(5)

2.285(5)

2.1437(17)

2.029(4)

1.9695(14)

M-N(5)

2.055(5)

M-O(1)

1.986(3)

1.997(2)

M-O(2)

1.998(3)

1.995(2)

O(1)-M-N(1)

92.31(13)

172.53(10)

171.61(18)

175.44(15)

100.38(6)

O(1)-M-N(2)

169.33(14)

90.38(9)

91.86(18)

95.84(16)

173.83(7)

O(1)-M-N(3)

92.78(13)

91.33(9)

88.37(19)

82.06(16)

108.72(6)

O(1)-M-N(4)

108.01(13)

85.18(9)

83.81(18)

96.88(16)

102.48(6)

O(1)-M-N(5)

1.989(4)

90.4(2)

O(1)-M-O(2)

90.84(12)

91.77(9)

90.30(15)

O(2)-M-N(1)

173.30(14)

94.96(9)

93.99(17)

O(2)-M-N(2)

94.72(14)

172.17(9)

171.34(17)

O(2)-M-N(3)

89.15(13)

91.69(9)

99.88(17)

O(2)-M-N(4)

89.34(14)

106.72(9)

105.54(16)

N(1)-M-N(2)

83.13(15)

82.53(10)

82.77(18)

80.06(18)

77.04(7)

N(1)-M-N(3)

96.59(15)

85.24(10)

84.5(2)

98.68(18)

108.75(6)

N(1)-M-N(4)

84.06(15)

95.97(10)

101.40(18)

80.50(17)

127.56(7)

75.03(18)

77.45(7)

N(1)-M-N(5)

94.8(2)

N(2)-M-N(3)

78.23(14)

80.73(10)

81.92(19)

N(2)-M-N(4)

81.20(15)

80.97(10)

79.13(19)

N(2)-M-N(5)
N(3)-M-N(4)

a

2.077(5)

75.25(6)

177.2(2)
159.18(14)

161.33(10)

159.22(19)

N(3)-M-N(5)

96.43(19)

N(4)-M-N(5)

102.82(19)

107.42(6)

Estimated standard deviations in the last significant figure are given in parentheses.

of

[(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4

(1),2b

specifically

the

Ni(II)

monobenzoate complex 6, along with benzoic acid and benzil. Thus, the Ni(II)-benzoate
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complex in the reaction mixture for the preparation of 3 could be due to oxidative
decomposition of the sample. Alternatively, the 6-PhTPA-supported Ni(II) benzoate
complex 6 might be formed via hydrolysis of the 2-oxo-2-phenylethylbenzoate ester
generated in the reaction mixture. This hypothesis was evaluated via treatment of the
solvent complex 5 with 2-oxo-2-phenylethylbenzoate in the presence of one equivalent of
Me4NOH⋅5H2O in CH3CN. The outcome of this reaction indicated the formation of new
Ni(II) species (as determined by 1H NMR), but no ester hydrolysis (95% recovery of
unaltered ester). Interestingly, performing the same reaction in the absence of the Ni(II)
complex results in ester hydrolysis to give Me4NO2CPh and PhC(O)CH2OH. Thus, in the
Ni(II)-containing reaction, hydroxide anion is unavailable for ester hydrolysis,
presumably due to the formation of Ni-OH species, which apparently does not promote
ester hydrolysis. Overall, this means that any Ni(II) benzoate complex 6 present in the
reaction mixture shown in Figure 3-1(a) would be due to oxidative decomposition.
Finally, we note that at this point we cannot identify species associated with resonances at
32.4 and 33.7 ppm in the “wet” reaction mixture (Figure 3-1(a)).
Co(II)

Chemistry:

The

challenges

in

preparing

[(6-

Ph2TPA)Co(PhC(O)C(OH)C(O)Ph)]ClO4 (7). We were interested in preparing the
Co(II) analog of 1 as it has been reported that reconstitution of apo-ARD with Co(II)
produces an enzyme having >90% Ni(II)-ARD-type reactivity (cleavage to give CO and
carboxylate products, Scheme 3-1(top)).13 Additionally, the ARD enzyme isolated from
K. pneumoniae contains ~20% Co(II) (with Ni(II) being present in ~70% and Fe(II)
~10%).14 Our initial attempt to prepare [(6-Ph2TPA)Co(PhC(O)C(OH)C(O)Ph)] ClO4 (7)
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involved following a procedure identical to that employed for the preparation of [(6Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (1) using the “wet” conditions. Specifically,
equimolar amounts of 6-Ph2TPA and Co(ClO4)2⋅6H2O were combined with a slight
stoichiometric excess of Me4NOH⋅5H2O and 2-hydroxy-1,3-diphenylpropane-1,3-dione
in CH3CN (~3000 ppm H2O; Karl-Fischer titration) and the reaction mixture was stirred
under N2 for 16.5 h. We noted the rapid formation of a green color in this reaction
mixture, which is significantly different from the orange-brown color that is found for
[(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4

(1)

and

[(6-

PhTPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (3). The 1H NMR spectral features of the green
mixture are shown in Figure 3-4(a). To interpret this 1H NMR data, we prepared and fully
characterized (including assignment of 1H NMR resonances) two new Co(II) complexes,
the dibenzoylmethane derivative [(6-Ph2TPA)Co(PhC(O)CHC(O)Ph)]ClO4 (8) and the
benzoate complex [(6-Ph2TPA)Co(O2CPh)]ClO4 (10). Additionally, we investigated the
1

H NMR features of the previously reported [(6-Ph2TPA)Co(CH3CN)](ClO4)2⋅CH3CN

(9).
The cationic portions of 8 and 10 are shown in Figure 3-5. Details of the X-ray
data collection are given in Table 3-2. Selected bond distances and angles for the
complexes are shown in Table 3-3. The Co(II) center in 8 exhibits a distorted octahedral
geometry. The bond distances involving the phenyl-appended pyridyl donors (N(3) and
N(4)) are ~0.16 Å longer than the other Co-N distances. The Co(II)-O distances involving
the enolate ligand differ by about ~0.03 Å, with the Co-O bond trans to the unsubstituted
pyridyl donor being slightly longer. Similar to [(6- Ph2TPA)Co(ONHC(O)CH3)]ClO4,15
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Figure 3-4. Regions of the 1H NMR spectra of (a) the reaction mixture produced upon
treatment of 6-Ph2TPA with an equimolar amount of Co(II)(ClO4)2⋅6H2O and slight
stoichiometric excesses of Me4NOH·5H2O and 2-hydroxy-1,3-diphenylpropan-1,3-dione
in CH3CN (~3000 ppm H2O); (b) the reaction mixture generated using conditions
identical to those employed for the preparation of 3 (predrying of base and solvent); (c)
the reaction mixture produced upon predrying of base and solvent and shorter reaction
time;
(d)
[(6-Ph2TPA)Co(PhC(O)CHC(O)Ph)]ClO4
(8);
(e)
[(6Ph2TPA)Co(CH3CN)](ClO4)2⋅ClO4⋅CH3CN (9); (f) [(6-Ph2TPA)Co(O2CPh)]ClO4 (10).
Spectra d-f are for analytically pure compounds. The 1H NMR spectra were collected in
CD3CN at ambient temperature and were referenced to the 1H NMR signal of CD2HCN
(1.94 ppm). The diamagnetic region of each spectrum is omitted to improve the clarity of
the spectral comparison.

the bidentate anion is positioned in a hydrophobic sandwich between the phenyl
appendages of the 6-Ph2TPA ligand. The benzoate complex 10 exhibits monodentate
coordination of the carboxylate (∆d = 0.8 Å; ∆θ = 36.6°).16 The overall geometry of the
Co(II) center is distorted trigonal bipyramial (τ = 0.77; for a perfect trigonal bipyramid τ
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Figure 3-5. Thermal ellipsoid drawings of the cationic portions of 8 and 10. Ellipsoids are
drawn at the 50% probability level. Hydrogen atoms are not shown for clarity. Only one
of two cations present in the asymmetric unit of 8 is shown.

= 1),17 with the carboxylate ligand in an axial position. A similar geometry was found for
[(6-Ph2TPA)Co(CH3CN)](ClO4)2⋅CH3CN (9) (τ = 0.89). The solution magnetic moments
for 8 and 10 were measured in CH3CN at 298 K using the Evans method.18 The µeff
values obtained for these complexes, 4.72 and 4.32 µB, respectively, are within the
expected experimental range for high-spin Co(II)

complexes.19 High-spin Co(II)

complexes generally exhibit a ligand field transition in the range of 500-600 ppm. The
intensity of this transition varies with the coordination number of the Co(II) center, with
six-coordinate Co(II) complexes generally having ε < 50 M-1cm-1.20
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The absorption spectrum of the red-orange dibenzoylmethane complex 8 contains a band
at 564 nm (ε = 77 M-1cm-1). Though the molar absorptivity value for the 564 nm band
exceeds the threshold of ε < 50 M-1cm-1, 1H NMR data for the complex (vide infra)
suggest that the solution form of the complex has a six-coordinate Co(II) center. For the
green benzoate complex 10 a ligand field transition is present at 590 nm (49 M-1cm-1).
This suggests an overall coordination number of six for the benzoate complex in CH3CN.
Assignments for the 1H NMR resonances of 8-10 are given in Table 3-4.
Initial assignments were made on the basis of integrated intensity and T1 values.
Signals associated with the aryl and methylene hydrogens of the 6-Ph2TPA ligand were
confirmed using analog complexes prepared with the deuterated ligand analogs 6-(d5Ph)2TPA and (6-Ph)2-d6-TPA and complementary 2H NMR spectroscopy.11 For each
complex the overall number of signals is consistent with an effective plane of symmetry
in the cation to give equivalent phenyl-appended pyridyl donors. This is also consistent
with the identification of three methylene proton resonances. Selected regions of the
spectra of 8-10 are shown in Figure 3-4(d-f).
Similar to the 1H NMR features of 6- Ph2TPA-supported Ni(II) complexes,11 each
Co(II) complex exhibits a pattern of isotropically shifted resonances for the pyridyl ring
protons with chemical shifts in the order α-H > β-H > γ-H. Resonances in the region of
~80-20 ppm clearly distinguish the complexes. Within this region are signals associated
with the β and β’ hydrogens of the pyridyl rings (Figure 3-6). A characteristic feature of
the 1H NMR spectrum of [(6-Ph2TPA)Co(PhC(O)CHC(O)Ph)]ClO4 (8) is a signal at -49
ppm, which has been assigned as a phenyl ring proton resonance of the 6-Ph2TPA ligand.
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Table 3-4. 1H NMR chemical shifts for 8-10 in CD3CN at 298 K.
assignment

chem. shift (ppm)a

∆ν1/2(Hz)b

T1exp(ms)c

rel. area

[(6-Ph2TPA)Co(PhC(O)CHC(O)Ph)]ClO4 (8)
α

151.21

247

2

1

β

77.42, 52.47

104, 49

10, 33

d, d

β’

27.12, 22.59

71, 62

20, 52

2, 2

γ

18.42

d

d

d

γ’

-10.06

69

74

2

193.14, 125.99, 75.82

632, 242, 104

2, 2, 10

2, 2, d

8.04, 3.87, -48.69

38, 42, 184

85, 41, 5

d, d, 4

CH2
Ph

[(6-Ph2TPA)Co(CH3CN)](ClO4)2 (9)
α

153.68

963

d

1

β

69.32, 48.34

141, 141

d, 35

1, 1

β’

73.05, 40.07

141, 141

48, 180

2, 2

γ

-4.28

65

150

2

γ’

-0.91

72

480

1

CH2

119.1, 87.60, 53.1

d, 2190, d

d

2, 2, d

Ph

25.68, 5.46, 2.96

751, 69, d

d, 160, 230

4, 2, d

[(6-Ph2TPA)Co(O2CPh)]ClO4 (10)
α

142.22

867

<1

1

β

52.99, 50.61

103, 153

11, 5

1, 1

β’

55.62, 35.43

153, 217

8, 4

2, 2

γ

0.64

72

9

1

γ’

-0.36

72

11

2

117.2, 76.35, d

d, 2190, d

<1

d, d, d

8.59, 4.19, d

65, 88, d

14, 7, d

2, 4, d

27.45, 15.73, 12.92

286, 103, 84

2, 23, 47

2, 2, 1

CH2
Ph
Benzoate
a

Chemical shifts in ppm relative to the residual solvent peak of CHD2CN (1H, 1.94 (quintet) ppm). bLine widths are full width at a
half-maximum. cT1 values were obtained on 300 MHz. dCould not be determined.

An additional distinct resonance for this compound is found at -10 ppm and is for the γ’
hydrogen. The spectrum of the benzoate complex is unique in a clustering of three of the
four β/β’ resonances in chemical shift range of 50-56 ppm.
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Figure 3-6. Labeling scheme for the 6-Ph2TPA ligand.

Having fully characterized 8-10 and assigned the 1H NMR signals of these
complexes, we were positioned to evaluate the “wet” reaction mixture (Figure 3-4(a))
generated upon treatment of 6-Ph2TPA and Co(ClO4)2⋅6H2O with a slight stoichiometric
excess of Me4NOH⋅5H2O and 2-hydroxy-1,3-diphenylpropane-1,3-dione in “wet”
acetonitrile

under

the

conditions

used

to

isolate

[(6-

Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (1).2a It is clearly evident by the 1H NMR
features shown in Figure 3-4(a) that the Co(II) benzoate complex 10 is present with β/β’H signals at ~55.6, 53.0, 50.6, and 35.5 ppm. Additionally, it is noteworthy that several
signals are present upfield of 0 ppm. This suggests that multiple enolate-type complexes
are also present (via comparison to the spectral features with those of the
dibenzoylmethane complex 8 (Figure 3-4(d)). Work-up of the “wet” reaction mixture
resulted in the isolation of the ester 2-oxo-2-phenylethylbenzoate in ~50% yield based on
the initial amount of 2-hydroxy-1,3-diphenylpropane-1,3-dione employed. Thus, similar
to the chemistry of 6-PhTPA-supported Ni(II), ester formation occurs in the Co(II) system
under the “wet” reaction conditions. Additionally, we isolated ~21 mg (58% recovery) of
unaltered 6-Ph2TPA from the reaction mixture.
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Rationalizing that removal of water might enable the preparation of the desired
enolate complex [(6-Ph2TPA)Co(PhC(O)C(OH)C(O)Ph)]ClO4 (7), we next attempted a
synthesis using the dry conditions involving predried Me4NOH and CH3CN that enabled
the isolation of [(6-PhTPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (3). Admixture of the
reagents followed by stirring for 3 h under N2 and workup resulted in the isolation of an
orange solid with features in the 1H NMR spectrum as shown in Figure 3-4(b). Notably,
this spectrum does not indicate the presence of Co(II) benzoate complex (8), and suggests
the formation of a single Co(II) enolate complex as evidenced by signals at ~-10 and -49
ppm. Based on the 1H NMR features of 8, these could be signals for the γ’ and phenyl
ring protons of the desired complex 7. Unfortunately, other signals are present indicating
that the isolated product is not pure. Evaluation of the organic products from the reaction
once again revealed the presence of a mixture of the ester 2-oxo-2-phenylethylbenzoate
and 6-Ph2TPA in a ~1:1 ratio. Thus, unlike the (6-PhTPA)Ni(II) system, reducing the
amount of water in the reaction mixture did not significantly reduce the amount of ester
generated. However, removal of water does prevent formation of the benzoate complex
10.
We next explored a variety of reaction conditions in attempts to prepare pure [(6Ph2TPA)Co(PhC(O)C(OH)C(O)Ph)]ClO4 (7) and have found that the best results are
obtained using dry conditions akin to those described herein for the prepartion of [(6PhTPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (3) but with a shorter reaction time. Specifically,
admixture of equimolar amounts of [(6-Ph2TPA)Co(CH3CN)](ClO4)2⋅CH3CN (9), 2hydroxy-1,3-diphenylpropane-1,3-dione, and predried Me4NOH in CH3CN (<10 ppm
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H2O) and stirring for 15 min results in the formation of a deep orange solution with λmax
= 397 nm. We note that this is the same wavelength that was identified for the π→π*
transition of the enolate ligand in [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (1)2b and
[(6-PhTPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (3). Immediate removal of the solvent under
vacuum, followed by workup, yielded a dark orange solid with the 1H NMR properties as
shown in Figure 3-4(c). The complex generated has many similar features to the
dibenzoylmethane complex 8, suggesting that both likely contain a six-membered ring
enolate ligand. These 1H NMR similarities, combined with the absorption maximum at
397 nm, suggest that [(6-Ph2TPA)Co(PhC(O)C(OH)C(O)Ph)]ClO4 (7), has been formed.
However, like all of the reaction mixtures targeting this complex, the ester 2-oxo-2phenylethylbenzoate and free 6-Ph2TPA are also generated. The presence of these
byproducts has prevented our obtaining elemental analysis data for 7. That being said,
evaluation of the O2 reactivity properties of this complex are underway. Preliminary
studies indicate that exposure of a CH3CN solution of 7 to air results in a rapid color
change from orange brown to green. The 1H NMR features of the reaction mixture are
consistent with formation of the benzoate complex [(6-Ph2TPA)Co(O2CPh)]ClO4 (10).
This

reaction

is

akin

to

Ph2TPA)Ni(PhC(O)CH(OH)CPh)]ClO4

that
(1).2b

previously
The

reported

generation

for
of

[(6-

2-oxo-2-

phenylethylbenzoate in the initial “wet” reaction mixture directed at the preparation of the
Co(II) enolate complex 7 (Figure 3-4(a)) , and the disappearance of the benzoate complex
[(6-Ph2TPA)Co(O2CPh)]ClO4 (10) once the reagents (base and solvent) were predried,
led us to hypothesize that the presence of water promotes ester hydrolysis to provide the
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benzoate ligand in 10. In an independent experiment admixture of the ester with [(6Ph2TPA)Co(CH3CN)](ClO4)2⋅CH3CN (9) and Me4NOH⋅5H2O resulted in the formation
of the Co(II) benzoate complex [(6-Ph2TPA)Co(O2CPh)]ClO4 (10) thus confirming our
notion.

As

noted

above,

an

PhTPA)Ni(CH3CN)(CH3OH)](ClO4)2

independent
(5),

experiment

involving

[(6-

2-oxo-2-phenylethyl

benzoate,

and

Me4NOH⋅5H2O showed no ester hydrolysis reactivity. Thus the two different
metal/ligand combinations (6-PhTPANi and 6-Ph2TPACo) exhibit different ester
hydrolysis reactivity.
Conclusions
The coordination chemistry of acireductone-type ligands reported to date is quite
limited.2,3,5,6 In our laboratory we have pursued synthetic studies directed at the
preparation of metal complexes of relevance to the ES adduct in Ni(II)-ARD, which
catalyzes a CO-producing reaction. As the Ni(II) center in this enzyme can be replaced
with Co(II) with almost full retention of enzyme activity,14 we are also interested in
examining the chemistry of Co(II) complexes of acireductone-type ligands.
The research described herein outlines our discovery that the presence of water
influences the preparation of a Ni(II) enolate complex of an acireductone-type ligand.
Reducing the amount of water present in the reaction mixture via predrying of the base
and solvent significantly reduced the amount of isomerization of 2-hydroxy-1,3diphenylpropane-1,3-dione to the ester 2-oxo-2-phenylethylbenzoate and increases the
yield of the desired Ni(II) enolate complex, [(6-PhTPA)Ni(PhC(O)CH(OH)CPh)]ClO4
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(3). We propose that water is involved in the acid/base chemistry necessary to promote
isomerization the reaction (Scheme 3-3). It is known that isomerization of 2-hydroxy-1,3diphenylpropane-1,3-dione to ester will occur in aqueous NaHCO3/methanol solution.10
In our system, a combination of a Ni(II)-OH moiety and H2O may be necessary to
promote isomerization reactivity in a general base/general acid type reaction sequence.
The 6-Ph2TPA-supported Co(II) system exhibits a more multifaceted waterdependent chemistry. Like the (6-PhTPA)Ni-containing system, isomerization of 2hydroxy-1,3-diphenylpropane-1,3-dione

to

2-oxo-2-phenylethylbenzoate

occurs

in

reaction mixtures containing water. However, predrying of the base and solvent in this
system does not significantly reduce the amount of ester generated. Instead, a dryer
reaction environment reduces the amount of a 6-Ph2TPA-supported Co(II) benzoate
complex generated relative to the “wet” reaction mixture. Independent studies of ester
hydrolysis

reactivity

showed

that

the

combination

Ph2TPA)Co(CH3CN)](ClO4)2⋅CH3CN

(9),

Me4NOH⋅5H2O

and

of

[(62-oxo-2-

phenylethylbenzoate in CH3CN results in ester hydrolysis and the liberation of benzoate
anion. Notably, a similar type of ester hydrolysis reactivity does not occur for a reaction
mixture containing [(6-PhTPA)Ni(CH3CN)(CH3OH)](ClO4)2 (5), Me4NOH⋅5H2O, and 2oxo-2-phenylethylbenzoate in CH3CN. This provides a rationale for why little, if any,
Ni(II) benzoate complex is generated in the “wet” reaction mixture.
Overall, our results have provided insight into the conditions required to prepare
two new complexes of relevance to the ES adduct in acireductone dioxygenases. The
differing effects of water on the reactions involving (6-PhTPA)Ni- and (6-Ph2TPA)Co-
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supported complexes (isomerization and/or ester hydrolysis) cannot be fully explained at
this point, but may relate to differences in M-OH/H2O chemistry for the two metal/ligand
combinations. As our group also has a strong interest in metal-promoted hydrolysis
reactions21, this area is under further investigation.
Experiments
General comments
All reagents and solvents were obtained from commercial sources and were used
as received unless otherwise noted. Solvents were dried according to published
procedures22 and were distilled under N2 prior to use. Air-sensitive reactions were
performed in a MBraun Unilab or Vacuum Atmospheres glovebox under an N2
atmosphere. The acireductone analog 2-hydroxy-1,3-diphenylpropan-1,3-dione,2a the
Ni(II) enolate complex [(6-Ph2TPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (1),2a and the Co(II)
complex [(6-Ph2TPA)Co(CH3CN)]ClO4 (9)15 were prepared as previously described.
Physical methods
UV-vis spectra were recorded on a Hewlett-Packard 8453 diode array
spectrophotometer. IR spectra were recorded on a Shimadzu FTIR-8400 spectrometer as
KBr pellets. 1H NMR spectra of diamagnetic species were recorded on a Bruker ARX400 spectrometer and the chemical shifts (in ppm) are referenced to the residual solvent
peak(s) in CHD2CN (1H, 1.94 (quintet) ppm). GC-MS data was obtained using a
Shimadzu QP5000 with an Alltech EC-5 column and ultra high purity helium as the
carrier gas. FAB-MS data was obtained at the Mass Spectrometry Facility, Department of
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Chemistry, University of California, Riverside. Elemental analyses were performed by
Atlantic Microlabs Inc., Norcross, GA or Canadian Microanalytical, Service, Inc., British
Columbia, Canada.
NMR methods for paramagnetic Ni(II) and Co(II) complexes
A typical one-dimensional 1H NMR spectrum consisted of 16 K data points, 300
scans, and a 250 ms relaxation delay. An exponential weighting function (lb = 30 Hz)
was used during processing. The 90° pulse (14.1 µs) was calibrated at 298 K.
Longitudinal relaxation times (T1) were measured using the inversion-recovery pulse
sequence (180°-τ-90°) method on a JEOL ECX-300. 2H NMR spectra were obtained at
298 K on a Bruker ARX-400 operating at 61.43 MHz using an unlocked system. Overall,
methods of data collection and processing for paramagnetic complexes followed closely
from those previously described.11
6-N-(6-phenyl-2-pyridyl)methyl)-N,N-((2-pyridyl)methyl)-amine (6-PhTPA).
This ligand has been previously reported8, however, the preparative method employed
herein is an alternative route. A round bottomed flask was charged with an acetonitrile
slurry of 2-(chloromethyl)-6-phenylpyridine hydrochloride (6.0 g, 0.025 mol), di-(2picolyl)-amine (5.0 g, 0.025 mol), sodium bicarbonate (13.3 g, 0.125 mol), and a catalytic
amount of tetrabutylammonium bromide. The reaction was then purged with N2 and
refluxed for 24 h. After this time, the mixture was cooled to room temperature and 0.1 M
NaOH was added until the pH > 11. The resulting mixture was extracted with methylene
chloride (3 x 200 mL). The organic fractions were combined, dried over anhydrous
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Na2SO4, and the solvent was removed under reduced pressure. The resulting brown oil
was purified using column chromatography using ethyl acetate:methanol (1:1) as the
eluent. Yield: 8.56 g (93%). 1H NMR (CDCl3, 400 MHz): δ 8.54 (d, J = 4.8 Hz, 2 H),
8.00 (d, J = 7.4 Hz, 2 H), 7.72 (t, J = 7. 8 Hz, 1 H), 7.68-7.65 (m, 3 H), 7.58 (d, J = 7. 8
Hz, 2H), 7.50 (d, J = 7. 8 Hz, 1H), 7.46 (t, J = 7.7 Hz, 2 H), 7.39 (dt, J = 7.3 Hz, J = 2.3
Hz, 1 H), 7.14 (dd, J = 7.8 Hz, J = 4.7 Hz, 2 H), 3.97 (s, 2 H), 3.95 (s, 4 H). These 1H
NMR features match those previously reported.8

Caution! Perchlorate salts of metal complexes with organic ligands are
potentially explosive. Only small amounts of material should be prepared, and these
should be handled with great care.23

Attempted preparation of [(6-PhTPA)Ni(PhC(O)C(OH)C(O)Ph]ClO4 (3)
under the conditions used to prepare 1. Isolation of isomerization product. In a
glovebox, equimolar amounts of 6-PhTPA (30 mg, 8.2 x 10-5 mol) and Ni(ClO4)2·6H2O
(30 mg, 8.2 x 10-5 mol) were combined in ~3 mL of acetonitrile (dried from CaH2; ~3000
ppm water determined via Karl-Fischer titration) and stirred until everything had
dissolved. This resulted in the formation of a purple-brown solution. This solution was
then added to solid Me4NOH·5H2O (16 mg, 9.0 x 10-5 mol) and the mixture was stirred
for an additional ~1 min. At this time, 2-hydroxy-1,3-diphenylpropane-1,3-dione (22 mg,
9.0 x 10-5 mol), dissolved in ~1 mL of acetonitrile, was added and the deep orange
solution was stirred overnight at ambient temperature. The solvent was then removed
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under vacuum and the remaining solid was dissolved in ~5 mL of dichloromethane. This
solution was passed through a celite/glass wool plug and the filtrate was then reduced in
volume to ~1 mL. Addition of excess hexanes (~20 mL) resulted in the deposition of an
orange powder, which was dried under vacuum. 1H NMR analysis indicated the presence
of the desired enolate complex ([(6-PhTPA)Ni(PhC(O)C(OH)C(O)Ph)]ClO4 (3) and
other (6-PhTPA)Ni(II) containing products. To identify the organic products in the
reaction mixture, the CH2Cl2/hexanes solution from which the metal complexes were
precipitated was filtered through a celite/glass wool plug. The filtrate was then dried
under vacuum leaving a white solid (10 mg). 1H NMR and GC-MS analysis of the white
solid confirmed its identity as a 2-oxo-2-phenylethylbenzoate via comparison with
independently synthesized sample. The amount of solid recovered is consistent with a
46% yield starting from 2-hydroxy-1,3-diphenylpropane-1,3-dione.
Evaluation of ester formation in the reaction leading to the formation of [(6Ph2TPA)]Ni(PhC(O)C(OH)C(O)Ph]ClO4 (1). In the glovebox, equimolar amounts of
6-Ph2TPA (34 mg, 7.6 x 10-5 mol) and Ni(ClO4)2·6H2O (28 mg, 7.6 x 10-5 mol) were
mixed in ~3 mL of acetonitrile and stirred until everything had dissolved, which gave a
purple solution. This solution was then combined with solid Me4NOH·5H2O (15 mg, 8.3
x 10-5 mol) and the mixture was stirred for ~1 min. At this time, a CH3CN solution (~1
mL) of 2-hydroxy-1,3-diphenylpropane-1,3-dione (20 mg, 8.3 x 10-5 mol) was added and
the mixture was stirred overnight at ambient temperature to give a deep orange solution.
After removal of the solvent under vacuum, the residue was dissolved dichloromethane
(~5 mL) and the solution was filtered through a celite/glass wool plug. The filtrate was
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collected and the solvent volume was reduced to ~1 mL under vacuum. Addition of
excess hexanes (~20 mL) resulted in the deposition of 1 as an orange-brown solid which
was dried under vacuum. (48.2 mg, 76% yield). The formulation of the complex was
confirmed by 1H NMR. The solution from which the precipitate was obtained was then
filtered through a celite/glass wool plug to remove any residual metal complex and the
filtrate was brought to dryness under vacuum yielding a white solid (11 mg). 1H NMR
analysis of this solid indicated the presence of 2-oxo-2-phenylethylbenzoate and 6Ph2TPA in a 2:1 ratio.
Isolation of analytically pure [(6-PhTPA)Ni(PhC(O)C(OH)C(O)Ph]ClO4 (3)
using predried base and solvent. In this entire procedure extra dry CH3CN purchased
from ACROS Organics (<10 ppm H2O) was used. Under a N2 atmosphere,
Me4NOH⋅5H2O (16 mg, 9.0 x x 10-5 mol) was dissolved in methanol in a Schlenk flask
and the mixture was dried under vacuum for >24 h. To the remaining solid was added an
acetonitrile solution (~2 mL) containing 6-PhTPA (30 mg, 8.2 x 10-5 mol) and
Ni(ClO4)2·6H2O (30 mg, 8.2 x 10-5 mol). The resulting mixture was stirred for ~1 min. At
this time, a CH3CN solution (~1 mL) of 2-hydroxy-1,3-diphenylpropane-1,3-dione (22
mg, 9.0 x 10-5 mol) was added and the reaction mixture was immediately put under
vacuum. Upon stirring for ~3 h at ambient temperature, the solution became deep
orange/brown. After removal of the solvent under reduced pressure, the remaining
orange/brown solid was dissolved in CH2Cl2 (~5 mL) and the solution was filtered
through a celite/glass wool plug. The filtrate was concentrated under reduced pressure to
a volume of ~1 mL, which was then added to excess hexanes (~20 mL). This resulted in
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the deposition of an orange/brown solid which was dried for ~ 2 h under vacuum. Yield:
59 mg (94%). X-ray quality crystals were obtained from CH2Cl2/n-pentane. Anal. Calcd
for: C39H33ClN4NiO7·1/6CH2Cl2: C, 60.56; H, 4.33; N, 7.22. Found: C, 60.48; H, 4.02;
N, 7.29. The presence of trace CH2Cl2 in the elemental analysis sample was confirmed by
1

H NMR. FTIR: 3439 (νO-H), 1095 (νClO4), 621 (νClO4); UV-vis (CH3CN) nm (ε, M-1cm-1)

393 (10600).
[(6-PhTPA)Ni(PhC(O)CHC(O)Ph)]ClO4 (4). A solution of Ni(ClO4)2·6H2O (35
mg, 1.0 x 10-4 mol) in acetonitrile (~3 mL) was added to solid 6-PhTPA (37 mg, 1.0 x
10-4 mol) and the resulting mixture was stirred until all of the solids had dissolved. An
acetonitrile solution (~2 mL) containing dibenzoylmethane (21 mg, 1.0 x 10-4 mol) and
Me4NOH·5H2O (17 mg, 1.0 x 10-4 mol) was then added and the mixture was stirred
overnight at ambient temperature. The solvent was removed under reduced pressure and
the remaining solid was dissolved in CH2Cl2. The solution was filtered through a
celite/glass wool plug and the solvent was subsequently removed from the filtrate under
vacuum. The remaining solid was dissolved in a small amount of acetonitrile and excess
diethyl ether (~20 mL) was added to precipitate the desired product. Yield: 40 mg (54%).
X-ray quality crystals were obtained by diethyl ether diffusion into an acetonitrile solution
of the complex. Anal. Calcd for: C39H33ClN4NiO6·0.95C4H10O: C, 62.82; H, 5.23; N,
6.85. Found: C, 62.98; H, 5.27; N, 7.00. FTIR (KBr, cm-1) 1092 (νClO4), 621 (νClO4). UVvis (CH3CN) nm (ε, M-1cm-1) 543 (26), 793 (22), 907 (30); FAB-MS m/z (relative
intensity) 647 ([M-ClO4]+, 100%).
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[(6-PhTPA)Ni(CH3CN)(CH3OH)](ClO4)2 (5). A solution of 6-Ph2TPA (48 mg,
1.3 x 10-4 mol) and Ni(ClO4)2·6H2O (45 mg, 1.3 x 10-4 mol) in acetonitrile (~3 mL) was
prepared and stirred until all solids had dissolved. The solution was then brought to
dryness under vacuum and the residue was dissolved in MeOH. Crystals were grown by
Et2O diffusion into the methanol solution. Yield: 72 mg (84%). Anal. Calcd for:
C27H29Cl2N5NiO9: C, 46.52; H, 4.19; N, 10.05. Found: C, 46.17; H, 4.30; N, 10.00. FTIR
(KBr, cm-1) 1092 (νClO4), 623 (νClO4). UV-vis (CH3CN) nm (ε, M-1cm-1) 541 (20), 793
(17), 913 (23); FAB-MS m/z (relative intensity) 424 ([M-2(ClO4)-CH3CN-CH3OH-H+]+,
9%).
[(6-PhTPA)Ni(O2CPh)]ClO4 (6). An acetonitrile solution (~3 mL) containing 6PhTPA (33 mg, 8.9 x 10-5 mol) and Ni(ClO4)2·6H2O (32 mg, 8.9 x 10-5 mol) was
prepared and stirred until all solids had dissolved. This solution was then combined with
solid sodium benzoate (13 mg, 8.9 x 10-5 mol) and ~1 mL of MeOH was added. This
mixture was stirred for ~1 h at ambient temperature and the solvent was then removed
under reduced pressure. The remaining solid was dissolved in CH2Cl2 and the solution
was passed through a celite/glass wool plug. The solvent was removed from the filtrate
under reduced pressure. The desired complex was obtained by dissolving the solid in
minimal CH2Cl2 followed by addition of excess n-pentane. The process was repeated
three times to obtain analytically pure complex Yield: 30 mg (53% yield). X-ray quality
crystals were obtained by diffusion of a CH2Cl2/i-PrOH/AcOEt solution of the complex
into n-pentane. Anal. Calcd for: C31H27ClN4NiO6·1/3CH2Cl2: C, 55.85; H, 4.14; N, 8.32.
Found: C, 55.59; H, 4.31; N, 8.31. The presence of CH2Cl2 in the elemental analysis
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sample was confirmed by 1H NMR. FTIR (KBr, cm-1) 1092 (νClO4), 623 (νClO4); UV-vis
(CH3CN) nm (ε, M-1cm-1) 543 (14), 802 (7), 953 (15); FAB-MS m/z (relative intensity)
545 ([M-ClO4]+, 75%).
Evaluation of 2-oxo-2-phenylethylbenzoate hydrolysis in the presence of [(6PhTPA)Ni(CH3CN)(CH3OH)](ClO4)2 (9) and Me4NOH⋅⋅5H2O. In a glovebox, [(6PhTPA)Ni(CH3CN)(MeOH)](ClO4)2 (5) (23 mg, 3.3 x 10-5 mol), was dissolved in
acetonitrile and combined with equimolar amounts Me4NOH·6H2O (6.0 mg, 3.29 x 10-5
mol) and PhC(O)OCH2C(O)Ph (7.9 mg, 3.29 x 10-5 mol) and the mixture was stirred for
16.5 h. The solvent was then removed under reduced pressure and the remaining solid
was dissolved in CH2Cl2, and the solution was filtered through a celite/glass wool plug.
The filtrate was concentrated under vacuum and precipitation of the metal complex(es)
was induced by the addition of excess hexane. The 1H NMR of this solid indicated the
presence of multiple Ni(II) complexes, as evidenced by several overlapping signals in the
region of 80-20 pm. These complexes are likely one or more Ni-OH species. The solution
from the precipitate was isolated was filtered through a celite/glass wool plug and the
filtrate was brought to dryness leaving a white solid (7.5 mg). 1H NMR of this solid
indicated the presence of unaltered ester PhC(O)OCH2C(O)Ph in 95% yield. No other
organic products were detected.
Attempted preparation of [(6-Ph2TPA)Co(PhC(O)C(OH)C(O)Ph]ClO4 (7)
under the conditions used to prepare 1. In a N2-filled glovebox, 6-Ph2TPA (36 mg, 8.2
x 10-5 mol) and Co(ClO4)2·6H2O (30 mg, 8.2 x 10-5 mol) were mixed in ~3 mL of
acetonitrile (~3000 ppm H2O via Karl-Fischer titration) and the solution was stirred until
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everything had dissolved. This purple solution was then combined with solid
Me4NOH·5H2O (16 mg, 9.0 x 10-5 mol) and the mixture was stirred for ~1 min. To this
solution was added a CH3CN solution (1 mL) of 2-hydroxy-1,3-diphenylpropane-1,3dione (22 mg, 9.0 x 10-5 mol). The deep orange solution was then stirred overnight at
ambient temperature during which time the color changed to green. The solvent was
removed under vacuum and the remaining solid was dissolved in CH2Cl2 (~5 mL). This
solution was passed through a celite/glass wool plug and the filtrate was reduced to ~1
mL under vacuum. Addition of excess hexanes (~20 mL) resulted in the deposition of a
brown

solid

(40

mg).

1

H

NMR

analysis

indicates

the

presence

of

[(6-

Ph2TPA)Co(O2CPh)]ClO4 (10) and other Co(II) compounds (Figure 4-3(a)). The solution
remaining after the isolation of the metal complexes was filtered through a celite/glass
wool plug and the filtrate was brought to dryness under vacuum leaving a white solid (32
mg). 1H NMR (in CD3CN) and GC-MS analysis of this solid confirmed the presence of
the ester 2-oxo-2-phenylethylbenzoate (~11 mg, 50% based on 2-hydroxy-1,3diphenylpropane-1,3-dione) and the 6-Ph2TPA (~21 mg, ~58% recovery).
Attempted preparation of [(6-Ph2TPA)Co(PhC(O)C(OH)C(O)Ph]ClO4 (7)
under conditions used to isolate 3. In this entire procedure extra dry CH3CN purchased
from ACROS Organics (<10 ppm H2O) was used. Prior to the synthesis, Me4NOH·5H2O
was dissolved in ~2 mL methanol, transferred to a Schlenk flask, and dried under vacuum
for >24 h. In the glovebox, [(6-Ph2TPA)Co(CH3CN)](ClO4)2 (9) (64 mg, 8.2 x 10-5 mol)
was dissolved in acetonitrile and stirred until everything had dissolved, yielding a purple
solution. Next, 2-hydroxy-1,3-diphenylpropane-1,3-dione (22 mg, 9.0 x 10-5 mol)
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dissolved in ~1 mL of acetonitrile was added to the solid, pre-dried Me4NOH·5H2O (16
mg; 9.0 x 10-5 mol). This mixture was immediately combined with the solution of [(6Ph2TPA)Co(CH3CN)](ClO4)2 and the mixture was stirred for 3 h, under vacuum, yielding
a deep orange/red solution. The solvent was then removed under reduced pressure. The
remaining orange solid was dissolved in ~5 mL of dichloromethane, and the solution was
filtered through a celite/glass wool plug. The filtrate was concentrated to ~1 mL under
vacuum and the Co(II)-containing products were precipitated by the addition of excess
hexanes (~20 mL). This resulted in the isolation of 54 mg of an orange solid. The 1H
NMR features of this solid are shown in Figure 4-3(b). The hexane layer was filtered
through a celite/glass wool plug and the filtrate was brought to dryness under vacuum. A
white solid was obtained (22 mg). 1H NMR analysis of this solid showed the presence of
2-oxo-2-phenylethylbenzoate and 6-Ph2TPA in ~1:1 ratio.
Attempted preparation of [(6-Ph2TPA)Co(PhC(O)C(OH)C(O)Ph]ClO4 (7)
under dry conditions and using a short reaction time. In this entire procedure extra
dry CH3CN purchased from ACROS Organics (<10 ppm H2O) was used. Me4NOH·5H2O
(5.9 mg, 3.3 x 10-5 mol) was dissolved in ~3 mL acetonitrile. This solution was brought
to dryness and the remaining solid was dried under vacuum for 2 h. This step was
repeated twice. Next, [(6-Ph2TPA)Co(CH3CN)](ClO4)2 (9) (26 mg, 3.3 x 10-5 mol) and 2hydroxy-1,3-diphenylpropane-1,3-dione (7.8 mg, 3.3 x 10-5 mol) were independently
dissolved in CH3CN (2 mL). The solution of 2-hydroxy-1,3-diphenylpropane-1,3-dione
was

added

to

the

solid

Me4NOH

and

the

CH3CN

solution

of

[(6-

Ph2TPA)Co(CH3CN)](ClO4)2 (9) was subsequently added. The reaction immediately
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turned dark orange (λmax 397 nm). It was stirred for 15 min and then the solvent was
removed under reduced pressure. The remaining dark orange solid was dissolved in
dichloromethane (~3 mL) and the solution was filtered through a celite/glass wool plug.
The filtrate was reduced in volume to ~1 mL and the Co(II) product was precipitated via
the addition of excess of hexanes (~20 mL). The 1H NMR features of this solid are shown
in Figure 4-3(c). UV-vis (CH3CN) λmax = 397 nm. The hexane layer was filtered through
a celite/glass wool plug and the filtrate was brought to dryness under vacuum. A white
solid was obtained (12 mg). 1H NMR analysis of this solid indicated the presence of the
ester 2-oxo-2-phenylethylbenzoate and 6-Ph2TPA in a ratio of 3:1.
[(6-Ph2TPA)Co(PhC(O)CHC(O)Ph)]ClO4 (8). A mixture of 6-Ph2TPA (18 mg,
4.1 x 10-5 mol) and Co(ClO4)2·6H2O (14 mg, 3.7 x 10-5 mol) in acetonitrile (~3 mL) was
prepared and stirred until everything had dissolved. To this solution was added
dibenzoylmethane (10 mg, 4.6 x 10-5 mol) as a solution in acetonitrile (~1 mL). The
resulting mixture was stirred for 10 min at which point it was transferred to a glass vial
containing solid Me4NOH·5H2O (7.5 mg, 4.1 x 10-5 mol). This mixture was then stirred
overnight at ambient temperature. After removal of the solvent under reduced pressure,
the remaining dark orange-red solid was dissolved in CH2Cl2 and filtered through a
celite/glass wool plug. The solvent was removed from the filtrate under vacuum and the
remaining solid was recrystallized by Et2O diffusion into the acetonitrile solution. Yield:
24 mg (79%). Anal. Calcd for: C45H37ClCoN4O6: C, 65.60; H, 4.52; N, 6.80. Found: C,
65.46; H, 4.39; N, 7.15. FTIR (KBr, cm-1) 1094 (νClO4), 623 (νClO4). UV-vis (CH3CN) nm
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(ε, M-1cm-1) 350 (7500), 564 (77); FAB-MS m/z (relative intensity) 724 ([M-ClO4]+,
45%).
[(6-Ph2TPA)Co(O2CPh)]ClO4 (10). A mixture of 6-Ph2TPA (36 mg, 8.1 x 10-5
mol) and Co(ClO4)2·6H2O (27 mg, 7.3 x 10-5 mol) in acetonitrile (~3 mL) was prepared
and stirred until everything had dissolved. This solution was then added to solid sodium
benzoate (13 mg, 8.9 x 10-5 mol) and the resulting mixture was stirred overnight at room
temperature. The solvent was then removed under reduced pressure. The remaining green
solid was dissolved in CH2Cl2 and filtered through a celite/glass wool plug. The filtrate
was brought to dryness under reduced pressure and the remaining solid was recrystallized
by Et2O diffusion into an acetonitrile solution. Yield: 51 mg (98%). Anal. Calcd for:
C37H31ClCoN4O6: C, 61.55; H, 4.33; N, 7.76. Found: C, 61.39; H, 4.34; N, 7.86. FTIR
(KBr, cm-1) 1097 (νClO4), 621 (νClO4); UV-vis (CH3CN) nm (ε, M-1cm-1) 462 (103), 619
(66); FAB-MS m/z (relative intensity) 622 ([M-ClO4]+, 14 %).
Preparation of deuterated analogs of 8-10 of either the 6-(d5-Ph)2TPA or (6Ph)2-d6-TPA ligand. These analogs were prepared using 6-(d5-Ph)2TPA and (6-Ph)2-d6TPA11 and following the procedures for their protio analogs. 2H NMR spectra of these
complexes were obtained as previously described. We note that a d5-analog of 10, [(6Ph2TPA)Co(O2C-d5-Ph)]ClO4, was also prepared to enable the identification of the
benzoate phenyl resonances.
Evaluation of 2-oxo-2-phenylethylbenzoate hydrolysis in the presence of [(6Ph2TPA)Co(CH3CN)](ClO4)2·CH3CN (9) and Me4NOH⋅⋅5H2O. Under a nitrogen
atmosphere, a solution of [(Ph2TPA)Co(CH3CN)](ClO4)2·CH3CN (9) (26 mg, 3.3 x 10-5
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mol) in acetonitrile (~3 mL) was added to solid Me4NOH·5H2O (6.0 mg, 3.3 x 10-5 mol)
and 2-oxo-2-phenylethylbenzoate (7.9 mg, 3.3 x 10-5 mol) and the mixture was stirred for
16.5 h at ambient temperature. The color of the solution changed from purple to green.
The solvent was removed under reduced pressure and the remaining solid was dissolved
in CH2Cl2. The solution was filtered through a glass wool/celite plug. The filtrate was
then concentrated to ~1 mL under reduced pressure and excess hexanes (~20 mL) was
added to induce precipitation of a green solid. Yield: 22 mg. 1H NMR analysis confirmed
the

presence

of

[(Ph2TPA)Co(O2CPh)]ClO4

(10,

major

species)

and

[(Ph2TPA)Co(CH3CN)](ClO4)2·CH3CN (9, minor species). The solution remaining
following the isolation of the solid was passed through a celite/glass wool plug and the
filtrate was brought to dryness under reduced pressure. A white solid was isolated (5.7
mg). By 1H NMR this solid is a mixture of unaltered ester (minor) and 6-Ph2TPA (major).
X-ray crystallography. A single crystal of each complex was mounted on a glass
fiber with viscous oil and then transferred to a Nonius Kappa CCD diffractometer (Mo
Kα, λ = 0.71073 Å) for data collection at 150(1) K. For each compound an initial set of
cell constants was obtained from 10 frames of data that were collected with an oscillation
range of 1°/frame and an exposure time of 20s/frame. Indexing and unit cell refinement
based on all observed reflections from those ten frames indicated monoclinic lattices for
3⋅⋅CH2Cl2 and 10, orthorhombic lattices for 4⋅⋅Et2O and 5, and a tetragonal lattice for
8⋅⋅0.5CH3CN. Final cell constants for each complex were determined from a set of strong
reflections from the actual data collection. For each data set, these reflections were
indexed, integrated, and corrected for Lorentz, polarization, and absorption effects using
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DENZO-SMN and SCALEPAC.24 The structures were solved by a combination of direct
methods and heavy atom using SIR97. All non-hydrogen atoms were refined with
anisotropic displacement coefficients. Unless otherwise noted, hydrogen atoms were
assigned isotropic displacement coefficients (U(H) = 1.2 U(C) or 1.5U(Cmethyl) and their
coordinates were allowed to ride on their respective carbons using SHELXL97.25
The Ni(II) enolate complex 3·CH2Cl2 crystallizes in the monoclinic crystal system
in the space group Cc with one molecule of methylene chloride per formula unit. The
Ni(II) dibenzoylmethane complex 4·Et2O crystallizes in the space group Pcab with one
molecule of diethyl ether per formula unit. All hydrogen atoms in this structure were
located and refined independently. The Ni(II) solvent-coordinated complex 5 crystallizes
in the space group P212121. The Co(II) dibenzoylmethane complex 8·0.5CH3CN
crystallizes in the space group I-4. There are two independent formula units per
asymmetric unit, with the second being denoted by “A”. One molecule of acetonitrile is
present per asymmetric unit. The perchlorate anion exhibits disorder. The Co(II) benzoate
complex 10 crystallizes in the space group P21/c. All hydrogen atoms in this structure
were located and refined independently.
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CHAPTER 4
SYNTHESIS, CHARACTERIZATION, AND LIGAND EXCHANGE REACTIVITY OF
A SERIES OF FIRST ROW DIVALENT METAL 3-HYDROXYFLAVONOLATE
COMPLEXES1
Abstract
A series of divalent metal flavonolate complexes of the general formula [(6Ph2TPA)M(3-Hfl)]X (1-5-X; X = OTf− or ClO4−; 6-Ph2TPA = N,N-bis((6-phenyl-2pyridyl)methyl)-N-((2-pyridyl)methyl)amine; M = Mn(II), Co(II), Ni(II), Cu(II), Zn(II); 3Hfl = 3-hydroxyflavonolate) was prepared and characterized by X-ray crystallography,
elemental analysis, FTIR, UV-vis, 1H NMR or EPR, and cyclic voltammetry. All of the
complexes have a bidentate coordinated flavonolate ligand. The difference in M-O
distances (∆M-O) involving this ligand varies through the series, with the asymmetry of
flavonolate coordination increasing in the order Mn(II) ~ Ni(II) < Cu(II) < Zn(II) < Co(II).
The hypsochromic shift of the absorption band I (π→π*) of the coordinated flavonolate
ligand in 1-5-OTf (relative to that in free anion) increases in the order Ni(II) < Mn(II) <
Cu(II) < Zn(II), Co(II). Previously reported 3-Hfl complexes of divalent metals fit well
with this ordering. 1H NMR studies indicate that the 3-Hfl complexes of Co(II), Ni(II),

1
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and Zn(II) exhibit a pseudo-octahedral geometry in solution. EPR studies suggest that the
Mn(II) complex 1-OTf may form binuclear structures in solution. The mononuclear
Cu(II) complex 4-OTf has a distorted square pyramidal geometry. The oxidation potential
of the flavonolate ligand depends on the metal ion present and/or the solution structure of
the complex, with the Mn(II) complex 1-OTf exhibiting the lowest potential, followed by
the pseudo-octahedral Ni(II) and Zn(II) 3-Hfl complexes, and the distorted square
pyramidal Cu(II) complex 4-OTf. The Mn(II) complex [(6-Ph2TPA)Mn(3-Hfl)]OTf (1OTf) is unique in the series in undergoing ligand exchange reactions in the presence of
M(ClO4)2⋅6H2O (M = Co, Ni, Zn) in CD3CN to produce [(6-Ph2TPA)M(CD3CN)n](X)2,
[Mn(3-Hfl)2⋅0.5H2O], and MnX2 (X = OTf- or ClO4-). Under similar conditions, the 3-Hfl
complexes of Co(II), Ni(II), and Cu(II) undergo flavonolate ligand exchange to produce
[(6-Ph2TPA)M(CD3CN)n](X)2 (M = Co, Ni, Cu; n = 1 or 2) and [Zn(3-Hfl)2⋅2H2O]. An
Fe(II) complex of 3-Hfl, [(6-Ph2TPA)Fe(3-Hfl)]ClO4 (8), was isolated and characterized
by elemental analysis, FTIR, UV-vis, 1H NMR, cyclic voltammetry, and a magnetic
moment measurement. This complex reacts with O2 to produce the diiron(III) µ-oxo
compound [(6-Ph2TPAFe(3-Hfl))2(µ-O)](ClO4)2 (6).
Introduction
Flavonoids are polyphenolic compounds that are produced in plants.1 One of these
compounds, quercetin (Scheme 4-1), is found in many fruits and vegetables, and is of
considerable current interest for its antioxidant and antimicrobial properties.2,3 In the soil
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Scheme 4-1.

environment, fungal and bacterial quercetin dioxygenases catalyze oxidative carboncarbon bond cleavage and CO release from a metal-coordinated quercetin in a 2,4dioxygenolytic ring cleavage reaction. Fungal quercetinases are known to contain a
mononuclear Cu(II) center and have been extensively investigated.4-9 Studies of a
bacterial quercetinase from Bacillus subtilis (YxaG) showed that when this enzyme is
produced in E. coli it will bind a variety of divalent metals, with the highest level of
reactivity being found for Mn(II).10,11 Recent investigations of a quercetinase from
Streptomyces sp. FLA expressed in E. coli revealed that this enzyme is most active in the
presence of Ni(II), with the next highest level of activity being found with Co(II).12
The quercetinase enzymes from Aspergillus japonicus and B. subtilis have been
characterized by X-ray crystallography.9,10 Both are members of the cupin superfamily of
proteins (bicupins), with two well-separated active site metal centers, each having a
ligand donor set comprised of three histidine donors and a glutamate ligand. In the
structure of the copper-containing enzyme from Aspergillus japonicus, the copper centers
exhibit two different geometries. One is a distorted tetrahedron comprised of three
histidine donors and a water molecule, and in the other, a glutamate ligand (Glu73) is also
coordinated in an axial position to give an overall distorted trigonal bipyramidal copper
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center. These geometries are present in a ~70:30 ratio. EPR studies of the protein are
consistent with this mixture of geometries also being present in solution. In the tetrahedral
geometry, Glu73 acts as a hydrogen bond acceptor for the metal-bound water molecule.
Coordination of quercetin to the copper center occurs in a monodentate fashion via the
deprotonated C(3)-OH moiety, with Glu73 possibly acting as the active site base for
substrate deprotonation.13 The overall geometry of the copper center in the
enzyme/substrate adduct is distorted trigonal bipyramidal. A key feature of the
coordinated quercetin is pyramidalization of the C(2) atom indicating increased sp3
character that may stabilize radical formation in a reaction involving O2.
The B. subtilis enzyme was initially reported to be an Fe(II)-containing quercetin
2,3-dioxygenase,14,15 and was crystallized with Fe(II) present in both active sites of this
bicupin enzyme.10 Both metal centers exhibit a coordination number of five, with three
histidine donors, a glutamate, and a water molecule. The overall geometry of the Fe(II)
center is distorted trigonal bipyramidal in the N-terminal active site and distorted square
pyramidal in the C-terminal domain of the protein. Metal ion replacement studies of the
B. subtilis enzyme (via reconstitution of the apo enzyme) indicated increased levels of
activity for Mn(II)- and Co(II)-containing enzyme (35- and 24-fold, respectively) relative
to that found for Fe(II). Based on this data, it has been suggested that Mn(II) may be the
preferred metal cofactor for the B. subtilis enzyme. EPR studies of the Mn(II)-containing
enzyme from B. subtilis suggest octahedral coordination of the metal center.11
The quercetinase QueD from Streptomyces sp. FLA is a monocupin
dioxygenase.16 When overexpressed in E. coli, this enzyme exhibited the highest level of
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activity when Ni(II) and Co(II) salts were added to the LB medium.12,17 An increase in
activity was not observed when Mn(II), Fe(II), Cu(II) or Zn(II) was added. EPR studies of
the cobalt-containing enzyme indicate a high-spin (S = 3/2) Co(II) center in a trigonal
bipyramidal or tetrahedral geometry in the resting state. EPR experiments performed in
the presence of quercetin and O2 revealed no evidence of a change in valency of the cobalt
ion during substrate turnover.12
Different mechanistic pathways have been proposed for the spin-forbidden, O2dependent quercetin oxidation reaction depending on whether a redox active metal center
is present in the active site of the enzyme. For Cu(II)-containing quercentinase enzymes, it
is unlikely that O2 will coordinate to the type II oxidized metal center, and the reaction is
suggested to involve valence tautomerism between the Cu(II)-quercetin adduct and a
Cu(I)-flavonoxy radical species, the latter of which can act as a one-electron reductant
toward O2. The pyramidalization of the C(2) center identified in the X-ray structure of the
ES adduct of the A. japonicus enzyme suggests possible stabilization of the radical at this
atom.13 For redox-active metal ions such as Mn(II), the metal center may serve as an
electron conduit in an adduct wherein both the flavonolate and O2 coordinate to the metal
center prior to oxygen activation. Specifically, electron transfer from the metal center to
coordinated O2, with subsequent electron transfer from the coordinated quercetin
monoanion to the oxidized metal center, would generate a quercetin radical-M(II)-O2species, from which C-C bond cleavage and CO release could proceed. This proposed
mechanism is similar to the reaction pathway suggested for Fe(II)- and Mn(II)-containing
extradiol catechol dioxygenases.18

107
Overall, from studies of the A. japonicus, B. subtilis, and Streptomyces sp. FLA
quercetinases, possible roles for the divalent metal center in substrate oxidation have been
suggested to include: (1) reduction of the pKa of quercetin to enable substrate
deprotonation, (2) stabilization of the flavonolate intermediate, (3) influence on the
coordination mode (mono- versus bidentate) and redox potential of the bound flavonolate,
(4) facilitation of the formation of radical character on the coordinated flavonolate via
valence tautomerism, and (5) acting as a redox conduit for structures wherein both
flavonolate and O2 are coordinated to the metal center.
Model studies of copper-containing forms of quercetinases have demonstrated that
both Cu(I) and Cu(II) flavonolate complexes undergo reaction with O2 to produce CO and
the depside.19 Kinetic studies of the reaction involving the Cu(II) complex [Cu(3-Hfl)2]
(3-Hfl = 3-hydroxyflavonolate) with O2 in DMF indicate a rate law that is second-order
overall (-d[Cu(3-Hfl)2]/dt = kobs[Cu(3-Hfl)2][O2]). In the presence of pyridine, the
observed rate increases by ~2.5-fold, which has been attributed to a change in the
coordination mode of the flavonolate ligand from bidentate to monodentate. Model
studies involving other divalent metal ions are considerably fewer in number. Catalytic
oxygenation

of

3-hydroxyflavone

derivatives

by

bis(salicylidene)ethylenediaminatocobalt(II) ([Co(salen]) at room temperature has been
reported.20 This catalysis occurs in the presence of DMSO and DMF, but not in methanol,
THF, or CH2Cl2. The involvement of a Co-O2 complex in the reaction has been proposed.
A Co(III) complex, [Co(III)(salen)(4’MeOflaH)], was found to be susceptible to
oxygenation in pyridine and DMF, but was found to be stable to oxygen in non-
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coordinating solvents. This O2 reactivity correlates with dissociation of the flavonolate
ligand from the Co(III) center.21,22 Two recent studies outlined the structural and O2
reactivity properties of Fe(III) and Mn(II) flavonolate complexes.23,24 Fe(III)(4’MeOflaH)3
and Mn(II)(3-Hfl)2(py)2 were found to undergo reaction with O2 at 100 °C in DMF with
second-order rate constants of 0.50 M-1s-1 and 0.08 M-1s-1, respectively. On the basis of
comparison of rate constants at 100 ºC, these complexes are more reactive than the copper
analogs Cu(3-Hfl)2 (k = 0.0087 M-1s-1) and Cu(3-Hfl)2(py)2 (0.04 M-1s-1), suggesting a
metal dependent reactivity order of Fe(III) > Mn(II) > Cu(II).23 The Fe(III) complex
Fe(III)(salen)(3-Hfl) contains a bidentate flavonolate ligand and undergoes reaction with
O2 at elevated temperatures (100-120 ºC).24 In the presence of excess carboxylate anion,
the rate of reaction with O2 increases, with bulky carboxylates (e.g. triphenyl acetate)
producing the greatest rate enhancement (~two orders of magnitude at 100 ºC). This is
attributed to the formation of a more reactive monondentate flavonolatoiron(III) complex.
Evidence for direct electron transfer from the flavonolate ligand to O2 to form O2- was
found in the reaction via the use of the superoxide scavenger nitroblue tetrazolium (NBT).
From the studies described above and investigations of the O2 reactivity of noncoordinated flavonolate anions, it is clear that enhancing the electron density within the
flavonolate anion through deprotonation and limiting its coordination mode to
monodentate, are key factors in enhancing the rate of oxygenation. What it is currently
unclear is how differences in the divalent metal ion present in quercetinase enzymes
produce differing rates of oxygenation, as has been found for the B. subtilis and
Streptomyces sp. FLA enzymes. Such differences may result from modulation of the
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coordination mode and/or the redox potential of the flavonolate, or may relate to the
ability of the metal center to serve as a redox conduit. As an approach toward
systematically examining the influence of the divalent metal ion, we report the
preparation and characterization of the first extensive series of structurally-related
divalent metal flavonolate complexes. Our initial goal in this research was to examine
how differences in the divalent metal center (Mn(II), Fe(II), Co(II), Ni(II), Cu(II), and
Zn(II)) influence flavonolate coordination, and spectroscopic and redox properties. The
choice of the tetradentate 6-Ph2TPA ligand as the supporting scaffold was based on its
relevance to the coordination environment in enzymes of the cupin superfamily.25 We
have previously used this ligand to study chemistry of relevance to Ni(II)-acireductone
dioxygenase,26-29 another dioxygenase of the cupin superfamily that produces CO upon
substrate oxygenation. The results presented herein indicate that the nature of the divalent
metal ion influences the coordination mode and redox potential of a 3-hydroxyflavonolate
ligand in complexes of the general formula [(6-Ph2TPA)M(3-Hfl)]X (M = Mn(II), Co(II),
Ni(II), Cu(II), Zn(II); X = OTf- or ClO4-). In the course of characterizing the Mn(II)
complex, we found evidence for ligand exchange reactions, which were subsequently
further explored. The Fe(II) flavonolate complex [(6-Ph2TPA)Fe(3-Hfl)]ClO4 was
prepared and characterized, albeit an X-ray structure was not obtained. This is due to the
fact that the complex is very O2 sensitive and quickly undergoes reaction to produce a
diiron(III) µ-oxo compound, wherein each iron center has a coordinated flavonolate
ligand. The structure of this diiron(III) complex was determined by X-ray crystallography.
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Experimental
General and Physical Methods. All chemicals were purchased from commercial
sources and used as received unless otherwise noted. Synthetic reactions were performed
in a MBraun Unilab glovebox under a N2 atmosphere. Solvents for glovebox use were
dried according to published methods and distilled under N2 prior to use.30 The 6-Ph2TPA
ligand was prepared as previously described.25
1

H NMR spectra of 2-5 were obtained in CD3CN solution on a Bruker ARX-400

spectrometer. Data was collected for paramagnetic complexes as previously described.26
Chemical shifts (in ppm) are referenced to the residual solvent peak(s) in CHD2CN (1H,
1.94 (quintet) ppm). FTIR spectra were collected using KBr pellets on a Shimadzu FTIR8400 spectrometer. UV-vis spectra were recorded at ambient temperature using a
Hewlett-Packard 8453 diode array spectrophotometer. Cyclic voltammetry data was
collected using a BAS-Epsilon system.25 Conditions for the CV experiments are listed in
a footnote of Table 4-5 and in the text. EPR spectra were collected on a Bruker EMX-Plus
spectrometer fitted with a liquid helium cooled probe. ESI/APCI and MALDI mass
spectral data for complexes was collected at the Mass Spectrometry Facility, University of
California, Riverside. Room temperature magnetic susceptibilities were determined by the
Evans method.31 Elemental analyses were performed by Atlantic Microlab, Inc., Norcross,
GA.
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Caution! Perchlorate salts of metal complexes with organic ligands are
potentially explosive. Only small amounts of material should be prepared, and these
should be handled with great care.32

General

Procedure

for

the

Synthesis

of

[(6-Ph2TPA)M(3-Hfl)]OTf

Complexes: (a) M = Mn (1-OTf), Cu (4-OTf), or Zn (5-OTf). In a N2-filled glovebox, a
methanol solution (2 mL) of M(OTf)2 (1.37 x 10-4 mol) was added to solid 6-Ph2TPA
(1.37 x 10-4 mol) and the mixture was stirred until all of the chelate ligand had dissolved.
The resulting solution was added to a methanol solution (2 mL) containing 3-Hfl (1.37 x
10-4 mol) and Me4NOH·5H2O (1.37 x 10-4 mol). The mixture was then allowed to stir
overnight at ambient temperature. The reaction mixture was taken out of the glovebox
and the solvent was removed under reduced pressure. The residual solid was suspended
on the top of a celite plug and washed several times with distilled water. The wet solid
was then dissolved in CH2Cl2 and the filtrate was collected and brought to dryness under
reduced pressure. The residue was dissolved in CH2Cl2 and the analytically pure
microcrystalline flavonolate complex was precipitated via the addition of excess Et2O and
cooling of the mixture at -30 °C for 12 h.
Note regarding experimental data: Extensive characterization data (FTIR, UVvis, mass spectrometry, magnetic moment, cyclic voltammetry) for the triflate compounds
1-5-OTf is provided in Table 4-5. Selected data for the perchlorate analogs 1-5-ClO4,
which were primarily prepared for X-ray crystallographic studies, is given below.
[(6-Ph2TPA)Mn(3-Hfl)]OTf (1-OTf). Yield: 73% (green crystals).
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[(6-Ph2TPA)Cu(3-Hfl)]OTf (4-OTf). Yield: 74% (dark green crystals).
[(6-Ph2TPA)Zn(3-Hfl)]OTf (5-OTf). Yield: 98% (yellow crystals). 1H NMR
(CD3CN, 400 MHz): δ 8.53 (d, J = 5.2 Hz, 1 H), 8.18 (dt, J = 7.3 Hz, J = 1.5 Hz, 2 H),
7.92 (td, J = 7.8 Hz, J = 7.7 Hz, J = 1.7 Hz, 1 H), 7.78 (t, J = 7.7 Hz, 2 H), 7.65 (m, 5 H),
7.39 (m, 11 H), 7.13 (dt, J = 6.8 Hz, J = 1.5 Hz, 4 H), 7.03 (tt, J = 7.4 Hz, J = 1.2 Hz, 2
H), 6.94 (tt, J = 8.0 Hz, J = 1.5 Hz, 4 H), 4.85 (d, J = 14.7 Hz, 2 H), 4.51 (d, J = 14.8 Hz,
2 H), 4.39 (s, 2 H);

13

C{1H} NMR (CD3CN, 400 MHz): δ187.7, 168.1, 164.0, 163.8,

162.9, 156.5, 154.6, 148.8, 147.6, 146.3, 141.1, 140.5, 137.4, 136.8, 136.1, 135.7, 135.6,
135.1, 134.8, 132.2, 131.9, 131.3, 130.9, 130.2, 130.1, 125.8, 125.2, 64.6, 61.5 (29
signals expected for equivalent phenyl-appended pyridyl donors; 29 observed).
(b) M = Co (2-OTf) or Ni (3-OTf). Under a nitrogen atmosphere, a methanol (~2
mL) solution of MCl2·5H2O (1.37 x 10-4 mol) was added to solid 6-Ph2TPA (1.37 x 10-4
mol) and the mixture was stirred until all of the chelate ligand had dissolved. Two
equivalents of silver triflate (AgOTf; 2.74 x 10-4 mol) was then added to the mixture.
After stirring for 30 min, the solution was filtered through a celite/glass wool plug. The
filtrate was added to a methanol solution (~2 mL) containing 3-Hfl (1.37 x 10-4 mol) and
Me4NOH·5H2O (1.37 x 10-4 mol). The resulting solution was stirred overnight at ambient
temperature. At this time, the reaction was taken out of the glovebox and the solvent was
removed under reduced pressure. Using a work-up procedure identical to that described
above for 1-OTf, analytically pure microcrystalline products were obtained.
[(6-Ph2TPA)Co(3-Hfl)]OTf (2-OTf). Yield: 54% (dark red crystals).
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[(6-Ph2TPA)Ni(3-Hfl)]OTf·0.25CH2Cl2 (3-OTf). Yield: 82% (green crystals).
The presence of dichloromethane in the elemental analysis sample was confirmed using
1

H NMR spectroscopy.
General

Procedure

for

the

Synthesis

of

[(6-Ph2TPA)M(3-Hfl)]ClO4

Complexes (1-5-ClO4). In a glovebox, a acetontrile solution (~2 mL) of M(ClO4)2·6H2O
(M = Mn, Co, Ni, Cu, Zn; 1.37 x 10-4 mol) was added to solid 6-Ph2TPA (1.37 x 10-4
mol) and the resulting mixture was stirred until all of the chelate ligand had dissolved. An
acetonitrile

slurry

(~2

mL)

of

tetramethylammonium

hydroxide

pentahydrate

(Me4NOH·5H2O; 1.37 x 10-4 mol) and 3-hydroxyflavone (3-Hfl; 1.37 x 10-4 mol) was
then added and the resulting mixture was stirred overnight at ambient temperature. After
removal of the solvent under reduced pressure, the remaining solid was dissolved in
CH2Cl2 and the solution was filtered through a glass wool/celite plug. The filtrate was
then brought to dryness under reduced pressure. Crystals suitable for single crystal X-ray
crystallography were obtained using the following approaches at ambient temperature: 1ClO4 (green crystals), diethyl ether diffusion into a dichloromethane solution; 2-ClO4
(dark red crystals) and 3-ClO4 (green crystals), diethyl ether diffusion into a acetonitrile
solution;

and

4-ClO4

(green

crystals),

diethyl

ether

diffusion

into

dichloromethane:isopropanol:methanol (1:0.1:1) solution. For 5-ClO4, yellow crystals
were obtained from dichloromethane/diethyl ether solution at 4 °C.
The 1H NMR features of 2-ClO4, 3-ClO4, and 5-ClO4 match those found for the
triflate analogs. 1-ClO4: Anal. Calcd for C45H35ClMnN4O7·1/4CH2Cl2: C, 63.54; H, 4.18;
N, 6.55. Found: C, 63.47; H, 4.11; N, 6.45. 2-ClO4: Anal. Calcd for C45H35ClCoN4O7
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·1/4CH2Cl2: C, 63.77; H, 4.18; N, 6.59. Found: C, 4.03; H, 4.19; N, 6.54. 3-ClO4 : Anal.
Calcd for C45H35ClN4NiO7: C, 64.50; H, 4.21; N, 6.69. Found: C, 64.18; H, 3.92; N, 6.55.
4-ClO4: Anal. Calcd for C45H35ClCuN4O7·1/5CH2Cl2: C, 63.14; H, 4.30; N, 6.52. Found:
C, 63.45; H, 4.15; N, 6.31. 5-ClO4: Anal. Calcd for C45H35ClN4O7Zn·1/5CH2Cl2: C,
63.01; H, 4.14; N, 6.50. Found: C, 63.15; H, 4.31; N, 6.33.
[(6-Ph2TPA)Fe(NCCH3)](ClO4)2

(7).

A CH3CN solution (~ 2mL) of

Fe(ClO4)2·6H2O (0.030 g, 0.083 mmol) was added to solid 6-Ph2TPA. The resulting
solution was stirred for 1 h at room temperature under a N2 atmosphere. The solvent was
then removed under reduced pressure and the remaining solid product was recrystallized
via Et2O diffusion into a CH3CN solution. Yellow crystals suitable for single crystal Xray analysis and yellow powder were isolated from a blue solution. Yield: 73%. Anal
Calcd. for C32H29N5FeCl2O8·H2O: C, 50.81; H, 4.13; N, 9.26. Found: C, 51.03; H, 3.99;
N, 9.35. FTIR (KBr, cm-1) 1092 (νClO4), 623 (νClO4); UV-vis (CH3CN, nm) 509, 892.
LRFAB-MS (CH2Cl2/NBA), m/z (relative intensity), 597 ([(6-Ph2TPA)Fe(ClO4)]+ 15%).

Table 4-1. Summary of 1H NMR of 7 in CD3CN:
α, CH2

β

β’

Ph

γ

γ’

112
99.4
82.4
60

61.1
60.2

59.8
44.1

10.2
4.7
2.5

-8.5

-11.8

Ligand Exchange Reactions. (a) To a solution of [(6-Ph2TPA)Mn(3-Hfl)]OTf
(9.0 x 10-6 mol) in CD3CN (0.8 mL) solid M(ClO4)2⋅6H2O (M = Co, Ni, or Zn; 9.0 x 10-6
mol) was added. Each reaction mixture was then capped, shaken vigorously, and a 1H
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NMR spectrum was recorded within 15 min. For each metal perchlorate salt, the NMR
spectrum is consistent with the formation of [(6-Ph2TPA)M(CD3CN)n](ClO4)2 (M = Co
(n = 1), Ni (n = 2), or Zn (n = 1)). The product [Mn(3-Hfl)2⋅0.5H2O] is formed in each
reaction, and was isolated from the Ni(II)-containing reaction mixture and characterized
by elemental analysis, FTIR, and UV-vis.
(b) In a NMR tube, a CD3CN solution (0.8 mL) of [(6-Ph2TPA)M(3-Hfl)]OTf (M
= Co, Ni, and Cu; 2-4-OTf; 7.7 x 10-6 mol) was treated with solid 0.5 eq Zn(ClO4)2⋅6H2O
(3.9 x 10-6 mol). Each reaction mixture was then capped, shaken vigorously, and a 1H
NMR spectrum was recorded within 15 min. For the reactions involving the Co(II) and
Ni(II) derivatives, the 1H NMR spectroscopic features are consistent with the formation of
[(6-Ph2TPA)M(CD3CN)n](X)2 (M = Ni, n = 2; M = Co, n = 1; X = OTf- or ClO4-). A
poorly soluble, yellow precipitate is also formed in each reaction mixture. Spectroscopic
analysis (1H NMR (CD3OD) and FTIR (KBr)) of this solid suggested the formation of
[Zn(3-Hfl)2]. This compound was independently synthesized via treatment of
Zn(ClO4)2⋅6H2O with two equivalents each of 3-Hfl and Me4NOH⋅5H2O in methanol,
which yielded a yellow precipitate. Analysis of this material by 1H NMR (CD3OD), UVvis, and elemental analysis indicated the formulation [Zn(3-Hfl)2⋅2H2O]. The UV-vis and
1

H NMR spectroscopic features of this material match that of the yellow precipitate

generated in the ligand exchange reaction.
Synthesis of [(6-Ph2TPA)Fe(3-Hfl)]ClO4 (8). Under a nitrogen atmosphere, a
methanol solution (~2 mL) of Fe(ClO4)2·6H2O (1.37 x 10-4 mol) was added to solid 6Ph2TPA (1.37 x 10-4 mol) and the resulting mixture was stirred for 2 h at ambient
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temperature. The solvent was then removed under reduced pressure, and the solid was
dissolved in a small amount of methanol (~1 mL). Addition of Et2O produced a yelloworange precipitate, which was dried under vacuum. A 1H NMR spectrum of the complex
in CD3CN was obtained. This spectrum matched that of [(6-Ph2TPA)Fe(CH3CN)](ClO4)2,
which has been independently generated and characterized. A methanol solution (~2 mL)
of [(6-Ph2TPA)Fe(CH3CN)](ClO4)2 (1.37 x 10-4 mol) was treated with 3-Hfl (1.37 x 10-4
mol) and Me4NOH⋅5H2O (1.37 x 10-4 mol) dissolved in methanol (~2 mL). The resulting
mixture was stirred for 15 minutes and the solvent was then removed under vacuum. The
remaining green-yellow solid was dissolved CH2Cl2 (~2 mL) and passed through a
celite/glass wool plug. The filtrate was brought to dryness under reduced pressure, and the
resulting solid (yield: 96%) was analyzed by 1H NMR, FTIR, UV-vis, a magnetic moment
measurement, and elemental analysis. FTIR (KBr, cm-1) 1558 (νC=O); UV-vis (CH3CN)
nm (ε, M-1cm-1) 415 (14700); µeff = 4.7 µB. Anal. Calcd for C45H35ClFeN4O7: C, 64.72;
H, 4.22; N, 6.71. Found: C, 65.23; H, 4.22; N, 6.71.
Reactivity of [(6-Ph2TPA)Fe(3-Hfl)]ClO4 in Air; Isolation of [(6-Ph2TPAFe(3Hfl))2(µ
µ-O)](ClO4)2 (6). A methanol solution (~2 mL) of [(6-Ph2TPA)Fe(3-Hfl)]ClO4
was prepared by mixing equimolar amounts (1.37 x 10-4 mol) of 6-Ph2TPA,
Fe(ClO4)2⋅6H2O, Me4NOH⋅5H2O and 3-Hfl and stirring under a nitrogen atmosphere for
2 h. The solvent was then removed under reduced pressure and the remaining solid was
dissolved in CH2Cl2 (~2 mL) and filtered through a celite/glass wool plug. The filtrate
was then brought to dryness. A portion of the solid (8.45 x 10-5 mol) was dissolved in
CH3CN (~ 5 mL) and this solution was exposed to air for 24 h. Diethyl ether was then
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diffused into the CH3CN solution, resulting in the deposition of dark-brown crystals
suitable for single crystal X-ray crystallography. Yield: 58%. UV-vis (MeOH), nm (ε, M1

cm-1) 388 (24400), 490 (7300); ESI/APCI-MS, m/z (relative intensity) 743.2 ([M-

2ClO4]2+, 30%). Anal. Calcd for: C90H70Cl2Fe2N8O15·2H2O: C, 62.77; H, 4.33; N, 6.51.
Found: C, 62.96; H, 4.19; N, 6.70.
X-ray Crystallography. For each compound, 1-5-ClO4 and 6, a single crystal
was mounted on a glass fiber with traces of viscous oil and then transferred to a Nonius
KappaCCD diffractometer equipped with Mo Kα radiation (λ = 0.71073 Å) for data
collection. For unit cell determination, ten frames of data were collected at 150(1) K with
an oscillation range of 1 deg/frame and an exposure time of 20 sec/frame. Final cell
constants were determined from a set of strong reflections from the actual data collection.
Reflections were indexed, integrated, and corrected for Lorentz, polarization, and
absorption effects using DENZO-SMN and SCALEPAC.33 The structures were solved by
a combination of direct and heavy-atom methods using SIR 97.34 All of the non-hydrogen
atoms were refined with anisotropic displacement coefficients. Unless otherwise stated,
all hydrogen atoms were assigned isotropic displacement coefficients U(H) = 1.2U(C) or
1.5U(Cmethyl), and their coordinates were allowed to ride on their respective carbons using
SHELXL97.35
Structure Solution and Refinement. Complex 1-ClO4 crystallizes in the space
group P21/n, with a disordered ClO4- molecule in the asymmetric unit. Complex 2-ClO4
crystallizes in the space group C2/c with two cation/anion pairs per asymmetric unit along
with two molecules of CH3CN. The differences in the cations (with the second being
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labeled with (A)) are subtle, with the most noticeable differences being in one Co-NPhPy
bond distance and in O-Co-N bond angles involving the O(1) atom of the flavonolate and
nitrogen atoms of the chelate ligand. One of the two CH3CN solvate molecules is
comprised of two 50% occupied positions for all heavy atoms. Complex 3-ClO4
crystallizes in the space group P21/a. Two oxygen atoms of the perchlorate anion exhibit
disorder (80:20) over two positions. Complex 4-ClO4 crystallizes in the space group
P21/c. One molecule of diethyl ether is also present in the asymmetric unit. Complex 5ClO4 crystallizes in the space group P-1. Two independent cation/anion pairs and two
CH2Cl2 solvent molecules are found in the asymmetric unit. The two cations (with the
second being labeled with (A)) have very minor differences in bond lengths/angles
involving the Zn(II) center and both exhibit a distorted square pyramidal geometry (τ =
0.35).36 One CH2Cl2 solvate exhibits disorder over two positions (50:50) for each heavy
atom. Complex 6 crystallizes in the space group P-1 with 2.5 CH3CN solvate molecules
per asymmetric unit. Two oxygen atoms and the chlorine atom of a perchlorate anion are
disordered over two positions (90:10).
Results
The goal of this investigation was to prepare and comprehensively characterize a
structurally similar set of divalent metal flavonolate complexes as a prelude to O2
reactivity studies of these complexes. The metal ions employed are those of relevance to
bacterial and fungal quercetin dioxygenases (Mn(II), Fe(II), Co(II), Ni(II), Cu(II)). For
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spectroscopic and redox behavior comparisons, the d10 Zn(II) flavonolate analog complex
was also prepared.
Synthesis. Divalent metal flavonolate complexes of the general formula [(6Ph2TPA)M(3-Hfl)]X were prepared by the synthetic routes outlined in Scheme 4-2.
Triflate derivatives were isolated as analytically pure polycrystalline materials.
Perchlorate analogs were found to be highly crystalline materials suitable for single
crystal X-ray crystallography. All syntheses were performed under a N2 atmosphere.
X-ray Crystallography. The perchlorate analogs 1-5-ClO4 were characterized by
single crystal X-ray crystallography. A summary of the data acquisition and refinement
parameters are given in Table 4-2. Selected bond distances and angles are given in Tables
4-3 and 4-4, respectively.
Thermal ellipsoid drawings of the Mn(II) (1-ClO4) and Ni(II) (3-ClO4) complexes
are shown in Figure 4-1. Each metal center exhibits a pseudo-octahedral geometry with
the ketone oxygen (O(2)) of the flavonolate positioned trans to the tertiary amine nitrogen
of the chelate ligand. In both complexes, the flavonolate ligand is located between the two
hydrophobic phenyl appendages of the chelate ligand.
To our knowledge, complex 1-ClO4 is the first Mn(II) complex of the 6-Ph2TPA
ligand to exhibit coordination of both phenyl-appended pyridyl donors. Complexes having
an additional bidentate ligand, such as the hydroxamate complex [(κ3-6-Ph2TPAMn)2(µONHC(O)CH3)2](ClO4)225

and

the

oxalate

derivative

[(κ3-6-Ph2TPAMn)2(µ-

C2O4)](ClO4)2,37 have previously been found to exhibit κ3-coordination (facial and
meridional, respectively) of the chelate ligand, with one non-coordinated phenylpyridyl
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appendage. In 1-ClO4, the Mn(1)-O(1) and Mn(1)-O(2) distances (2.121(3) Å
2.143(3) Å, respectively) are similar.

Scheme 4-2.

and
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Figure 4-1. Thermal ellipsoid drawings (50% probability) of the cationic portions of 1ClO4 (top) and 3-ClO4 (bottom). Hydrogen atoms have been omitted for clarity.

In the only other Mn(II) complex of 3-hydroxyflavonolate reported to date,
[(Mn(3-Hfl)2(py)2],23 the Mn-O distances differ by ~0.06 Å, with the bond involving the
ketone oxygen being longer. The average Mn-O distance in 1-ClO4 (2.13 Å) is shorter
than that found in [(Mn(3-Hfl)2(py)2] (2.16 Å).23 The average Mn-N distance in 1-ClO4
is

~2.33

Å,

which

is

similar

to

that

found

in

[(κ3-6-Ph2TPAMn)2(µ-

ONHC(O)CH3)2](ClO4)225 and [(κ3-6-Ph2TPAMn)2(µ-C2O4)](ClO4)2.37
The mononuclear 3-ClO4 is structurally similar to Ni(II) acetohydroxamate and
enolate complexes of the 6-Ph2TPA ligand.25,28 For example, the average Ni-O and NiNPhPy, as well as the NPy and NAmine distances (Table 4-3) are similar in these complexes.
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The Ni(1)-O(1) distance (1.996(2) Å) is slightly shorter than the distance involving the
ketone oxygen atom (Ni(1)-O(2), 2.010(3) Å). In the only other Ni complex of 3hydroxyflavonolate reported to date, [(Ni(3-Hfl)2(py)2]38, the Ni-O distances are slightly
longer (2.023(2) and 2.067(2) Å). The structure of the Co(II) complex [(6-Ph2TPA)Co(3Hfl)]ClO4 (2-ClO4⋅2CH3CN) contains two independent cation/anion pairs per
asymmetric unit (the second labeled with an “A” designation). The two cations are
structurally similar, each having a pseudo-octahedral geometry (Figure 4-2). Unlike the
Mn(II) and Ni(II) analogs (1-ClO4 and 3-ClO4), this complex has the deprotonated
oxygen atom of the 3-Hfl ligand positioned trans to the tertiary amine nitrogen atom of
the chelate ligand and exhibits notably different Co-O distances (Co(1)-O(1) 1.956(2) Å;
Co(1)-O(2), 2.172(2) Å). This is similar to the bidentate ligand coordination present in the
Co(II) acetohydroxamate complex [(6-Ph2TPA)Co(ONHC(O)CH3)]ClO4, which exhibits
Co-O bond lengths of 1.935(2) and 2.142(2) Å.25

Figure 4-2. Thermal ellipsoid drawing (50% probability) of the cationic portion of one
of the two cations present in the asymmetric unit of 2-ClO4⋅2CH3CN. Hydrogen atoms
have been omitted for clarity.
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Table 4-2. Summary of X-ray Data Collection and Refinement.
1-ClO4

2-ClO4⋅2CH3CN

Empirical formula

C45H35ClMnN4O7

Mr

3-ClO4

4-ClO4⋅Et2O

5-ClO4⋅2CH2Cl2

C94H76Cl2Co2N10O14 C45H35ClN4NiO7

C49H45ClCuN4O8

C94H74Cl6N8O14Zn2

834.16

1758.41

837.93

916.88

1859.04

Crystal system

Monoclinic

Monoclinic

Monoclinic

Monoclinic

Triclinic

Space group

P21/n

C2/c

P21/a

P21/c

P-1

a/ Å

11.6175(8)

43.8551(6)

18.5881(4)

17.7565(6)

11.6633(2)

b/ Å

16.3708(14)

18.27219(2)

19.6427(4)

12.6011(2)

18.3461(3)

c/ Å

20.6689

21.2336(3)

10.4897

19.0305(6)

20.3958(3)

α /°

90

90

90

90

103.0861(8)

β /°

94.219(5)

101.7509(8)

90.4537(11)

90.0709(12)

90.5675(9)

γ /°

90

90

90

90

98.3257(9)

V / Å3

3920.3(5)

16658.4(4)

3829.88(13)

4258.1(2)

4201.95(12)

4

8

4

4

2

Dc / Mg m

1.413

1.402

1.453

1.430

1.469

T/K

150(1)

150(1)

150(1)

150(1)

150(1)

Color

Yellow

Brown

Yellow/Green

Green

Yellow

Crystal habit

Prism

Plate

Dichroic Prism

Prism

Prism

Crystal size/ mm

0.38 × 0.13 × 0.13 0.38 × 0.38 × 0.20

0.35 × 0.18 × 0.10 0.25 x 0.23 x 0.05

Diffractometer

Nonius KappaCCD Nonius KappaCCD

Nonius KappaCCD Nonius KappaCCD Nonius KappaCCD

µ/ (mm-1)

0.464

0.536

0.636

0.638

0.833

2θ max /°

50.02

54.96

54.98

50.74

52

Completeness to θ (%) 97.8

99.9

99.2

98.8

99.2

Reflections collected

36402

15907

14181

30941

Independent reflections 6770

19074

8729

7731

16397

Rint

0.0623

0.0519

0.0410

0.0377

0.0519

Variable parameters

552

1084

532

568

1127

R1 / wR2b

0.0640/0.1367

0.0562/0.1411

0.0576/0.1087

0.0646/0.1564

0.0458/0.1011

1.043

1.027

1.036

1.029

1.027

0.415/-0.304

1.181/-0.760

0.744/-0.672

1.093/-0.772

0.709/-0.726

Z
-3

Goodness-of-fit (F2)
-3

∆ρmax/min / e Å

10543

0.28 x 0.28 x 0.15

a
Radiation used: Mo Kα (λ = 0.71073 Å) bR1 = ∑ | |Fo| - |Fc| | / ∑ |Fo|; wR2 = [∑[w(Fo2-Fc2)2]/[∑(Fo2)2]]1/2, where w = 1/[σ2(Fo2) +
(aP)2 + bP].
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Table 4-3. Selected Bond Distances (Å) for Complexes 1-5-ClO4.
1-ClO4

3-ClO4

4-ClO4⋅Et2O

2.061(2)

1.993(3)

5-ClO4
⋅2CH2Cl2a
2.085(2)

M–N(1)

2.284(4)

2-ClO4
⋅2CH3CNa
2.111(3)

M–N(2)

2.340(3)

2.175(2)

2.067(3)

2.029(3)

2.144(2)

M–N(3)

2.390(3)

2.244(2)

2.278(2)

2.340(3)

2.107(2)

M–N(4)

2.338(3)

2.331(3)

2.231(2)

M–O(1)

2.121(3)

1.956(2)

1.996(2)

1.921(3)

1.951(2)

M–O(2)

2.143(3)

2.172(2)

2.031(2)

2.010(3)

2.1175(19)

∆M-O

0.022

0.22

0.035

0.089

0.17

C(31)-O(1)

1.313(4)

1.317(4)

1.315(3)

1.349(5)

1.315(3)

C(32)-O(2)

1.262(5)

1.260(4)

1.267(3)

1.252(5)

1.255(3)

a

Data for one of two cations present in the asymmetric unit.

Table 4-4. Selected Bond Angles (deg) for Complexes 1-5-ClO4.
1-ClO4

2-ClO4⋅2CH3CN a

3-ClO4

4-ClO4⋅Et2O

5-ClO4⋅2CH2Cl2 a

O(1)–M–O(2)

75.15(10)

79.81(8)

82.95(8)

84.27(13)

81.73(8)

N(1)–M–O(1)

159.22(12)

91.14(9)

172.29(9)

98.47(14)

102.36(9)

N(1)–M–O(2)

82.14(12)

169.84(9)

99.77(9)

166.64(13)

147.28(8)

N(1)–M–N(2)

72.07(13)

76.66(10)

83.05(10)

84.17(14)

81.18(9)

N(1)–M–N(3)

103.35(12)

105.45(10)

98.73(9)

102.15(13)

108.81(9)

N(1)–M–N(4)

99.40(13)

101.11(9)

81.10(9)

N(2)–M–N(3)

74.56(13)

77.37(9)

77.36(9)

77.24(12)

79.91(9)

N(2)–M–N(4)

69.16(12)

71.48(9)

80.88(10)

N(2)–M–O(1)

128.54(11)

161.56(9)

95.33(9)

172.93(14)

164.64(9)

N(2)–M–O(2)

154.14(12)

110.92(9)

171.21(9)

91.68(13)

87.35(8)

N(3)–M–N(4)

128.10(12)

132.59(9)

158.08(9)

N(3)–M–O(1)

86.95(11)

119.73(9)

88.22(8)

108.43(12)

112.38(8)

N(3)–M(1)–O(2)

114.42(12)

83.24(8)

93.95(8)

89.24(12)

99.07(8)

N(4)–M(1)–O(1)

87.74(11)

97.96(9)

91.21(9)

N(4)–M(1)–O(2)

114.48(11)

75.85(8)

107.73(9)

a

Data for one of two cations present in the asymmetric unit.
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The average Co-NPhPy distance is notably longer in 2-ClO4⋅2CH3CN (av 2.39 Å) versus
the hydroxamate complex (av 2.27 Å), while the Co-NAmine and Co-NPy distances are
similar. A search of the Cambridge Crystallographic Database (version 5.30 (November))
revealed that 2-ClO4 is the first structurally characterized Co(II) flavonolate complex.
One Co(III) flavonolate complex has been previously characterized by X-ray
crystallography.39
The cationic portions of the Cu(II) and Zn(II) analogs 4-ClO4⋅Et2O and 5ClO4⋅2CH2Cl2 are shown in Figure 4-3. The Cu(II) center in 4-ClO4⋅Et2O is distorted

Figure 4-3. Thermal ellipsoid drawings (50% probability) of the cationic portions of 4ClO4⋅Et2O (top) and 5-ClO4⋅2CH2Cl2 (bottom). Hydrogen atoms have been omitted for
clarity.
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square pyramidal (τ = 0.11).36 For the Zn(II) complex, there are two cation/anion pairs per
asymmetric unit. The cations have only minor differences in bond lengths/angles
involving the Zn(II) center and both exhibit a distorted square pyramidal geometry (τ =
0.35).36 The overall features of 6-Ph2TPA chelate ligand coordination in the cationic
portions of 4-ClO4⋅Et2O and 5-ClO4⋅2CH2Cl2 differ in terms of the M-NPhPy distance,
which is ~0.24 Å longer in the Cu(II) complex, and the M-NPy and M-NAmine distances
which are > 0.05 Å longer in the Zn(II) complex. In both 4-ClO4⋅Et2O and 5ClO4⋅2CH2Cl2 the coordination of the flavonolate ligand involves a shorter bonding
interaction between the metal and the deprotonated hydroxyl donor (1.921(3) and
1.951(2) Å, respectively) and a longer bond with the ketone oxygen (2.010(3) and
2.1175(19) Å, respectively). Several Cu(II) complexes having a 3-hydroxyflavonolate
ligand have been previously characterized by X-ray crystallography.40-46 A portion of
these compounds have a bidentate or tridentate supporting chelate ligand,40-43 whereas
others are species such as [Cu(3-Hfl)2(py)2] and [Cu(3-Hfl)2]. In these two types of
complexes, the Cu-O bond distances are generally in the range of 1.90-2.21 Å, and the
∆M-O varies from 0.04 to 0.29 Å.47 For Zn(II), three 3-Hfl complexes, having either a
bidentate or tridentate supporting chelate ligand, have been previously reported.48-50 These
complexes exhibit a range of Zn-O distances of 1.98-2.24 Å and ∆M-O values of 0.16-0.26
Å. The bond lengths and ∆M-O values for 4-ClO4⋅Et2O and 5-ClO4⋅2CH2Cl2 fall within
the noted ranges.
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Considering the entire series of 6-Ph2TPA-supported complexes, the asymmetry in
terms of the M-O interactions in 5-ClO4⋅2CH2Cl2 (∆M-O ~ 0.17 Å) is slightly less than
that found in the Co(II) derivative 2-ClO4 (∆M-O ~ 0.21 Å), considerably greater than that
found in the Mn(II) and Ni(II) analogs (∆M-O < 0.04 Å), and approximately double that
found in the Cu(II) complex (∆M-O ~ 0.09 Å). Hence, in the series of 6-Ph2TPA supported
complexes, the asymmetry of flavonolate coordination increases in the order Mn (II) ~
Ni(II) < Cu(II) < Zn(II) < Co(II). Examination of the bond lengths within the coordinated
flavonolate ligands of 1-5-ClO4 revealed that the Mn(II), Co(II), Ni(II), and Zn(II)
complexes exhibit only a slight elongation (0.02-0.03 Å) of the C(32)-O(2) bond
involving the ketone moiety, and a slight contraction (~0.04 Å) of the C(31)-O(1) bond of
the hydroxyl donor, relative to the distances found in uncoordinated flavonol (1.232(3)
and 1.357(3) Å, respectively).51 The Cu(II) analog 4-ClO4⋅Et2O exhibits C-O distances
(C(32)-O(2) 1.252(5) Å; C(31)-O(1), 1.349(5) Å) that are quite close to those of the free
flavonol.51 Notably, the Cu(II) complex exhibits a short C(31)-C(32) bond (1.399(6) Å)
relative to that found in the other 6-Ph2TPA-supported complexes (av 1.45 Å). A similar
short C-C bond length was found in [Cu(II)(bpy)(3-Hfl)(2-HOC6H4COCO2)] (1.369(14)
Å),41 but other known Cu(II) flavonolate derivatives exhibit a distance of ~1.44 Å.42-46
Overall, the bond lengths within the flavonolate ligands of 1-5-ClO4 are minimally
affected by the identity of the metal ion present.
Spectroscopic, Magnetic, and Redox Properties of 1-5-OTf. Presented in Table
4-5 are selected spectroscopic features of 1-5-OTf. Also given are magnetic moments,
which indicate that each complex has a high-spin divalent metal center, and redox
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features identified in the range of +1.4 V to -1.0 V. 1H NMR spectra were also collected
for the Co(II), Ni(II), and Zn(II) complexes.
Infrared Spectroscopy. In the solid state, each complex exhibits a νC=O vibration
for the coordinated flavonolate ketone moiety. The highest energy νC=O is found for the
cobalt complex 2-OTf, which is consistent with the fact that the perchlorate analog has
the longest M(1)-O(2) distance of the series of complexes and therefore should polarize
the carbonyl to the weakest extent. That being said, we note that the C(32)-O(2) bond
lengths throughout the series 1-5-ClO4 are the same within experimental error. The Cu(II)
complex 4-OTf exhibits the lowest energy νC=O vibration, which is consistent with the
structural data for 4-ClO4, which has the shortest M(1)-O(2) distance of the series of
complexes.

Table 4-5. Analytical, Spectroscopic, Magnetic, and Cyclic Voltammetry Data for 1-5OTf.
Complex
Anal. Calcd.
(found):
C:
H:
N:
UV-vis, nm
(ε, M-1 cm-1)a
ESI-MS m/z (rel
intensity)
[M-OTf]+
FTIRc, cm-1 νC=O

1-OTf

2-OTf

3-OTf
⋅0.25CH2Cl2

4-OTf

5-OTf

62.51 (62.05)
3.99 (4.06)
6.34 (6.16)

62.23 (61.94)
3.97 (3.89)
6.31 (6.11)

61.11 (61.06)
3.97 (4.04)
6.31 (5.86)

61.91 (62.02)
3.95 (3.98)
6.28 (6.21)

61.78 (61.74)
3.94 (4.01)
6.28 (6.30)

431 (17600)

422 (17100)

443 (20000)

428 (22200)

420 (20100)

734.2059 (100)b

738.2037 (16)

737.2064 (15)

742.2002 (16)

743.1984 (2)

1550

1557

1548

1542

1552
e

µeff, µBd

5.90

4.38

3.34

1.93

Epaf versus Fc/Fc+

+365

g

+506

+660h

a

b

c

+534
d

Spectra collected in dry CH3CN. Obtaind by MALDI. Spectra collected as dilute KBr pellets. Determined by Evans method (Evans
D. F. J. Chem. Soc. 1959, 115, 2003). eDiamagnetic. fAll cyclic voltammetry data was obtained under argon in CH2Cl2 with a
complex concentration of 1 mM and Bu4NClO4 (0.1 M) as the supporting electrolyte. The scan rate was 50-100 mV/s. The
experimental set-up consisted of a platinum button working electrode, a silver wire reference electrode, and a platinum wire auxiliary
electrode. All potentials are reported relative to an internal Fc/Fc+ standard. Under these conditions, the Fc/Fc+ couple is at +460 mV
versus silver wire. gNo electrochemical behavior between +1.4 V and -1.0 V. hA quasi-reversible reduction peak at -1088 mV vs.
Fc/Fc+ has been tentatively assigned to the Cu(II)/Cu(I) couple as no other compound of the group has waves at potentials lower than
Fc/Fc+.
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UV-vis Spectroscopy. Neutral flavonol compounds exhibit an absorption feature
in the range of 350-380 nm, which is termed band I and is assigned to the π→π*
transition.52 When dissolved in CH3CN under anaerobic conditions, each complex 1-5OTf exhibits an intense absorption feature in the range of 420–443 nm. For comparison,
we have measured the absorption features of a flavonolate salt ([Me4N+][3Hfl-]) in
CH3CN (band I, λmax = 458 nm).53 For each metal complex, a hypsochromic shift of the
absorption band is found relative to the 3-Hfl salt, with the exact shift being influenced by
the nature of the metal ion. For example, the Mn(II) complex 1-OTf exhibits band I at
431 nm. This matches well with the band I reported for Mn(3-Hfl)2(py)2 (432 nm).23 To
our knowledge, absorption spectra of an enzyme/substrate complex a Mn(II)-containing
quercetinase enzyme have not been reported.11 Notably, the Ni(II) complex 3-OTf
exhibits the smallest shift with band I at 443 nm, and the zinc and cobalt complexes 5OTf and 2-OTf exhibit the largest shifts, with band I at 420 and 422 nm, respectively. For
the Ni(II)-containing form of QueD from Streptomyces sp. FLA, under anaerobic
conditions, addition of quercetin at pH = 8 produces an absorption feature at 385 nm,
which represents a hypsochromic shift relative to the absorption feature of free quercetin
at pH = 8 (λmax = 391 nm). Similarly, addition of quercetin to anaerobic cobalt-containing
QueD produces a band I absorption at 378 nm.12 Thus, in both the synthetic and enzyme
systems, the presence of Co(II) produces a more significant hypsochromic shift in band I.
The absorption maximum found for the Cu(II) complex 4-OTf (428 nm) is within the
reported range for Cu(II) flavonolate complexes (416-434 nm).19 The band I absorption of
[Zn(3-Hfl)(idpa)]ClO4 (idpa = 3,3’-iminobis(N,N-dimethylpropylamine) has been
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reported as 419 nm, which matches well with that found for 5-ClO4.54 Overall, from the
limited set of well-characterized divalent metal 3-hydroxyflavonolate complexes reported
in the literature to date (including those reported herein), the hypsochromic shift of the
band I π→π* transition (relative to the free 3-Hfl anion) generally increases in the order
Ni(II) < Mn(II) < Cu(II) < Zn(II), Co(II).
EPR Spectroscopy. EPR spectra were obtained for the Mn(II) and Cu(II)
complexes of the series (1-OTf and 4-OTf) and are shown in Figure 4-4. The spectrum
collected for 1-OTf is similar to the spectrum collected for the hydroxamate-bridged
dimanganese complex [(6-Ph2TPAMn)(µ-ONHC(O)CH3)2](ClO4)2.25 No hyperfine
coupling is discernable in the spectrum of either 1-OTf or the Mn(II) hydroxamate
complex. The similarity of these spectra suggested to us the possible formation of a
flavonolate-bridged dimanganese complex in solution. Reactivity studies outlined below
provide additional evidence for the chemical similarities of 1-OTf and the hydroxamate
complex in CH3CN. We note that the Mn(II)-containing form of the B. subtilis quercetin
dioxygenase in the presence of quercetin under anaerobic conditions exhibits a six-line
EPR signal at g = 2, with a hyperfine coupling constant of approximately 93 G.11 A
second, less intense six-line signal is also present at g = 9 and exhibits a similar hypefine
coupling constant. This data is consistent with the enzyme containing a mononuclear
psuedooctahedral Mn(II) center having oxygen/nitrogen ligands.55 The axial EPR
spectrum of 4-OTf is consistent with the distorted square pyramidal geometry of the
Cu(II) center and a dx2-y2 ground state (g// ~ 2.24; g⊥ ~ 2.06; A// ~ 180 G). The
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Figure 4-4. EPR spectra of 1-OTf and 4-OTf. Spectra were recorded at 4.7 K, 1.002 mW
microwave power, and 9.39 GHz. The samples were ≤ 1 mM in CH3CN.

anaerobic enzyme/substrate complex of the quercetinase enzyme from Aspergillus
japonius exhibits an EPR signal with g// = 2.366 and A// ~ 110 G.56
1

H NMR Spectroscopy. The 1H NMR spectra of analytically pure 2-OTf, 3-OTf,

and 5-OTf were measured in CD3CN at ambient temperature. The spectra for the
paramagnetic Co(II) and Ni(II) complexes are shown in Figure 4-5. While full assignment
of the resonances of 2-OTf and 3-OTf have not been made, the spectra are clearly distinct
from those of other complexes of bidentate ligands (e.g. hydroxamate derivatives) and can
be used to evaluate complex purity and reactivity.25 There are no concentration dependent
changes in these NMR spectra. Attempts were made to collect two-dimensional COSY
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Figure 4-5. 1H NMR spectra of 2-OTf (top) and 3-OTf (bottom) in CD3CN at ambient
temperature.

spectra to assign the pyridyl ring proton resonances of the 6-Ph2TPA ligands in 2-OTf
and 3-OTf.26 Unfortunately, these experiments did not reveal any crosspeaks. It is
important to note that the total number of paramagnetically shifted resonances in the
spectra of 2-OTf and 3-OTf is consistent with the presence of an effective plane of
symmetry containing the pyridyl donor, which gives equivalent phenyl-appended pyridyl
donors. This indicates that the solution structure of these compounds is generally similar
to that found in the solid state. The features of the 1H and 13C NMR spectra of 5-OTf (see
experimental section) are consistent the formation of a six-coordinate Zn(II) center in
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solution via coordination of all donors of the supporting 6-Ph2TPA ligand. Most notably,
the total number of carbon signals is consistent with the presence of an effective plane of
symmetry that makes the phenyl-appended pyridyl donors equivalent.
Cyclic Voltammetry. The redox properties of 1-5-OTf were examined by cyclic
voltammetry. An irreversible oxidation wave was identified for 1-OTf and 3-5-OTf and
the Epa values are given in Table 4-3. The Co(II) complex 2-OTf did not show any
electrochemical behavior in the range examined. A quasi-reversible reduction peak at
-1088 mV vs. Fc/Fc+ (Figure 4-6) for 4-OTf has been tentatively assigned to the
Cu(II)/Cu(I) couple, as no other compound of the group has waves at potentials lower
than Fc/Fc+. These data for 1-5-OTf indicate that the nature of the divalent metal
influences the redox potential of the coordinated flavonolate over a range of ~300 mV.
The differences in oxidation potential found for this series of complexes depends on the
metal and/or the solution structure of the metal complex. The Mn(II) derivative 1-OTf,

Figure 4-6. Cyclic voltammogram for the Cu(II) complex 4-OTf.
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which based on EPR, may form binuclear species in solution, has the lowest potential,
indicating that the flavonolate is a better reductant toward O2 than the same ligand in the
Ni(II), Cu(II), and Zn(II) analog complexes. For the Ni(II) and Zn(II) complexes 3-ClO4
and 5-ClO4, irreversible oxidation of the flavonolate ligand occurs at +0.506 and +0.536
V vs. Fc/Fc+, respectively. For the Cu(II) complex, which is distorted square pyramidal in
acetonitrile, the potential is more positive (+0.660 V). Potentials previously reported for
3-hydroxyflavonolate complexes of the general formula [M(3-Hfl)(H2O)n]Cl (M = Cu, n
= 2; M = Fe, n = 4) are in the same range as those reported herein.57
Ligand Exchange Reactivity. The results of initial electrospray ionization mass
spectrometry experiments suggested that the Mn(II) flavonolate complex 1-OTf would
undergo reaction with available Zn(II) ion to produce a ligand exchange product, [(6Ph2TPA)Zn(OTf)]+. To examine this reactivity, in independent NMR tube experiments,
[(6-Ph2TPA)Mn(3-Hfl)]OTf was treated with an equimolar amount of M(ClO4)2⋅6H2O (M
= Co(II), Ni(II), and Zn(II)) in CD3CN. For each reaction, well resolved 1H NMR spectra
consistent with the quantitative formation of a divalent metal solvate complex of the
added metal, [(6-Ph2TPA)M(CD3CN)n](X)2 (n = 1 or 2; X = OTf- or ClO4-) were
obtained.25,26 A yellow-green precipitate formed in each reaction mixture and was
identified as [Mn(3-Hfl)2⋅0.5H2O] by elemental analysis. This compound was isolated
from the reaction mixture involving Ni(II) by selective crystallization in 39% yield (for
0.5

equivalent).

In

addition

to

the

stoichiometric

formation

of

[(6-

Ph2TPA)M(CD3CN)n](X)2 and 0.5 eq. of [Mn(3-Hfl)2⋅0.5H2O], mass balance requires the
formation of 0.5 eq. of MnX2 salt (equation 4-1), which could not be isolated from the
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reaction mixture. Notably, we found that the Mn(II) hydroxamate complex [(6Ph2TPAMn)(µ-ONHC(O)CH3)2](ClO4)225 also reacts with M(ClO4)2⋅6H2O to produce
[(6-Ph2TPA)M(CD3CN)](X)2 (M = Co, Ni, Zn; X = OTf- or ClO4-; equation 4-2), as
determined by 1H NMR. The similarity in EPR spectral features (vida supra) and
reactivity of [(6-Ph2TPA)Mn(3-Hfl)]OTf and [(6-Ph2TPAMn)(µ-ONHC(O)CH3)2](ClO4)2
suggest that the compounds may have similar solution structures. We propose that these
structures include µ-η1:η2-coordination of the chelate anion (3-Hfl or acetohydroxamate)
as is found in the X-ray structure of [(6-Ph2TPAMn)(µ-ONHC(O)CH3)2](ClO4)2.25

M = Co, Ni, Zn; X = OTf- or ClO4-:
[(6-Ph2TPA)Mn(3-Hfl)]OTf + M(ClO4)2⋅6H2O + nCD3CN → [(6Ph2TPA)M(CD3CN)n](X)2 + 0.5 MnX2 + 0.5 [Mn(3-Hfl)2⋅0.5H2O] + 5.75 H2O

(4-1)

[(6-Ph2TPA)Mn(ONHC(O)CH3)]ClO4 + M(ClO4)2⋅6H2O + nCD3CN → [(6Ph2TPA)M(CD3CN)n](X)2 + 0.5MnX2 + 0.5 [Mn(ONHC(O)CH3)2] + 6H2O

(4-2)

In this coordination motif, each Mn(II) center coordinates the anionic oxygen of each
bridging ligand. We propose that from this structure an equilibrium mixture is formed,
and is comprised of 0.5 eq. [Mn(3-Hfl)2⋅0.5H2O], 0.5 eq. free chelate ligand, and 0.5 eq.
of [(6-Ph2TPA)Mn(CD3CN)2](X)2 (Scheme 4-3). Formation of the final product mixture,
including one equivalent of [(6-Ph2TPA)M(CD3CN)n](X)2 (M = Co, Ni, Zn), could result
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Scheme 4-3. Proposed reaction pathway for ligand exchange in the reaction of 1-OTf
with divalent metal perchlorate salts.

from coordination of the free divalent metal ion to the free chelate ligand, and
displacement of Mn(II) (as MnX2) from [(6-Ph2TPA)Mn(CD3CN)2](X)2. The latter
reaction has been independently investigated by 1H NMR and found to occur rapidly in
CD3CN for M = Co(II), Ni(II), and Zn(II).
In another type of ligand exchange reaction, we found that treatment of the nonmanganese flavonolate complexes [(6-Ph2TPA)M(3-Hfl)]OTf (M = Co (2-OTf), Ni (3OTf), and Cu (4-OTf)) with 0.5 eq Zn(ClO4)2⋅6H2O in CD3CN results in the formation of
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[(6-Ph2TPA)M(CD3CN)n](X)2 (n = 1 or 2; X = OTf- or ClO4-) species as indicated by 1H
NMR. Hence, in these reactions flavonolate ligand exchange occurs, but no change in the
metal bound by the 6-Ph2TPA ligand takes place. The other product in the reaction is
[Zn(3-Hfl)2⋅2H2O] (equation 4-3), which is a poorly soluble yellow precipitate. This
material was identified by independent synthesis and characterization, followed by
comparison of UV-vis and 1H NMR properties between the reaction product and the
independently generated material.

M = Co, Ni, Cu; X = OTf- or ClO4[(6-Ph2TPA)M(3-Hfl)]OTf

+ 0.5 Zn(ClO4)2⋅6H2O

+ n CD3CN

Ph2TPA)M(CD3CN)n](X)2 + 0.5 [Zn(3-Hfl)2⋅2H2O] + 2 H2O

→

[(6(4-3)

What about Fe(II)? The quercetinase enzyme from B. subtilis was originally
described as a non-heme iron enzyme.10 However, the turnover number for this enzyme
was reported to be two orders of magnitude lower than for the Cu(II)-containing A. flavus,
which led researchers to suggest that Fe(II) might not be the correct cofactor for the
enzyme. Follow-up studies suggested that Mn(II) was probably the correct cofactor for the
B. subtilis enzyme.11 To date, only two iron flavonolate complexes, both Fe(III)
derivatives, have been crystallographically characterized.23,24
To gauge the chemistry of Fe(II) relative to the other 3d metal ions investigated
herein, we initiated attempts to prepare a Fe(II) flavonolate complex supported by the 6Ph2TPA ligand. In our first approach, treatment of 6-Ph2TPA with equimolar amounts of
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Fe(ClO4)2⋅6H2O, 3-hydroxyflavonol, and Me4NOH⋅5H2O under a N2 atmosphere,
followed by stirring overnight, work-up, and crystallization from CH3CN/Et2O resulted in
the deposition of dark brown single crystals. X-ray crystallographic analysis of these
crystals revealed the formation of the diiron(III) µ-oxo compound [(6-Ph2TPAFe(3Hfl))2(µ-O)](ClO4)2 (6⋅⋅2.5CH3CN, Figure 4-7). The structural and spectroscopic
properties of this complex are discussed in detail below. However, as an approach toward
understanding the reaction pathway leading to the formation of 6, we further explored the
synthetic conditions.

Figure 4-7. Thermal ellipsoid drawings (50% probability) of the cationic portions of
6⋅⋅2.5CH3CN. Hydrogen atoms have been omitted for clarity.

Treatment of 6-Ph2TPA with Fe(ClO4)2⋅6H2O in CH3CN, followed by recrystallization
from CH3CN/Et2O, yielded [(6-Ph2TPA)Fe(CH3CN)](ClO4)2 (7) as pale yellow crystals.
Characterization details for this Fe(II) complex are given in the supporting information.
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Treatment of 7 with equimolar amounts of 3-hydroxyflavonol and Me4NOH⋅5H2O in
methanol, and stirring for 15 minutes under a freshly purged N2 atmosphere, gave a greenyellow solution from which, after work-up, a green-yellow precipitate was isolated. The
analytical and spectroscopic properties of this complex are consistent with the
formulation [(6-Ph2TPA)Fe(3-Hfl)]ClO4 (8). For this complex, the flavonolate νC=O
vibration is at 1558 cm-1, and the band I π →π* transition is at 415 nm (ε ~ 14700 M-1cm1

). These features are similar to those found for the Co(II) derivative 2-OTf, suggesting

that the flavonolate ligand may be coordinated with a ∆M-O similar to that found in the
cobalt complex. The magnetic moment for 8 (µeff = 4.7 µB) is consistent with the
presence of a high-spin Fe(II) center.58 The 1H NMR spectrum of 8 contains several
paramagnetically shifted resonances over a range of ~110 ppm (Figure 4-8). Investigation
of the redox properties of 8 by cyclic voltammetry (CH2Cl2, [8] = 1 mM, Bu4NClO4 (0.1
M) supporting electrolyte, scan rate 50-100 mV/s) revealed a quasi-reversible couple at ~0.05 V versus ferrocene/ferrocenium, which is assigned as the Fe(II)/Fe(III) couple. No
redox activity was found at more positive potentials, indicating that upon oxidation of the
iron center, the redox potential for the coordinated flavonolate is shifted from that
observed for the other divalent metal 3-Hfl complexes. This redox behavior is consistent
with the observed metal-centered O2 reactivity described below.
Complex 8 is very air sensitive, which complicated our efforts to characterize it,
especially in solution. Exposure of a CH3CN solution of 8 to air results in a rapid
darkening of the color, which corresponds to the formation of the µ-oxo compound 6
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Figure 4-8. 1H NMR spectrum of [(6-Ph2TPA)Fe(3-Hfl)]ClO4 (8) in CD3CN at ambient
temperature. In addition to the resonances shown, broad peaks are also present at 112 and
92 ppm.

This complex was characterized by X-ray crystallography, elemental analysis, UV-vis,
FTIR, and mass spectrometry. A summary of the iron coordination chemistry is shown in
Scheme 4-4.
The cationic portion of 6⋅⋅2.5CH3CN is shown in Figure 4-7. Details of the X-ray
data collection of this complex are given in Table 4-6. Selected bond distances and angles
are given in Tables 4-7 and 4-8, respectively. Each Fe(III) center has a κ3-6-Ph2TPA
ligand, a bidentate flavonolate ligand, and the µ-oxo bridge. The flavonolate ligands are
coordinated to Fe(1) and Fe(2) with ∆M-O = 0.17 and 0.14 Å, respectively. This is similar
to the coordination found in the Co(II) and Zn(II) flavonolate complexes 2-ClO4 and 5ClO4⋅CH2Cl2. Similarly, the Fe(III) complexes [(salen)Fe(III)(3-Hfl)] and [Fe(4’MeOflaH)3] have ∆M-O = 0.18 and 0.15 Å, respectively.23,24 Thus, all of the Fe(III)
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flavonolate complexes that have been structurally characterized to date exhibit very
similar levels of asymmetry with respect to flavonolate coordination.
The Fe-O(flavonolate) bond distances are also very similar in all three
compounds. We note that the flavonolate ketone oxygen donor is positioned trans to the
µ-oxo bridge in 6⋅⋅2.5CH3CN, whereas the deprotonated oxygen donor is trans to the
tertiary amine nitrogen. This results in a meridional donor array from the κ3-bound chelate
ligand. The Fe-O bond distances involving the oxo bridge in 6⋅⋅2.5CH3CN are within
experimental error identical to those found in [(6-C6H4O-TPAFe)2(µ-O)](BPh4)2.59 The
average Fe-N distance in 6⋅⋅2.5CH3CN (~2.20 Å) is slightly longer than what is found in
[(6-C6H4-TPAFe)2(µ-O)](BPh4)2 (~2.18 Å). However, both distances are consistent with a
high-spin (S = 5/2) state for each iron center.60
A vibration at 1549 cm-1 in the solid state infrared spectrum of 6 is assigned as the
νC=O vibration of the flavonolate, based on comparison to the spectral features of
[(salen)Fe(III)(3-Hfl)] (1549 cm-1).24 Compound 6 is slightly soluble in methanol and
exhibits absorption bands at 388 and 490 nm (Figure 4-9). Unlike its Fe(II) flavonolate
precursor 8, an absorption feature for the flavonolate ligand in the region of 400-450 nm
could not be readily identified. The absorption features of 6 and 8 are compared in Figure
4-9. For [(salen)Fe(III)(3-Hfl)], an absorption maximum at 407 nm was reported.24 The
1

H NMR spectrum of 6 in d4-methanol consists of broad resonances in the range of 0 to

~40 ppm (Figure 4-10).
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Table 4-6. Summary of X-ray Data Collection and
Refinement for 6⋅⋅2.5CH3CN.
Empirical formula

C97H77.5Cl2Fe2N10.5O15

Mr

1788.78

Crystal system

Triclinic

Space group

P-1

a/ Å

14.02370(10)

b/ Å

15.2054(2)

c/ Å

21.6638(3)

α /°

70.1168(7)

β /°

74.8473(7)
81.5826(8)

γ /°
3

4184.67(9)

V/Å
Z

2
-3

Dc / Mg m

1.420

T/K

150(1)

Color

Red

Crystal habit

Prism

Crystal size/ mm

0.28 x 0.18 x 0.15

Diffractometer

Nonius KappaCCD

µ/ (mm-1)

0.486

2θ max /°

54.92

Completeness to θ (%)

99.0

Reflections collected

35639

Independent reflections

18968

Rint

0.0393

Variable parameters

1151

R1 / wR2b

0.0460/0.1010

Goodness-of-fit (F2)
-3

∆ρmax/min / e Å

1.019
0.397/-0.487

a
Radiation used: Mo Kα (λ = 0.71073 Å) bR1 = ∑ | |Fo| - |Fc| | / ∑ |Fo|; wR2 =
[∑[w(Fo2-Fc2)2]/[∑(Fo2)2]]1/2, where w = 1/[σ2(Fo2) + (aP)2 + bP].
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Table 4-7. Selected Bond Distances (Å) for 6⋅⋅2.5CH3CN.
Fe(1)-O(1)

1.9712(14)

Fe(2)-O(1A)

1.9655(14)

Fe(1)-O(2)

2.1460(15)

Fe(2)-O(2A)

2.1054(15)

Fe(1)-O(4)

1.7890(14)

Fe(2)-O(4)

1.7992(14)

Fe(1)-N(1)

2.1679(17)

Fe(2)-N(1A)

2.1822(18)

Fe(1)-N(2)

2.2489(17)

Fe(2)-N(2A)

2.2180(18)

Fe(1)-N(3)

2.2241(17)

Fe(2)-N(3A)

2.2109(18)

O(1)-C(31)

1.330(3)

O(1A)-C(31A)

1.326(3)

O(2)-C(32)

1.271(3)

O(2A)-C(32A)

1.274(2)

Table 4-8. Selected Bond Angles (deg) for 6⋅⋅2.5CH3CN.
O(4)-Fe(1)-O(1)

96.02(6)

O(4)-Fe(2)-O(1A)

95.13(6)

O(4)-Fe(1)-O(2)

170.00(6)

O(4)-Fe(2)-O(2A)

169.80(6)

O(1)-Fe(1)-O(2)

78.51(6)

O(1A)-Fe(2)-O(2A)

79.72(6)

O(4)-Fe(1)-N(1)

97.29(7)

O(4)-Fe(2)-N(1A)

96.62(7)

O(1)-Fe(1)-N(1)

90.11(6)

O(1A)-Fe(2)-N(1A)

88.98(6)

O(2)-Fe(1)-N(1)

91.13(6)

O(2A)-Fe(2)-N(1A)

92.12(6)

O(4)-Fe(1)-N(3)

93.65(6)

O(4)-Fe(2)-N(3A)

93.35(6)

O(1)-Fe(1)-N(3)

117.63(6)

O(1A)-Fe(2)-N(3A)

118.27(6)

O(2)-Fe(1)-N(3)

81.72(6)

O(2A)-Fe(2)-N(3A)

81.55(6)

N(1)-Fe(1)-N(3)

148.90(7)

N(1A)-Fe(2)-N(3A)

149.99(7)

O(4)-Fe(1)-N(2)

93.62(6)

O(4)-Fe(2)-N(2A)

93.42(6)

O(1)-Fe(1)-N(2)

162.47(6)

O(1A)-Fe(2)-N(2A)

161.88(6)

O(2)-Fe(1)-N(2)

93.87(6)

O(2A)-Fe(2)-N(2A)

94.03(6)

N(1)-Fe(1)-N(2)

74.13(6)

N(1A)-Fe(2)-N(2A)

74.17(7)

N(3)-Fe(1)-N(2)

76.19(6)

N(3A)-Fe(2)-N(2A)

77.04(7)
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Scheme 4-4.

Figure 4-9. UV-vis absorption features of [(6-Ph2TPAFe(3-Hfl))2(µ-O)](ClO4)2 (6) and
[(6-Ph2TPA)Fe(3-Hfl)]ClO4 (8).
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Figure 4-10. 1H NMR spectrum of 6 in CD3CN.

Several features of this spectrum are significantly overlapped in the aromatic range (-10 to
40 ppm), consistent with the presence of several types of aryl protons. The dramatically
different features of this spectrum versus that found for [(6-Ph2TPA)Fe(3-Hfl)]ClO4 (8,
Figure 4-8) is likely due to antiferromagnetic coupling of the S = 5/2 metal centers via the
oxo bridge.59,61,62
Final Comments
The chemistry of metal complexes of flavonolate ligands is of significant current
interest. Metal flavonolate complexes have been prepared and investigated for their
antioxidant and DNA cleavage reactivity.63-74 Because of their biological relevance, metal
flavonolate complexes have also been the subject of several recent computational
investigations.75-78 As noted in the introduction, fungal and bacterial quercetinase
enzymes have been shown to exhibit varying levels of activity as a function of the
divalent metal ion present. While a few initial investigations directed at evaluating the
effect of the metal ion on flavonolate/O2 chemistry of relevance to quercetin dioxygenase
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enzymes have been reported,23,24 these studies lack a systematic approach. Specifically,
the studies reported to date have included comparisons between complexes having
different supporting chelate ligands and/or metal oxidation states. The research described
herein is the first detailed systematic mapping of how metal ion content influences the
structural, spectroscopic, redox properties, and ligand exchange reactivity of structurallyrelated flavonolate complexes. These complexes are relevant to the metal/flavonolate
adducts proposed to form in quercetinase enzymes of varying metal ion content. The
results presented herein lay the groundwork for detailed O2 reactivity studies as a function
of the divalent metal ion present. These investigations are currently in progress.
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CHAPTER 5
PHOTOCHEMICALLY-INDUCED DIOXYGENASE-TYPE CO-RELEASE OF
GROUP 12 FLAVONOLATE COMPLEXES1
Abstract

Exposure of 3-hydroxyflavonolate complexes of the group 12 metals to UV light
under aerobic conditions results in oxidative carbon-carbon bond cleavage and CO
release. This reactivity is novel in that it occurs under mild reaction conditions and
suggests that light-induced CO-release reactivity involving metal flavonolate species may
be possible in biological systems.
Introduction

Flavonoids are a class of a naturally occurring, polyphenolic substances produced
in plants. They are of current interest as potential therapeutic agents due to their antimicrobial, anti-oxidative, and UV-protective activity.1 A prominent member of this
family of compounds is quercetin (Figure 5-1), a natural compound that is being
investigated to prevent or treat a variety of diseases.1a,2 Quercetin is found in an
assortment of foods including black and green tea, red onions, and many other fruits and
vegetables that are widely touted for their beneficial health effects.

1

Coauthored by Katarzyna Grubel, Brynna Laughlin, Thora R. Maltais, Rhett C. Smith,
Atta M. Arif, and Lisa M. Berreau. Reproduced with permission from Chemical
Communications 2011. Copyright 2011 The Royal Society of Chemistry.
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Figure 5-1. Top: Structure of quercetin (including numbering of C-C bond that
undergoes oxidative cleavage) and the reaction catalyzed by quercetinase enzymes.
Bottom: Structure of 3-hydroxyflavonol (3-Hfl) and labeling of rings.

Studies of the interactions of flavonoids with metal ions are essential toward
understanding how complexation modulates the reactivity properties of the flavonoid.3
Investigations of metal-flavonoid species are relevant toward understanding the active site
chemistry of quercetinases from fungi and bacteria that catalyze oxidative cleavage of the
C(2)-C(3) bond (a dioxygenase-type reaction; Figure 5-1) and CO release.4,5 In another
area of research, metal complexes of 3-hydroxyflavonol (3-Hfl, Figure 5-1 (bottom)) are
being used as model systems to evaluate intereactions between components of soil
organic matter and bioavailable or contaminating heavy metal ions.6 To adequately
address these areas, systematic studies of structure/reactivity relationships of metal
flavonolate complexes are needed, including studies involving environmentally toxic
metals ions such as Cd(II) and Hg(II). However, to date such systematic studies are
lacking, and while the chemistry of copper flavonolate species has been significantly
advanced in recent years,7 far fewer X-ray crystallographically characterized flavonolate

155
complexes of other metal ions have been reported.8 To address this deficiency, we
recently prepared and characterized the first series of 3-Hfl complexes of the 3d metals,
including a Zn(II) derivative, [(6-Ph2TPA)Zn(3-Hfl)]ClO4 (1; 6-Ph2TPA, N,N-bis((6phenyl-2-pyridil)methyl)-N-((2-pyridil)methyl)amine).9
Discussion
Outlined herein is the first systematic study of the structural, spectroscopic, and
aerobic photochemical reactivity properties of Group 12 metal 3-Hfl complexes. Our
results demonstrate that all three group 12 metal ions form isolable flavonolate
complexes that can be characterized by X-ray crystallography, and that each complex
undergoes an aerobic photochemically-induced dioxygenase-type reaction to release CO
and form a metal-depside complex. These results are novel for a number of reasons. First,
aerobic photoinduced flavonoid ring-opening and CO release has not been previously
reported for any metal flavonolate complex and is relevant to plant and soil chemistry
involving metal-flavonoid interactions. Second, the observed dioxygenase reactivity for
the complexes contrasts with prior reports of Zn(II)-flavonolate species that exhibit
photoisomerization reactivity akin to that found for free 3-hydroxyflavonol.10
The Cd(II) and Hg(II) flavonolate complexes [(6-Ph2TPA)M(3-Hfl)]ClO4 (M =
Cd(II), 2; M = Hg(II), 3) were prepared in a similar manner to the Zn(II) analog.9 Each
complex was characterized by X-ray crystallography, elemental analysis, IR, multinuclear
NMR, UV-vis, and fluorescence. While the Zn(II) center of 1 has a coordination number
of five in the solid state, the Cd(II) and Hg(II) analogs 2 and 3 exhibit a distorted
octahedral geometry (Figure 5-2).11 In both complexes the ketone oxygen of the C ring is
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coordinated trans to the tertiary amine nitrogen of the chelate ligand. The average M-O
distance involving the flavonolate oxygen atoms increases down the group (1: 2.03 Å; 2:
2.25 Å; 3: 2.30 Å),12 and the asymmetry of the flavonolate coordination (∆M-O) is largest
for the Zn(II) and Hg(II) derivatives (0.17 and 0.21 Å, respectively). The flavonolate
moiety in 2 and 3 is positioned between the phenyl appendages of the 6-Ph2TPA ligand
(Figure 5-2). The average distance between the centroid of ring C of the flavonolate and
the centroids of the aryl rings of the chelate ligand is ~4.0 Å.

Figure 5-2. Thermal ellipsoid drawings of the cationic portions of 2 and 3. Ellipsoids
are plotted at the 50% probability level. Hydrogen atoms are omitted for clarity.

Comparison of the 1H NMR spectra of 1-3 (Figure 5-3) shows that each complex
has effective Cs symmetry in solution with equivalent phenyl-appended pyridyl
appendages. There are interesting differences in the 1H NMR spectra of this series of
complexes in terms of the chemical shifts of proton resonances associated with the phenyl
appendages of the 6-Ph2TPA ligand. Namely, in 2 and 3 the resonances of the meta and
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Figure 5-3. 1HNMR spectra of [(6-Ph2TPA)Zn(3-Hfl)]ClO4 (1, top), [(6Ph2TPA)Cd(3-Hfl)]ClO4 (2, middle), and [(6-Ph2TPA)Hg(3-Hfl)]ClO4 (3, bottom).

para protons of the phenyl appendages are shifted upfield, which is consistent with πstacking involving the C ring of the flavonolate. Additionally, the signal for the C(1)-H of
the unsubstituted pyridyl ring in 2 and 3 is shifted downfield by ~0.9 ppm relative to the
same signal in 1. We attribute this deshielding to the presence of close contact between
C(1) of the unsubstituted pyridyl ring and the carbonyl O(2) atom of the coordinated
flavonolate (for both complexes 2 and 3 C(1)…O(2) distance is ~3.0 Å).
The π→π* transition of the flavonolate moiety of 2 is found at 430 nm and is redshifted relative to that of 1 (420 nm) and 3 (415 nm). Fluorescence emission spectra of
the complexes show a Stokes shift of 60 nm for 1 and 3, and 46 nm for 2 (Figures 5-4, 55, and 5-6). The excited states associated with these emissions have lifetimes of ~2.0 ns
(1: 2.0(1); 2: 1.7(1) ns; 3: 2.0(1) ns)). The fluorescence quantum yields are 1-3 0.18, 0.06,
and 0.02, respectively. We note that the complexes presented herein have lower
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Figure 5-4. Absorption and emission spectra of 1.

fluorescence quantum yields than that previously reported for [Zn(3-Hfl)]+ (0.38), albeit
the structure of this species has not been determined.10 The divalent metal flavonolate
complexes 1-3 are stable with respect to exposure to oxygen in the solid state under room
light for >90 days. However, exposure of aerobic CH3CN solutions of 1-3 to UV light
(Rayonet, 300 nm irradiation) results in clean, high-yield dioxygenase-type reactivity to
give the depside complexes [(6-Ph2TPA)M(O-bs)]ClO4 (M = Zn (4), Cd (5), Hg (6); O-bs
= O-benzoylsalicylate; Scheme 5-1) and CO.13 Each reaction proceeds with a high
quantum yield at 300 nm: 1 (ϕ = 0.9), 2 (ϕ = 1.0), and 3 (ϕ = 0.8).
The shorter excited state lifetime and lower reaction quantum yield of the Hg(II)
complex is due to enhanced spin-orbit coupling.14 Use of 18O2 in the reactions of 1 and 2
resulted in quantitative incorporation (>98% as determined by mass spectrometry and
FTIR) of two labeled oxygen atoms into the depside ligand. Comparison of the fully
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assigned 13C NMR spectra of 2, 5, and [(6-Ph2TPA)Cd(CH3CN)](ClO4)2 (7, Figures 7-9)
clearly show that the carbon lost as CO is derived from the C(31)-O(1) unit (Figure 5-7).

Figure 5-6. Absorption and emission spectra of 3.

Figure 5-5. Absorption and emission spectra of 2.
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Complexes 4 and 5 were characterized by X-ray crystallography, elemental
analysis, NMR spectroscopy, IR spectroscopy, and mass spectrometry. Complex 6 was
characterized by NMR spectroscopy, IR spectroscopy, and mass spectrometry. The
cationic portions of 4 and 5 are shown in Figure 3. In 415 the zinc center has a nearly
trigonal bipyramidal geometry,16 with the O-bs ligand coordinated in a monodentate
fashion in an axial position.17 In 5, the depside is coordinated as a bidentate ligand.17,18
The spectroscopic properties of the depside complexes 4 and 5 are as expected (Figure 510). We note that 1H NMR spectra of 6 give evidence for a small amount of loss of the 6Ph2TPA ligand in CD3CN solutions of this complex.19
The results presented herein are novel when considered in the context of the
previously reported photochemistry of 3-Hfl. Irradiation of a pyridine solution of 3-Hfl
using a 300 W tungsten lamp, in the presence of a photosensitizer (Bengal rose), has been
reported to result in the formation of the photooxygenation products depside (O-bs) and
CO.20 This reaction involves the generation of 1O2 which reacts with ground state 3-Hfl.
Struder et al. reported that photooxygenation of 3-Hfl occurs in O2-saturated nonpolar
solvents in the absence of a photosensitizer.21
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Figure 5-7. 13C{1H} NMR chemical shift assignments (in ppm) for 2. The resonances
were assigned on the basis of HMQC and COSY data.
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Figure 5-8. 13C{1H} NMR chemical shift assignments (in ppm) for 5. The resonances
were assigned on the basis of HMQC and COSY data. aThirteen signals could not be
definitively assigned. These are found at: 134.0, 133.8, 132.7, 130.7, 130.4, 130.0,
129.4, 128.6, 127.1 125.9, 126.7, 124.3, 123.0.
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Figure 5-9. 13C{1H} NMR chemical shift assignments (in ppm) for [(6Ph2TPA)Cd(CH3CN)](ClO4)2 (7). The resonances were assigned on the basis of
HMQC and COSY data.

Figure 5-10. 1HNMR spectra of [(6-Ph2TPA)Zn(O-bs)]ClO4 (4, top), [(6Ph2TPA)Cd(O-bs)]ClO4 (5, middle), and [(6-Ph2TPA)Hg(O-bs)]ClO4 (6, bottom).
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In this case, photooxygenation was suggested to result from reaction between a triplet
tautomer state, wherein the C(3) hydroxyl proton has been transferred to the C(4)carbonyl moiety in a zwitterionic structure, and ground state 3O2. We note that this
chemistry is solvent dependent, as un CH3OH, CH3CN, or CH2Cl2 photooxygenation
does not happen and instead photorearrangement to give 3-penyl-3-hydroxy-1,2inandione occurs.
Previously, the presence of metal ions was reported to prevent the photoinduced
rearrangement of neutral 3-Hfl, or have no effect on the photochemical reaction.10,22a
However, the results presented herein show that metal 3-hydroxyflavonolate complexes
can undergo photoinduced dioxygenase type CO-release reactivity when irradiated with
UV light. In these complexes the coordinated flavonolate anion is akin to the triplet
tautomeric structure of 3-Hf23, thereby enabling photoinduced photooxygenation and COrelease reactivity, Notably, this reactivity occurs under conditions that are considerably
milder than those reported for thermal dioxygenase-type reactions of Cu(3-Hfl)
complexes.7 Overall, the results presented herein suggest that the formation of metalflavonolate species in nature may enable light-induced dioxygenase-type CO-release
reactivity under mild conditions.
Experimental
General Methods. All reagents and solvents were obtained from commercial
sources and were used as received unless otherwise noted. Anaerobic procedures were
performed in a VAC atmospheres glovebox. Solvents for glovebox use were dried
according to published methods and distilled under N2.24 The zinc complexes [(6-
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Ph2TPA)Zn(3-Hfl)]X (1-X, X = OTf- or ClO4-) were prepared as previously described.9
Physical Methods. UV-vis spectra were collected using a HP8453A
spectrometer. FTIR spectra were recorded on a Shimadzu FTIR-8400 spectrometer as
KBr pellets. 1H,

13

C, and

113

Cd NMR spectra were obtained using a Bruker ARX-400.

Chemical shifts are referenced to the residual solvent peak(s) in d3-acetonitrile (1H: 1.94
(quintet) ppm;

13

C{1H} 1.39 (heptet)).

113

Cd NMR spectra were recorded at 88.9 MHz

using CD3CN as the solvent and were referenced to an external standard of 0.5 M
Cd(ClO4)2·5H2O in D2O (0.00 ppm). Additional details regarding the acquisition of 113Cd
NMR spectra have been previously reported.25 CO formation was determined
qualitatively via the PdCl2 method14 or using an Agilent 3000A Micro GC. Mass spectral
data was collected at the Mass Spectrometry Facility, University of California, Riverside.
Elemental analyses were performed by Atlantic Microlabs Inc., Norcross, GA.
Acetonitrile solutions of 1–3 (6.70 x 10-5 M) for fluorescence measurements were
prepared under anaerobic conditions. Each solution was transferred to a quartz cell sealed
with a septum-containing screw cap (VWR Spectrosil). Anaerobic emission spectra were
obtained using Shimadzu RF-530XPC in the range of 250-900 nm with excitation
wavelength corresponding to the absorption maximum of the complex above 400 nm.
The excitation slit width was set at 5 nm and the emission slit width was set at 5 nm for
all fluorescence experiments.
Quantum Yield Measurements. In a 100 mL volumetric flask complex 1, 2, or 3
(7.1 x 10-6 mol; 6.0 mg, 6.3 mg, and 7.0 mg, respectively) was dissolved in acetonitrile
and filled to the mark. Three samples (3 mL each) were prepared for each complex and
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put into an air-free quartz cuvettes. Each cuvette was then inserted into an UV reactor and
exposed to 300 nm radiation for 60 s. After this time, reaction progress was evaluated
using UV-vis spectroscopy, by measuring the intensity of the band I absorption of the
metal-bound flavonolate.9 The lamp output was measured using standard actinometry.26

Caution! Perchlorate salts of metal complexes with organic ligands are
potentially explosive. Only small amounts of material should be prepared, and these
should be handled with great care.27

Synthesis of [(6-Ph2TPA)Cd(3-Hfl)]ClO4 (2). In a glovebox, a methanol solution
(~2 mL) of Cd(ClO4)2·6H2O (50.0 mg, 1.19 x 10-4 mol) was added to solid 6-Ph2TPA
(52.8 mg, 1.19 x 10-4 mol) and the mixture was stirred until all of the ligand had
dissolved. The colorless solution was added to a methanol solution (~2 mL) of 3-Hfl
(28.4 mg, 1.19 x 10-4 mol) and Me4NOH·5H2O (21.6 mg, 1.19 x 10-4 mol). The mixture
was then allowed to stir for 3 h at ambient temperature. After this time, the solvent was
removed under reduced pressure. The residual bright yellow solid dissolved in CH2Cl2
and filtered through a glass wool/celite plug. Precipitation of the product was induced by
the addition of excess hexanes. The solid that deposited was then brought to dryness
under reduced pressure. Yield: 91 mg, 94%. X-ray quality crystals were obtained by
diethyl ether diffusion into an acetonitrile solution. Elemental analysis: found: C, 59.42;
H, 3.97; N, 6.06. Calcd for C45H35CdN4O7·0.25CH2Cl2: C, 59.54; H, 3.92; N, 6.14 (the
presence of CH2Cl2 was confirmed by a

1

H NMR measurement); UV-vis
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λmax(CH3CN)/nm (ε/M-1cm-1) 430 (13500); FTIR (KBr, cm-1) 1549 (νC=O); 1H NMR
(CD3CN, 400 MHz): δ 9.47 (s, 1H), 8.32 (d, J = 7.6 Hz, 2H), 8.14 (t, J = 8.4 Hz, 1H),
7.93 (t, J = 7.7 Hz, 2H), 7.80 (t, 1H), 7.66-7.30 (m, 10H), 7.24 (dt, J1 = 7.9 Hz, J2 = 1.1
Hz, 1H), 7.11 (d, J = 7.1 Hz, 3H), 6.66 (t, J = 7.4 Hz, 3H), 6.58 (t, J = 6.9 Hz, 1H), 4.384.22 (m, 6H);

13

C{1H} NMR (CD3CN, 100 MHz): δ 177.7, 160.8, 156.2, 155.6, 154.3,

150.9, 148.5, 146.3, 141.0, 140.7, 139.5, 135.2, 132.4, 129.3, 129.2, 128.8, 128.6, 128.3,
127.8, 126.2, 125.8, 125.6, 124.6, 124.3, 123.8, 121.0, 118.5, 58.4, 58.3 (29 signals
expected for equivalent phenyl-appended pyridyl donors; 29 observed).; 113Cd{1H} NMR
(CD3CN, 88.9 MHz): δ 186.8; ESI-APCI, m/z (relative intensity) 793.1732 ([M-ClO4]+,
3%).
The

13

C NMR spectral features of 2 are given in Figure 5-7. In order to make

signal assignments for this complex a related compound lacking the 3-Hfl ligand [(6Ph2TPA)Cd(CH3CN)](ClO4)2 (7) was prepared and characterized (see below).
Synthesis of [(6-Ph2TPA)Hg(3-Hfl)]ClO4 (3). A methanol solution (~2 mL) of
Hg(ClO4)2·6H2O (50.0 mg, 9.85 x 10-5 mol) was added to solid 6-Ph2TPA (43.6 mg, 9.85
x 10-5 mol) and the mixture was stirred until all of the ligand had dissolved. The colorless
solution was added to a methanol solution (~2 mL) of 3-Hfl (23.5 mg; 9.85 x 10-5 mol)
and Me4NOH·5H2O (17.9 mg; 9.85 x 10-5 mol). The mixture was then allowed to stir for
3 h at ambient temperature. After this time, the solvent was removed under reduced
pressure. The residual bright-yellow solid dissolved in CH2Cl2 and filtered through a
glass wool/celite plug. Precipitation of the product was induced by the addition of excess
hexanes. The solid that deposited was then brought to dryness under reduced pressure.
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Yield: 94 mg, 97%. X-ray quality crystals were obtained by ether diffusion into a
dichloromethane solution. Elemental analysis: found: C, 54.80; H, 3.63; N, 5.56. Calcd
for C45H35HgN4O7: C, 55.16; H, 3.60; N, 5.72; UV-vis λmax (CH3CN)/nm (ε/M-1cm-1) 415
(14000); FTIR (KBr, cm-1) 1566 (νC=O); 1H NMR (CD3CN, 400 MHz): δ 9.34 (d, J = 4.7
Hz, 1H), 8.15-8.05 (m, 3 H), 7.91 (t, J = 7.8 Hz, 2H), 7.80-7.60 (m, 4 H), 7.58-7.20 (m,
13 H), 6.74 (t, J = 7.5 Hz, 4H), 6.61 (t, J = 7.4 Hz, 2H), 4.50-4.20 (m, 6H);

13

C{1H}

NMR (CD3CN, 100 MHz): δ 175.2, 160.1, 155.0, 154.3, 154.1, 151.1, 146.5, 145.8,
141.2, 140.4, 139.4, 134.7, 132.7, 129.3, 129.1, 129.1, 128.8, 128.3, 128.0, 127.1, 126.3,
125.9, 124.5, 124.3, 124.1, 121.3, 118.7, 58.9, 58.2 (29 signals expected for equivalent
phenyl-appended pyridyl donors; 29 observed); ESI-APCI, m/z (relative intensity)
881.2434 ([M-ClO4]+, 1.8%).
Photoinduced

dioxygenase-type

reactivity

of

1-3:

Isolation

of

[(6-

Ph2TPA)Zn(O-bs)]OTf (4), [(6-Ph2TPA)Cd(O-bs)]ClO4 (5), and [(6-Ph2TPA)Hg(Obs)]ClO4 (6) (bs = O-benzoylsalicylate). Aerobic CH3CN solutions of 1-3 were
irradiated using a Rayonet Photoreactor equipped with 300 nm Hg lamps. The progress of
each reaction was monitored by UV-vis. After each reaction reached completion, the
solvent was removed under reduced pressure. Complexes 3-6 were precipitated from
acetonitrile via the addition of excess diethyl ether. Each isolated solid was dried under
vacuum. X-ray quality crystals for 4 and 5 were obtained by diethyl ether diffusion into
an acetonitrile solution.
[(6-Ph2TPA)Zn(O-bs)]ClO4 (4). Yield: 88%. Elemental analysis: found: C,
59.13; H, 3.81; N, 6.29. Calcd for C45H35F3N4O7SZn·0.75H2O: C, 59.28; H, 4.04; N, 6.14
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(the presence of H2O was also confirmed by a 1H NMR measurement); FTIR (KBr, cm-1):
1736 (νC=O); 1H NMR (CD3CN, 400 MHz): δ 8.0 (d, J = 4.3 Hz, 1H), 8.02 (dt, J = 7.7
Hz, 3H), 7.80 (dd, J1 = 8.3 Hz, J2 = 1.2 Hz, 2H), 7.28-7.65 (m, 12H), 6.96-7.20 (m, 10H),
6.65 (m, 1H), 4.20-4.50 (m, 6H);

13

C{1H} NMR (CD3CN, 100 MHz): δ 169.6, 166.0,

160.6, 156.4, 155.2, 151.2, 149.1, 141.8, 141.6, 139.4, 134.1, 133.9, 132.4, 131.2, 130.6,
130.2, 129.4, 129.3, 129.0, 126.0, 125.7, 125.5, 125.1, 123.6, 123.3, 57.7, 57.5 (26
signals observed); MALDI-MS, m/z (relative intensity) 747.1933 ([M-OTf]+, 100%).
[(6-Ph2TPA)Cd(O-bs)]ClO4 (5). Yield: 96%. Elemental analysis: found: C,
58.74; H, 3.98; N, 6.75. Calcd for C45H35CdN4O7·0.4CH3CN: C, 59.00; H, 4.00; N, 6.76
(the presence of CH3CN was also confirmed by a 1H NMR measurement); FTIR (KBr,
cm-1): 1736 (νC=O). 1H NMR (CD3CN, 400 MHz): δ 8.3 (s, 1H), 8.00-7.85 (m, 4H), 7.657.00 (m, 21H), 4.26-4.00 (m, 6H);

13

C{1H} NMR (CD3CN, 100 MHz): δ 171.9, 165.1,

160.6, 156.2, 155.3, 151.6, 149.7, 141.1, 140.0, 134.0, 133.8, 132.7, 131.4, 130.7, 130.4,
130.0, 129.4, 128.6, 125.9, 125.9, 125.7, 124.8, 124.3, 124.0, 58.5, 58.2 (26 signals
observed).

113

Cd{1H} NMR (CD3CN, 88.9 MHz): δ 134.3; ESI-APCI, m/z (relative

intensity) 797.1700 ([M-ClO4]+, 9%).
[(6-Ph2TPA)Hg(O-bs)]ClO4 (6). FTIR (KBr, cm-1): 1734 (νC=O); ESI-APCI, m/z
(relative intensity) 885.2381 ([M-ClO4]+, 10%).
18

O2 Labeling of Photooxygenation Reactions 1 and 2. In the glovebox 1-ClO4

(2.24 x 10-5 mol) or 2 (1.12 x 10-5 mol) was dissolved in ~10 mL of acetonitrile and the
solution was then transferred to a solvent transfer flask from which was promptly
degassed by three freeze-pump-thaw cycles. After the third thawing, ~25 cm3 of

18

O2
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(99%; ICON Isotopes) was introduced and the reaction was put into a Rayonet
Photoreactor equipped with 300 nm Hg lamps until the color of the reaction bleached
from bright yellow to colorless. Upon completion of each reaction, the solvent was
removed under reduced pressure. Mass spectral analysis of the products (4 and 5)
indicated quantitative (>98%)

18

O incorporation into two oxygen atoms of the O-

benzoylsalicylato (O-bs) ligand.
Synthesis of [(6-Ph2TPA)Cd(CH3CN)](ClO4)2 (7). An acetonitrile solution (~2
mL) of Cd(ClO4)2·6H2O (50.0 mg, 1.19 x 10-4 mol) was added to solid 6-Ph2TPA (52.8
mg, 1.19 x 10-4 mol) and stirred until all of the ligand had dissolved. Crystals were
obtained by diethyl ether diffusion into an acetonitrile solution. Yield: 95 mg, 92%;
Elemental analysis: found: C, 48.08; H, 3.66; N, 8.80. Calcd for C32H29CdCl2N5O8: C,
48.35; H, 3.68; N, 8.81; FTIR (KBr, cm-1) 1092 (νClO4), 621 (νClO4). 1H NMR (CD3CN,
400 MHz): δ 8.41 (d, J = 4.8 Hz, 1H), 8.09-8.02 (m, 3H), 7.65-7.37 (m, 16H), 4.45-4.23
(m, 6H); δ 160.5, 156.3 (J (13C113Cd) = 67.2 Hz), 155.1 (J (13C113Cd) = 93.2 Hz), 149.3,
141.9, 141.7, 140.3, 131.0, 130.6, 129.1, 126.5 (J (13C113Cd) = 42.4 Hz), 126.3 (J
(13C113Cd) = 33.6 Hz), 125.4, 124.8, 58.7, 58.2 (16 signals expected for equivalent
phenyl-appended pyridyl donors; 16 observed).

113

Cd{1H} NMR (CD3CN, 88.9 MHz): δ

187.02.
X-ray Crystallography. A single crystal of 2-5 was mounted on a glass fiber
with traces of viscous oil and then transferred to a Nonius KappaCCD diffractometer
equipped with Mo Kα radiation (λ = 0.71073 Å). For unit cell determination, ten frames
of data were collected at 150(1) K with an oscillation range of 1 deg/frame and an
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exposure time of 20 sec/frame. Final cell constants were determined from a set of strong
reflections from the actual data collection. All reflections were indexed, integrated, and
corrected for Lorentz polarization and absorption effects using DENZO-SMN and
SCALEPAC.28 Structures were solved by a combination of direct and heavy-atom
methods using SIR 97.29 All of the non-hydrogen atoms were refined with anisotropic
displacement coefficients. For complexes 2, 3, and 4 the hydrogen atoms were assigned
isotropic displacement coefficients (U)H = 1.2U(C) or 1.5U(Cmethyl), and their coordinates
were allowed to ride on their respective carbons using SHELXL97.30 Hydrogen atoms in
4 were located and refined independently using SHELXL97.30
Structure Solution and Refinement. Complex 2 crystallizes in the space group
P21/n. Three out of four oxygen atoms in the perchlorate anion are disordered. Complex 3
crystallizes in the space group P21/n. Complex 4 crystallizes in the space group P21/c.
Complex 5 crystallizes in P-1 space group with one molecule of acetonitrile in the crystal
lattice. Two out of four oxygen atoms in the perchlorate anion of 5 are disordered.
Details of the X-ray data collection and refinement are given in Table 5-1.
Selected bond distances and angles are given in Tables 5-2 and 5-3.
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Table 5-1. Summary of X-ray Data Collection and Refinement for 2-5.
2

3

4

5

Empirical formula

C45H35CdClN4O7

C45H35ClHgN4O7

C45H35F3N4O7SZn

C46H38CdClN5O8

Mr

891.62

979.81

898.20

936.66

Crystal system

Monoclinic

Monoclinic

Monoclinic

Triclinic

Space group

P21/n

P21/n

P21/c

P-1

a/ Å

11.4616(2)

11.4117(2)

10.1785(2)

14.2066(2)

b/ Å

16.3861(3)

16.3761(2)

16.3337(5)

13.24300(10)

c/ Å

20.8770(4)

20.9794(3)

24.1620(5)

14.3060(2)

α /°

90

90

90

102.5400(9)

β /°

95.0205(11)

95.0070(9)

91.0370(14)

116.8087(6)

γ /°

90

90

90

99.7178(9)

V / Å3

3905.89(12)

3905.65(10)

4016.34(17)

2075.18(5)

4

4

4

2

Dc / Mg m

1.516

1.666

1.485

1.499

T/K

150(1)

150(1)

150(1)

150(1)

Color

Yellow

Yellow

Colorless

Colorless

Crystal habit

Prism

Prism

Prism

Prism

Crystal size/ mm

0.28 x 0.23 x 0.13

0.20 x 0.15 x 0.10

0.25 x 0.20 x 0.13

0.23 x 0.20 x 0.13

Diffractometer

Nonius Kappa CCD

Nonius Kappa CCD

Nonius KappaCCD

Nonius Kappa CCD

µ/ (mm-1)

0.686

4.068

0.736

0.652

2θ max /°

54.96

54.98

54.92

54.94

Completeness to θ (%)

99.9

99.8

99.5

99.7

Reflections collected

15965

16904

15119

17877

Independent reflections

8943

8946

9139

9483

Rint

0.0303

0.0366

0.0342

0.0202

Variable parameters

552

552

690

571

R1 / wR2b

0.0631/0.0859

0.0565/0.0674

0.0829/0.1034

0.0469/0.0803

1.019

1.039

1.016

1.037

0.840/-0.573

1.486/-0.784

0.332/-0.482

0.907/-1.184

Z
-3

Goodness-of-fit (F2)
-3

∆ρmax/min / e Å

Radiation used: Mo Kα (λ = 0.71073 Å) bR1 = ∑ | |Fo| - |Fc| | / ∑ |Fo|; wR2 = [∑[w(Fo2-Fc2)2]/[∑(Fo2)2]]1/2, where w = 1/[σ2(Fo2) +
(aP)2 + bP].

a
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Table 5-2. Selected Bond Distances (Å) for Complexes 2-5.
2

3

4

5

M–N(1)

2.337(2)

2.324(3)

2.115(2)

2.3328(19)

M–N(2)

2.430(2)

2.470(3)

2.1913(18)

2.3762(18)

M–N(3)

2.4636(19)

2.563(3)

2.155(2)

2.4592(18)

M–N(4)

2.420(2)

2.494(3)

2.132(2)

2.4172(17)

M–O(1)

2.2134(17)

2.194(2)

1.9387(15)

2.4062(16)

M–O(2)

2.2792(16)

2.408(2)

2.2439(16)

∆M-O

0.07

0.21

0.16

C(31)-O(1)

1.316(3)

1.317(4)

C(32)-O(2)

1.256(3)

1.248(4)

Table 5-3. Selected Bond Angles (deg) for Complexes 2-5.
2

3

4

5

O(1) – M – O(2)

74.74(6)

73.37(8)

N(1) – M – O(1)

156.95(7)

155.23(10)

N(1) – M – O(2)

82.45(7)

82.05(10)

N(1) – M – N(2)

71.13(7)

71.10(11)

77.34(7)

72.65(7)

N(1) – M – N(3)

103.81(7)

103.23(10)

121.81(8)

99.30(7)

N(1) – M – N(4)

98.09(7)

97.57(10)

117.93(8)

105.14(6)

N(2) – M – N(3)

72.82(7)

71.72(10)

75.42(7)

73.96(6)

N(2) – M – N(4)

67.65(7)

66.12(9)

78.53(7)

70.54(6)

N(2) – M – O(1)

131.54(7)

133.43(9)

176.79(8)

156.65(6)

N(2) – M – O(2)

153.56(7)

153.15(9)

N(3) – M – N(4)

124.990(7)

123.03(10)

105.51(8)

127.72(6)

N(3) – M – O(1)

89.41(6)

90.47(9)

105.88(7)

107.88(6)

N(3) – M – O(2)

116.00(7)

115.92(9)

N(4) – M – O(1)

89.28(7)

91.84(9)

N(4) – M – O(2)

116.60(6)

119.16(9)

56.42(6)
99.53(7)

84.18(6)
140.59(6)

146.73(6)

94.16(6)
103.78(7)

119.88(6)
95.08(6)

174
References
1. (a) Bischoff, S. C. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 733-740; (b)
Cazarolli, L. H.; Zanatta, L.; Alberton, E. H.; Figueiredo, M. S. R. B.; Folador, P.;
Damazio, R. G.; Pizzolatti M. G.; Silva, F. R. M. B. Mini-Rev. Med. Chem. 2008,
8, 1429-1440; (c) Boots, A. W.; Haenen G. R. M. M.; Bast, A. Eur. J. Pharmacol.
2008, 585, 325-337; (d) Friedman, M. Mol. Nutr. Food Res. 2007, 51, 116-134;
(e) Amic, D.; Davidovic-Amic, D.; Beslo, D.; Rastija, V.; Lucic, B.; Trinajstic, N.
Curr. Med. Chem. 2007, 14, 827-845; (f) Cushnie T. P. T.; Lamb, A. J. Int. J.
Antimicrob. Agents 2005, 26, 343-356.
2. (a) Yao, H.; Xu, W.; Shi, X.; Zhang, Z. J. Environ. Sci. Health, Part C: Environ.
Carcinog. Ecotoxicol. Rev. 2011, 29, 1-31; (b) Jagtap, S.; Meganathan, K.; Wagh,
V.; Winkler, J.; Hescheler, J.; Sachinidis, A. Curr. Med. Chem. 2009, 16, 14511462.
3. (a) de Souza, R. F. V.; De Giovani, W. F. Spectrochim. Acta, Part A 2005, 61,
1985-1990; (b) de Souza, R. F. V.; Sussuchi, E. M.; De Giovani, W. F. Synth.
React. Inorg. Met-Org. Chem. 2003, 33, 1125-1144.
4. Steiner, R. A.; Kalk, K. H.; Dijkstra, B. W. Proc. Natl. Acad. Sci 2002, 99,
16625-16630.
5. (a) Merkens, H.; Kappl, R.; Jakob, R. P.; Schmid, F. X.; Fetzner, S. Biochemistry
2008, 47, 12185-12196; (b) Schaab, M. R.; Barney, B. M.; Francisco, W. A.
Biochemistry 2006, 45, 1009-1016; (c) Gopal, B.; Madan, L. L.; Betz, S. F.;
Kossiakoff, A. A. Biochemistry 2005, 44, 193-201.

175
6. (a) Dangleterre, L.; Cornard, J. P. Polyhedron 2005, 24, 1593-1598; (b) Lapouge,
C.; Cornard, J. P. J. Phys. Chem. A 2005, 109, 6752-6761.
7. (a) Pap, J. S.; Kaizer, J.; Speier, G. Coord. Chem. Rev. 2010, 254, 781-793; (b)
Kaizer, J.; Balogh-Hergovich, É.; Czaun, M.; Csay, T.; Speier, G. Coord. Chem.
Rev. 2006, 250, 2222-2233.
8. (a) Barath, G.; Kaizer, J.; Speier, G.; Parkanyi, L.; Kuzmann, E.; Vertes, A. Chem.
Commun. 2009, 3630-3632; (b) Kaizer, J.; Barath, G.; Pap, J.; Speier, G.; Giorgi,
M.; Reglier, M. Chem. Commun. 2007, 5235-5237.
9. Grubel, K.; Rudzka, K.; Arif, A. M.; Klotz, K.; Halfen, J. A.; Berreau, L. M.
Inorg. Chem. 2010, 49, 82-96.
10. Protti, S. ; Mezzetti, A. ; Lapouge, C. ; Cornard, J. P. Photochem. Photobiol. Sci.
2008, 7, 109-119.
11. 2: C45H35CdClN4O7, M = 891.62, monoclinic, a = 11.4616(2), b = 16.3861(3), c =
20.8770(4) Å, U = 3905.89(12) Å3, T = 151(1) K, space group P21/n, Z = 4,
15965 reflections measured, 8943 unique (Rint = 0.0303) which were used in all
calculations. The final R values (I>2sigma(I)) are R1 = 0.0364 and wR2 = 0.0765.
3: C45H35HgClN4O7, M = 979.81, monoclinic, a = 11.4117(2), b = 16.3761(2), c =
20.9794(3) Å, U = 3905.65(10) Å3, T = 151(1) K, space group P21/n, Z = 4,
16904 reflections measured, 8946 unique (Rint = 0.0366) which were used in all
calculations. The final R values (I >2sigma(I)) are R1 = 0.0364 and wR2 =
0.0883.

176
12. The average M-N distance involving the chelate ligand increases by ≥ 0.3 Å for
the Cd(II) and Hg(II) derivatives relative to 1 (avg. M-N: 1: 2.11 Å; 2: 2.41 Å; 3:
2.46 Å).
13. CO formation was detectected via GC and the PdCl2 method. Allen, T. H.; Root,
W. S. J. Biol. Chem. 1955, 215, 309-317. CO2 formation was minimal and the
error range of the GC analysis.
14. (a) Tamayo, A.; Pedras, B.; Lodeiro, L.; Escriche, L.; Casabó, J.; Capelo, J. L.;
Covelo, B.; Kivekäs, R.; Silanpää, R. Inorg. Chem. 2007, 46, 7818-7826; (b)
Burress, C. N.; Bodine, M. I.; Elbjeirami, O.; Reibenspies, J. H.; Omary, M. A.;
Gabbai, F. P. Inorg. Chem. 2007, 46, 1388-1395.
15. 4: C45H35F3N4O7SZn, M = 898.20, monoclinic, a = 10.1785(2), b = 16.3337(5), c
= 24.1620(5) Å, U = 4016.34(17) Å3, T = 151(1) K, space group P21/c, Z = 4,
15119 reflections measured, 9139 unique (Rint = 0.0342) which were used in all
calculations. The final R values (I >2sigma(I)) are R1 = 0.0432 and wR2 =
0.0883.
16. 4: τ5 = 0.92; τ5 is a parameter that describes the geometry of a five-coordinate
metal center. A trigonal bipyramidal geometry correlates with τ5 = 1, whereas a
square pyramidal geometry has τ5 = 0. Addison, A. W.; Rao, T. N.; Reedijk, J.;
van Rijn, J.; Verschoor, G. C. J. Chem. Soc., Dalton Trans. 1984, 1349-1356.
17. Monodentate: ∆d > 0.6 Å, ∆θ > 28°; bidentate: ∆d < 0.3 Å, ∆θ < 14°. Kleywegt,
G. J.; Wiesmeijer, W. G. R.; van Driel, G. J.; Driessen, W. L.; Reedijk, J.;
Noordik, J. H. J. Chem. Soc., Dalton Trans. 1985, 2177-2184.

177
18. 5: C46H38CdClN5O8, M = 936.66, triclinic, a = 14.2066(2), b = 13.24300(10), c =
14.3060(2) Å, U = 2075.18(5) Å3, T = 151(1) K, space group P-1, Z = 4, 17877
reflections measured, 9483 unique (Rint = 0.0202) which were used in all
calculations. The final R values (I >2sigma(I)) are R1 = 0.0348 and wR2 =
0.0749.
19. Additional studies of the solution NMR properties of 6 are currently in progress.
20. (a) Matsuura, T.; Matsushima, H.; Sakamoto, H. J. Am. Chem. Soc. 1967, 89,
6370-6371; (b) Matsuura, T.; Matsushima, H.; Nakashima, R. Tetrahedron 1970,
26, 435-443.
21. Studer, S. L.; Brewer, W. E.; Martinez, M. L.; Chou, P.-T. J. Am. Chem. Soc.
1989, 111, 7643-7644.
22. (a) Sisa, M.; Bonnet, S. L.; Ferreira, D.; Van der Westhuizen, J. H. Molecules
2010, 15, 5196-5245; (b) Matsuura, T.; Takemoto, T.; Nakashima, R.
Tetrahedron 1971, 19, 1539-1540; (c) Matsuura, T.; Takemoto, T.; Nakashima, R.
Tetrahedron 1973, 29, 3337-3340; (d) Ficarra, R.; Ficarra, P.; Tommasini, S.;
Campagna, S.; Guglielmo, G. Boll. Chim. Farm. 1994, 133, 665-669.
23. Yokoe, I.; Higushi, K.; Shirataki, Y.; Komatsu, M. Chem. Pharm. Bull. 1981, 29,
894-898.
24. Armarego,W. L. F.; Perrin, D. D. Purification of Laboratory Chemicals, 4th ed.;
Butterworth-Heinemann: Boston, MA, 1996.
25. Allred, R. A.; McAlexander, H. L.; Arif A. M.; Berreau, L. M. Inorg. Chem.
2002, 41, 6790-6801.

178
26. (a) Hatchard, C. G.; Parker, C. A. Proceedings of the Royal Society, London A
1956, 518-536; (b) Kuhn, H. J.; Braslavsky, S. E.; Schmidt, R. Chemical
Actinometry, IUPAC Technical Report, 2004, 1-47.
27. Wolsey, W. C. J. Chem. Educ. 1973, 50, A335-A337.
28. Otwinowski, Z.; Minor, W.; Methods Enzymol. 1997, 276, 307-326.
29. Altomare, M. C.; Burla, M.; Camalli, G. L.; Cascarano, C.; Gacovazzo, A.;
Guagliardi, A. G. G.; Moliterni, G.; Polidori, R.; Spagna, J. Appl. Cryst. 1999, 32,
115-119.
30. Sheldrick, G. M. SHELXL-97 Program for the Refinement of Crystal Structures;
University of Göttingen, Germany, 1997.

179
CHAPTER 6
PHOTOCHEMICAL CO RELEASE REACTIVITY OF OPEN-SHELL 3d
DIVALENT FLAVONOLATE COMPLEXES
Abstract
Irradiation of 3-hydroxyflavonolate complexes of Mn(II), Co(II), Ni(II), and
Cu(II) supported by the 6-Ph2TPA ligand (1-4) at 300 nm results in CO release and
the formation of the corresponding depside complexes (8-11) which were isolated and
characterized. These reactions proceed considerably slower than those involving
closed-shell metal ions due to quenching of the excited state by the open-shell metal
ion. Each depside complex reacts with 3-Hfl, with the Ni(II) and Cu(II) depside
complexes undergoing reaction to regenerate the flavonolate complex to the greatest
extent. This suggests that all of the flavonolate complexes should exhibit catalytic
CO-release reactivity under photochemical conditions. Higher conversion is
anticipated for the systems containing Ni(II) and Cu(II).
Introduction
Flavonoids are naturally occurring compounds found in plants. Due to their
anti-microbial, anti-oxidative, and UV-protective properties the chemistry of this class
of molecules is of considerable current interest.1 3-hydroxyflavonol (3-Hfl, Figure 61(top)) is a flavonoid, albeit it is not found naturally in plants. This molecule has been
used as an analog for the flavonoid quercetin (Figure 6-1(bottom)) in model studies of
relevance to quercetin dioxygenases.2,3 These enzymes, which are found in bacteria

180
and fungi, catalyze the oxidative ring-opening of the C ring of quercetin, a reaction
which results in the release of one equivalent of CO (Figure 6-1(bottom)).4,5 Notably,
quercetinase has been found to utilize different 3d metal ions depending on the
source.4,5 Specifically, quercetinases found in fungi are Cu(II) enzymes, while the
bacterial enzyme from Streptomyces sp. FLA was shown to exhibit the highest
activity with Ni(II) or Co(II) as the active site metal, with other metal ions, such as
Mn(II), yielding lower activity.

Figure 6-1. Top: Structure of 3-hydroxyflavonol. Bottom: Structure of quercetin and
reaction catalyzed by quercetinase enzymes.

Several investigations of the thermally-induced oxidative cleavage reactivity
of copper-flavonolate complexes have been reported.2,3 Recently, similar studies have
been described for mononuclear Mn(II) and Fe(III) flavonolate species.3 However, it
should be noted that to date, no series of structurally-similar 3-Hfl complexes has
been examined in terms of oxidative carbon-carbon bond cleavage reactivity. Thus,
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the influence of the metal ion cannot be clearly evaluated. To begin to address this
issue, we recently reported the first series of structurally-related flavonolate
complexes of 3d metals (1-5, Figure 6-2).6 We have also prepared a structurally
similar series for the Group 12 metal ions (5-7, Figure 6-2).7

Figure 6-2. Structural features of 1-7. X = ClO4- or OTf-.

We discovered that the latter series of complexes undergo clean photoinduced
dioxygenase-type reactivity with release of CO when irradiated at 300 nm. These
complexes exhibit high reaction quantum yields (ϕ>0.8) resulting in short reaction
times. This chemistry is novel in that photoinduced CO-release had not been
previously reported for divalent metal-flavonolate complexes. We are interested in
examining such chemistry as it may be used toward the development of new CO-
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releasing molecules (CORMs).8 Such molecules are of current interest for potential
therapeutic applications, as the administration of small quantities of CO has been
shown to enhance blood vessel dilation and exhibits antimicrobial and antiinflammatory activity.9
Herein we report studies of the photoinduced CO-release reactivity of the 3Hfl complexes 1-4 (Figure 6-2). While undergoing reactions similar to those found for
5-7, low quantum yields from quenching of the flavonolate excited state result in
slower CO-release for these compounds relative to that exhibited by 5-7. The divalent
depside complexes generated upon irradiation of 1-4 (labeled as 8-11) react with 3Hfl to differing extents, suggesting that under photochemical conditions catalytic
flavonolate conversion and CO release should be possible. However, we anticipate
that such reactions will exhibit variable turnovers depending on the divalent metal ion
present.
Results and Discussion
Spectroscopic properties and UV reactivity of 1-4. Complexes 1-4 were
investigated in terms of their fluorescent emission properties. Irradiation of each
complex at 285-300 nm produces an emission at ~475 nm. The intensity of the
emission band increases when the irradiation is performed at 420 nm into the π→π*
band I of the flavonolate. Representative absorption and emission (λex = 420 nm)
spectra of 1 collected under anaerobic conditions are shown in Figure 6-3. Similar
spectra were found for 2-4. Notably, the emission intensity of these complexes is
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Figure 6-3. Absorption and emission spectra of 1.

similar and significantly lower than that exhibited by 5-7. This is a result of
quenching of the excited state by the open shell 3d metal center in 1-4.10
Irradiation of O2-purged solutions of 1-4 at 300 nm using a Rayonet photoreactor
resulted in the gradual loss of the π→π* absorption bandof the flavonolate. The total
reaction time needed for reaction completion ranged from hours for the Ni(II)
complex 3 to more than 8 days of continuous irradiation for the Cu(II) analog 4. The
quantum yield for each reaction was determined by actinometry using ferrioxalate as a
standard to measure photon flux. The values obtained (1, 2, and 4: ϕ = 0.05; 3: ϕ =
0.08) are much lower than that found for 5-7 and are consistent with the significantly
longer reaction times required completion of the reactions involving the open-shell
complexes. Sampling of the headspace gas of each reaction by GC and via the PdCl2
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method11 indicated the formation of CO. Following work-up, the depside complexes
8-11 (Scheme 6-1) were characterized by elemental analysis, 1H NMR (only 9 and
10), FTIR, mass spectrometry, and in one case (9⋅⋅0.5CH3CN) by X-ray
crystallography.
The cationic portion of 9⋅⋅0.5CH3CN is shown in Figure 6-4. A summary of
the X-ray data collection is given in Table 6-1, selected bond distances and angles are
given in Table 6-2. The geometry surrounding the Co(II) center is a distorted trigonal
bipyramid (τ = 0.80)12 with the depside coordinated monodentate in an axial position.
The Co(II)-NPhPy and Co-NPy bonds are similar to those found in the Co(II)
flavonolate complex 2.

Figure 6-4. Thermal ellipsoid drawing of the cationic portion of 9⋅⋅0.5CH3CN.
Ellipsoids are drawn at the 50% probability level. Hydrogen atoms are omitted for
clarity.
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Table 6-1. Summary of X-ray data collection and parameters for 9.
9⋅⋅0.5CH3CN
Empirical formula

C45H36.50ClCoN4.50O8

Mr

862.67

Crystal system

Monoclinic

Space group

C2/c

a/ Å

31.0219(6)

b/ Å

11.0735(2)

c/ Å

23.9944(5)

α /°

90

β /°

106.9654(10)

γ /°

90

V / Å3

7883.9(3)

Z

8
-3

Dc / Mg m

1.454

T/K

150(1)

Color

Green

Crystal habit

Prism

Crystal size/ mm

0.30 x 0.28 x 0.15

Diffractometer

Nonius KappaCCD

µ/ (mm-1)

0.566

2θ max /°

55.00

Completeness to θ (%)

99.5

Reflections collected

16568

Independent reflections

9028

Rint

0.0417

Variable parameters
R1 / wR2

b

0.0894/0.1330

Goodness-of-fit (F2)
-3

∆ρmax/min / e Å
a

544

1.036
0.675/-0.624

Radiation used: Mo Kα (λ = 0.71073 Å) bR1 = ∑ | |Fo| - |Fc| | / ∑ |Fo|; wR2 = [∑[w(Fo2Fc2)2]/[∑(Fo2)2]]1/2, where w = 1/[σ2(Fo2) + (aP)2 + bP].
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Table 6-2. Selected Bond Distances (Å) and Angles (°) for 9.
Co – N(1)

2.105(2)

Co – N(2)

2.177(2)

Co – N(3)

2.120(2)

Co – N(4)

2.110(2)

Co – O(1)

1.9460(17)

N(1) – Co – O(1)

100.35(8)

N(1) – Co – N(2)

76.53(9)

N(1) – Co – N(3)

110.42(9)

N(1) – Co – N(4)

123.49(9)

N(2) – Co – N(3)

76.91(9)

N(2) – Co – N(4)

74.92(9)

N(2) – Co – O(1)

176.42(8)

N(3) – Co – N(4)

109.07(9)

N(3) – Co – O(1)

106.01(8)

(4) – Co – O(1)

105.73(8)

Complexes 9 and 10 are amenable to investigation by 1H NMR using
paramagnetic parameters. The spectral features of analytically pure 9 are shown in
Figure 6-5 (middle), along with the spectral features of [(6-Ph2TPA)Co(3-Hfl)]ClO4
(2, Figure 6-5 (top)). Assignment of ligand-based resonances in the spectra of 2 and
9 will require additional studies using deuterated versions of the 6-Ph2TPA ligand.
However, the pattern of resonances exhibited by the compounds is sufficiently
different to indicate that 1H NMR will be useful in examining interconversions of
these compounds (vide infra). The 1H NMR spectrum of the Ni(II) flavonolate and
depside complexes (3 and 10) are shown in the top and middle portions of Figure 66, respectively. Based on prior 1H NMR studies of Ni(II) complexes supported by the
6-Ph2TPA ligand, assignment of the β, β’, and γ protons of the pyridyl rings can be
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Figure 6-5. Features of the 1H NMR spectra of [(6-Ph2TPA)Co(3-Hfl)]ClO4 (2, top),
[(6-Ph2TPA)Co(O-bs)]ClO4 (9, middle), and 9 upon treatment with one equivalent of
3-Hfl in CD3CN (bottom).

Figure 6-6. Features of the 1H NMR spectra of [(6-Ph2TPA)Ni(3-Hfl)]ClO4 (3, top),
[(6-Ph2TPA)Ni(O-bs)]ClO4 (10, middle), and 10 upon treatment with one equivalent
of 3-Hfl in CD3CN (bottom).

made on the basis of chemical shift and integrated intensity.13 The features of the
depside complex 10 in the region of 30-55 ppm are generally similar to those
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exhibited by the benzoate complex [(6-Ph2TPA)Ni(O2CPh)]ClO4, the structure of
which contains a bidentate benzoate ligand in the absence of water.14
Evaluation of reactivity of depside complexes with 3-Hfl. Speier et al. have
previously reported that various Cu(II) 3-Hfl complexes can serve as catalysts for the
oxidative degradation of the flavonol under thermal conditions.15 We are interested in
determining whether catalytic activity is possible under photochemical conditions
with various metal 3-Hfl complexes. As a prelude to catalytic studies, we have
examined the reactivity of the depside complexes 8-11 with 3-Hfl using UV-vis, and
in two cases ([(6-Ph2TPA)Co(O-bs)]ClO4 (9) and [(6-Ph2TPA)Ni(O-bs)]ClO4 (10),
using 1H NMR. The UV-vis spectra of the reactions of 8-11 with one equivalent of 3Hfl are shown in Figures 6-7 thru 6-10.

Figure 6-7. Features of the UV-vis spectra of 1, 8, and the reaction of 8 with one
equivalent of 3-Hfl in CH3CN.
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Figure 6-8. Features of the UV-vis spectra of 2, 9, and the reaction of 9 with one
equivalent of 3-Hfl in CH3CN.

Figure 6-9. Features of the UV-vis spectra of 3, 10, and the reaction of 10 with one
equivalent of 3-Hfl in CH3CN.
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Figure 6-10. Features of the UV-vis spectra of 4, 11, and the reaction of 11 with one
equivalent of 3-Hfl in CH3CN.

Comparison of the spectra reveals that all of the complexes show some regeneration
of the flavonolate complex, as determined by comparison of the absorption bands at
~420-440 nm. The Ni(II) and Cu(II) systems regenerate the flavonolate complexes to
the greatest extent, whereas the Mn(II) and Co(II) systems exhibit spectra suggesting
the presence of a significant amount of free 3-Hfl (λmax ~340 nm). The substantial
regeneration of the Ni(II) flavonolate complex 3 is also supported by 1H NMR data
(Figure 6-6(bottom)) wherein the spectral features generated match those exhibited by
analytically pure 3. In contrast, the 1H NMR data for the reaction involving the Co(II)
depside complex and 3-Hfl shows multiple species, which suggests that only partial
regeneration of 2 has been accomplished (Figure 6-5 (bottom).

191
Conclusions
Irradiation of 3-hydroxyflavonolate complexes of Mn(II), Co(II), Ni(II), and
Cu(II) supported by the 6-Ph2TPA ligand (1-4) at 300 nm results in CO release and
the formation of the corresponding depside complexes (8-11). Complexes 8-11 were
isolated and characterized by multiple methods, including X-ray crystallography in
case of complex 9. Due to quenching of the excited state by the open-shell metal ion,
the photooxidation reactions of complexes 1-4 proceed considerably slower than those
involving closed-shell metal ions. The depside complexes 8-11 were shown to react
with neutral 3-Hfl to regenerate 1-4, with complexes 3 and 4 undergoing this
regeneration to the greatest extent. This suggests that these flavonolate complexes
should exhibit catalytic CO-release reactivity under photochemical conditions, with
the highest conversion anticipated for the Ni(II)- and Cu(II)-containing systems.
Experiments
General comments. All reagents and solvents were obtained from
commercial sources and were used as received unless otherwise noted. Solvents were
dried according to published procedures and were distilled under N2 prior to use.16
Air-sensitive reactions were performed in a MBraun Unilab or Vacuum Atmospheres
glovebox under an N2 atmosphere. The flavonolate complexes 1-4 were prepared as
previously described.6
Physical methods. UV-vis spectra were recorded on a Hewlett-Packard 8453
diode array spectrophotometer. Fluorescence emission spectra were obtained using a
Shimadzu RF-530XPC spectrometer in the range of 250-900 nm with excitation
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wavelength corresponding to the absorption maximum of the complex above 400 nm.
The excitation and emission slit widths were set at 5 nm for all experiments. Reaction
quantum yield measurements were determined using actinometry with ferrioxalate as
a standard to measure photon flux.17 IR spectra were recorded on a Shimadzu FTIR8400 spectrometer as KBr pellets. 1H NMR spectra of paramagnetic species were
recorded on a Bruker ARX-400 spectrometer as previously described and the
chemical shifts (in ppm) are referenced to the residual solvent peak(s) in CHD2CN
(1H, 1.94 (quintet) ppm).12 Elemental analyses were performed by Atlantic Microlabs
Inc., Norcross, GA.

Caution! Perchlorate salts of metal complexes with organic ligands are
potentially explosive. Only small amounts of material should be prepared, and these
should be handled with great care.18

Irradiation of 1-4 with UV light. Isolation and characterization of 8-11. A
solution of each complex (1-4, ~5 x 10-3 M) was dissolved in 10 mL of acetonitrile
and transferred to a round-bottomed flask. The flask was purged with O2 for 40 s and
then inserted into a UV reactor. The reaction progress was periodically evaluated
using UV-vis spectroscopy by measuring the intensity of the absorption of the metalbound flavonolate at λmax ~420-440 nm. After each reaction reached completion, the
solvent was evaporated under reduced pressure. The remaining residue was then
dissolved in a minimal amount of acetonitrile. Addition of excess diethyl ether
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resulted in the deposition of powders of 8-11. Each powdered sample was
subsequently dried under vacuum. Crystals of 9 suitable for a single crystal X-ray
diffraction study were obtained via diffusion of diethyl ether into a dilute solution of
the complex at room temperature.
[(6-Ph2TPA)Mn(O-bs)]OTf·0.25CH2Cl2 (8). Green/beige powder. Yield:
74% Anal. Calcd for C45H35F3MnN4O7S·0.25CH2Cl2: C, 55.36; H, 3.78; N, 5.57.
Found: C, 55.48; H, 4.00; N, 5.76. FTIR (KBr, cm-1): 1736 (νC=O). ESI/APCI-MS, m/z
(relative intensity) 738.2049 ([M-OTf]+, 1.8%).
[(6-Ph2TPA)Co(O-bs)]ClO4·0.2H2O (9). Green crystals. Yield: 88%. Anal.
Calcd for C44H35ClCoN4O8·0.2H2O: C, 60.18; H, 4.48; N, 6.38. Found: C, 60.45; H,
4.22; N, 6.26. FTIR (KBr, cm-1): 1736 (νC=O). ESI/APCI-MS, m/z (relative intensity)
742.1982 ([M-ClO4]+, 100%).
[(6-Ph2TPA)Ni(O-bs)]ClO4·2H2O·0.6ACN (10). Beige/pink powder. Yield:
78%. Anal. Calcd for C44H35ClN4NiO8·2H2O·0.6ACN: C, 60.15; H, 4.56; N, 7.14.
Found: C, 60.57; H, 4.34; N, 7.46. FTIR (KBr, cm-1): 1736 (νC=O). ESI/APCI-MS, m/z
(relative intensity) 741.1995 ([M-ClO4]+, 100%).
[(6-Ph2TPA)Cu(O-bs)]ClO4·3H2O·0.9ACN (11). Blue crystals. Yield: 85%.
Anal. Calcd for C44H35ClCuN4O8·3H2O·0.9ACN: C, 58.66; H, 4.70; N, 7.32. Found:
C, 58.71; H, 4.07; N, 7.32. FTIR (KBr, cm-1): 1736 (νC=O). ESI/APCI-MS, m/z
(relative intensity) 746.1952 ([M-ClO4]+, 48%).
X-ray Crystallography. A single crystal of 9⋅⋅0.5CH3CN was mounted on a
glass fiber using a viscous oil and then was transferred to a Nonius Kappa CCD for
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data collection at 150(1) K. Methods for determination of cell constants and unit cell
refinement have been previously reported.19 The structure was solved using a
combination of direct methods and heavy atom using SIR 97. All non-hydrogen atoms
were refined with anisotropic displacement coefficients.
Structure Solution and Refinement. Complex 9⋅⋅0.5CH3CN crystallizes in
the space group C2/c with three oxygen atoms of the perchlorate anion exhibiting
disorder.
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CHAPTER 7
SUMMARY

Since their first introduction in 2002, CO-releasing molecules (CORMs) have
attracted a significant amount of attention as potential therapeutic agents. However,
the vast majority of known CORMs involve carbonyl groups coordinated on toxic
metal centers. Moreover, currently, there is little or no control over the time and
dosage of carbon monoxide released from existing CORMs. In the Berreau group, we
are interested in elucidating factors influencing CO release from bioinspired and
biofriendly molecules. The work described in this dissertation presented our
contribution to understanding multiple aspects affecting the coordination and
stabilization of acireductone and flavonolate anions on metal centers, as well as
subsequent CO release from these moieties.
We have shown that both secondary coordination sphere alterations and the
identity of the metal ion influence the coordination of the enolate acireductone-type
moiety to a metal center. Even though the influence of the secondary environment on
the coordination and reactivity of exogenous ligands is widely recognized, our
laboratory is the first to determine how alterations in the supporting ligand affect the
formation of Ni(II)-enolate species of relevance to acireductone dioxygenases.
Notably, the identity of the metal center plays a crucial role in the chemistry of the
ARD enzyme. Although apo-ARD can be reconstituted with either Ni(II) or Co(II) to
yield the same type of reactivity, we have shown that synthetic model complexes of
these forms of the enzyme show considerable metal-dependence in their ability to
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stabilize the enolate anion. Our research has also highlighted the influence of water on
the aforementioned process. These results will benefit the design of new structural
and functional models of the acireductone dioxygenase enzyme, which is one of only
a few enzymes known to release CO.
In another study we have synthesized the first series of divalent metalflavonolate complexes supported by the same chelate ligand 6-Ph2TPA. This has
allowed us to evaluate the influence of the metal center on the coordination properties
and spectroscopic features of a metal-coordinated flavonolate moiety. We have shown
that these complexes exhibit photo-induced CO-release reactivity that is highly
dependent on the metal electron configuration, with d10 metals such as the Zn(II)containing complex exhibiting in the most rapid CO release. This result is interesting
for several reasons. First, we have shown that the photo-induced CO release can be
accomplished from metal-bound flavonolate anion. Second, use of a bio-relevant COrelease molecule (flavonol) and a bio-friendly metal such as Zn(II), is a significant
step toward developing a new class of biofriendly CO-releasing molecules.
The next stage of the research will need to involve the generation of analogs of
[(6-Ph2TPA)Zn(3-Hfl)]X wherein modulation in the supporting chelate ligand and
flavonolate improve the biological-relevant features (e.g. solubility, absorption
properties) of the complex. CO generated from each of these new complexes will
need to be quantified, and the half-life of each CO-release reaction determined. This
will enable comparison of CO-release reactivity with previously reported CORMs.
Additionally, collaborations with other laboratories should be established to perform

199
tests with the synthetic zinc flavonolate complexes that are pertinent to living
subjects. Such tests include examining the effect of irradiation of the complex (to
induce CO release) on the: 1) modification of K+-channels, 2) vasodilation of mouse
aorta, and 3) photoinduced cytotoxicity against cancer cells, to name a few. The
results of these tests will provide insight into the feasibility of the use of zinc
flavonolate complexes as CORMs.
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